2025 Annual Meeting | P1 - Poster Session 01
Program Materials Program Evaluations
| Thomas Gossard, MD | Mr. Gossard has nothing to disclose. |
| Aivi Nguyen | Aivi Nguyen has nothing to disclose. |
| David S. Knopman, MD, FAAN | Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH. |
| Diego Z. Carvalho, MD | Dr. Carvalho has nothing to disclose. |
| Erik K. St. Louis, MD | The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care. |
| Hugo Botha, MD | Dr. Botha has received research support from NIH. An immediate family member of Dr. Botha has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. |
| David T. Jones, MD | Dr. Jones has stock in Cephlodyne Neurotechnologies, Inc.. Dr. Jones has received intellectual property interests from a discovery or technology relating to health care. |
| Vijay K. Ramanan, MD, PhD | The institution of Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daridorexant trial for AD prevention (funded by Weston Family Foundation). The institution of Dr. Ramanan has received research support from the National Institutes of Health. The institution of Dr. Ramanan has received research support from the Mangurian Foundation for Lewy Body Disease Research. The institution of Dr. Ramanan has received research support from as part of clinical trials sponsored by the Alzheimer's Association, Eisai, the Alzheimer's Treatment and Research Institute at USC, and Transposon Therapeutics, Inc.. The institution of Dr. Ramanan has received research support from Medscape. The institution of Dr. Ramanan has received research support from Expert Perspectives in Medicine. The institution of Dr. Ramanan has received research support from Roche/ADLM. The institution of Dr. Ramanan has received research support from American College of Radiology. Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving as a Conference Speaker/Organizer (Honoraria) with AANI. Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving as a Speaker/CME Content with Clinical Care Options. |
| Toji Miyagawa, MD, PhD | Dr. Miyagawa has nothing to disclose. |
| Rodolfo Savica, MD, PhD, FAAN | The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc. |
| Kris A. Johnson, RN | Ms. Johnson has nothing to disclose. |
| Tanis J. Ferman, PhD | Ms. Ferman has nothing to disclose. |
| Julie A. Fields, PhD | The institution of Dr. Fields has received research support from National Institutes of Health. The institution of Dr. Fields has received research support from Patient-Centered Outcomes Research Institute. |
| Mary M. Machulda, PhD | The institution of Dr. Machulda has received research support from NIH. |
| Melissa Murray, PhD | Dr. Murray has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avid Radiopharmaceuticals. The institution of Dr. Murray has received research support from National Institute on Aging. The institution of Dr. Murray has received research support from Alzheimer's Association. The institution of Dr. Murray has received research support from Chan Zuckerberg Initiative. |
| Prashanthi Vemuri, PhD | The institution of Dr. Vemuri has received research support from NIH. |
| Jonathan Graff-Radford, MD, FAAN | Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD . |
| Dennis W. Dickson, MD | Dr. Dickson has nothing to disclose. |
| Ross Reichard | Ross Reichard has nothing to disclose. |
| Ronald C. Petersen, MD, PhD, FAAN | Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities. |
| Bradley F. Boeve, MD, FAAN | Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care. |
| Stuart J. McCarter, MD | The institution of Dr. McCarter has received research support from NIH. The institution of Dr. McCarter has received research support from American Academy of Sleep Medicine Foundation. |
| Andreu Vilaseca-Jolonch, MD | Dr. Vilaseca-Jolonch has received research support from Fundación Martín Escudero. |
| Ana Zabalza, MD, PhD | Dr. Zabalza has nothing to disclose. |
| Gloria Iacoboni, MD, PhD | Ms. Iacoboni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, AstraZeneca, Autolus, Bristol-Myers Squibb, Kite/Gilead, Miltenyi, Novartis. |
| Cecilia Carpio, MD | Dr. Carpio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Carpio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Carpio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Carpio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Carpio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Carpio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Carpio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. Dr. Carpio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Carpio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Gilead. Dr. Carpio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Carpio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Carpio has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Regeneron. |
| Mario Sánchez | No disclosure on file |
| Helena Arino, MD, PhD | Dr. Arino has nothing to disclose. |
| Xavier Montalban, MD, PhD, FAAN | The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene. |
| pere barba, MD, PhD | Dr. barba has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. barba has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kite. Dr. barba has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. |
| Angela Vidal Jordana | Ms. Vidal Jordana has nothing to disclose. |
| Mar Tintoré, MD, PhD | The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche . The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela bio. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parexel and UCB Biopharma. Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal: Experimental, Translational and Clinical. The institution of Mar Tintoré, MD, PhD has received research support from Fundació La Marató de TV3. The institution of Mar Tintoré, MD, PhD has received research support from Instituto de Salud Carlos III. The institution of Mar Tintoré, MD, PhD has received research support from Instituto de Salud Carlos III. The institution of Mar Tintoré, MD, PhD has received research support from Instituto de Salud Carlos III. |
| Samantha Feijoo, MD | Dr. Feijoo has nothing to disclose. |
| Maria-Jesus Arevalo | Maria-Jesus Arevalo has nothing to disclose. |
| Christopher A. Scheiner, MD, PhD | Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Scheiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx Pharmaceuticals. Dr. Scheiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansssen. Dr. Scheiner has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for CSL Behring . Dr. Scheiner has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Scheiner has received research support from Alexion Pharmaceuticals . |
| Samir P. Macwan, MD | Dr. Macwan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion,Argenx,Grifols,Kabafusion, UCB. Dr. Macwan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie,Alexion,Argenx,Grifols and UCB. The institution of Dr. Macwan has received research support from Alexion, Argenx,Immunovant, UCB. |
| Nicholas S. Streicher, MD | Dr. Streicher has nothing to disclose. |
| Karen Yee, PhD | Dr. Yee has received personal compensation for serving as an employee of Alexion. Dr. Yee has stock in Alexion. Dr. Yee has stock in Takeda. |
| Chloe S. Sader, PharmD | Chloe Sader has received personal compensation for serving as an employee of Alexion. Chloe Sader has received stock or an ownership interest from Alexion. |
| Michael Blackowicz, PhD | Dr. Blackowicz has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Dr. Blackowicz has stock in Alexion Pharmaceuticals. |
| Nana Numapau | Nana Numapau has received personal compensation for serving as an employee of Alexion Pharmaceutical. |
| Danielle Gentile | Dr. Gentile has received personal compensation for serving as an employee of Cardinal Health. |
| Prathamesh Pathak, MS, BPharm | Mr. Pathak has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cardinal Health. |
| Michael T. Pulley, MD, PhD, FAAN | Dr. Pulley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for csl/behring. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta. Dr. Pulley has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Multiple law firms. |
| Jason Sharpe, PhD, PT | Dr. Sharpe has received personal compensation for serving as an employee of Department of Veterans Affairs. Dr. Sharpe has received personal compensation for serving as an employee of Cardinal Health. Dr. Sharpe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with University of North Carolina. |
| Michelle Manzo | Ms. Manzo has received personal compensation for serving as an employee of UCB Pharma. Ms. Manzo has stock in UCB Pharma. |
| Gus Baker | No disclosure on file |
| Agnes Koncz, MD, PhD | Dr. Koncz has received personal compensation for serving as an employee of UCB. |
| Michelle Shell | Michelle Shell has received personal compensation for serving as an employee of UCB Pharma. Michelle Shell has received personal compensation for serving as an employee of UCB Pharma. |
| Konrad Werhahn | Konrad Werhahn has received personal compensation for serving as an employee of UCB Pharma. Konrad Werhahn has stock in UCB Pharma. |
| Andrea L. Wilkinson, BA | Ms. Wilkinson has received personal compensation for serving as an employee of UCB. Ms. Wilkinson has or had stock in UCB. |
| Jessica K. Smith, NA | Ms. Smith has nothing to disclose. |
| Dimitrios Bourikas | Dr. Bourikas has nothing to disclose. |
| Mark Dibbs | Mr. Dibbs has nothing to disclose. |
| Jeremy Moeller, MD, FAAN | Dr. Moeller has received publishing royalties from a publication relating to health care. |
| Muhammad W. Ansari, MD | Dr. Ansari has nothing to disclose. |
| Hassan Waseem | Hassan Waseem has nothing to disclose. |
| Zain U. Abideen, MBBS | Dr. Abideen has nothing to disclose. |
| Muhammad Fawad Tahir, MBBS | Dr. Fawad Tahir has nothing to disclose. |
| Rowaid Ahmad, MBBS | Dr. Ahmad has nothing to disclose. |
| Sania Aimen, MBBS | Dr. Aimen has nothing to disclose. |
| Jessica Ailani, MD, FAAN | Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspya. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kallyope. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Self Magazine. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. The institution of Dr. Ailani has received research support from Lundbeck. The institution of Dr. Ailani has received research support from Merz. The institution of Dr. Ailani has received research support from Pfizer. Dr. Ailani has received research support from Mi-Helper. The institution of Dr. Ailani has received research support from ShiraTronic. Dr. Ailani has a non-compensated relationship as a Executive Board Member with American Headache Society that is relevant to AAN interests or activities. |
| Krutika Jariwala-Parikh, PhD | Dr. Jariwala-Parikh has received personal compensation for serving as an employee of AbbVie. Dr. Jariwala-Parikh has stock in AbbVie. |
| Amanda Howarth | Miss Howarth has nothing to disclose. |
| Lauren Wilson | Lauren Wilson has nothing to disclose. |
| Molly Duan | Molly Duan has received personal compensation for serving as an employee of AbbVie. |
| Amit Bodhani, Other | Mr. Bodhani has received personal compensation for serving as an employee of AbbVie. Mr. Bodhani has stock in AbbVie. |
| Richard B. Lipton, MD, FAAN | Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care. |
| Alexandra R. Balshi | Ms. Balshi has nothing to disclose. |
| John Dempsey, BA | Mr. Dempsey has nothing to disclose. |
| Jacob A. Sloane, MD, PhD | Dr. Sloane has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for biogen. Dr. Sloane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sloane has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. |
| Nova Manning | Miss Manning has nothing to disclose. |
| Chiahao Lu, PhD | Dr. Lu has received personal compensation for serving as an employee of Cala health. |
| Dingwei Dai, MD, PhD | Dr. Dai has nothing to disclose. |
| Joaquim Fernandes | Mr. Fernandes has stock in AstraZeneca. Mr. Fernandes has stock in Insmead. Mr. Fernandes has stock in Novavax. |
| Leena Samuel | No disclosure on file |
| Alexandra Berk | No disclosure on file |
| Samantha Reitmaier | Samantha Reitmaier has received personal compensation for serving as an employee of Cala Health. |
| Alon Gorenshtein | Mr. Gorenshtein has nothing to disclose. |
| Shiri Fistel, Msc | Mrs. Fistel has nothing to disclose. |
| Moran Sorka, PhD | Mrs. Sorka has nothing to disclose. |
| Shahar Shelly, MD | Dr. Shelly has or had stock in Remepy. |
| Alireza Atri, MD, PhD | Dr. Atri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prothena. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Atri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Life Molecular Imaging. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Atri has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lunbeck. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO. Dr. Atri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AriBio. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaxxinity. The institution of Dr. Atri has received research support from National Institute of Aging (NIA). The institution of Dr. Atri has received research support from AZ Department of Health Services. The institution of Dr. Atri has received research support from Gates Ventures. The institution of Dr. Atri has received research support from Multiple companies, universities & consortia for contracted clinical trials to institution. The institution of Dr. Atri has received research support from Washington University in St. Louis. The institution of Dr. Atri has received research support from Foundation for NIH. The institution of Dr. Atri has received research support from ACTC/NIH. Dr. Atri has received publishing royalties from a publication relating to health care. |
| Bradford Dickerson, MD, FAAN | Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lantheus. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Dickerson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Dickerson has received publishing royalties from a publication relating to health care. Dr. Dickerson has received publishing royalties from a publication relating to health care. |
| Akio Kimura, MD | Dr. Kimura has nothing to disclose. |
| Takayoshi Shimohata, MD, FAAN | Dr. Shimohata has nothing to disclose. |
| Yasushi Shiba, MD | Dr. Shiba has nothing to disclose. |
| Akira Takekoshi | Akira Takekoshi has nothing to disclose. |
| Hiroshi Shimizu, MD, PhD | Dr. Shimizu has nothing to disclose. |
| Elizabeth A. Coon, MD, FAAN | Dr. Coon has received publishing royalties from a publication relating to health care. Dr. Coon has a non-compensated relationship as a Non-Voting Member of the Board of Directors with UCNS that is relevant to AAN interests or activities. |
| Rikki Cunningham, MD | Dr. Cunningham has nothing to disclose. |
| Claudia Z. Chou, MD | Dr. Chou has nothing to disclose. |
| Lauren Jackson, MD | Dr. Jackson has nothing to disclose. |
| Laura Rhee, DO | Dr. Rhee has nothing to disclose. |
| Negin Badihian, MD | Dr. Badihian has nothing to disclose. |
| Erin D'Agostino, MD | Dr. D'Agostino has nothing to disclose. |
| Sabrina J. Wirth, MD | Dr. Wirth has nothing to disclose. |
| Leland H. Nguyen, MD | Mr. Nguyen has nothing to disclose. |
| Alissa A. Thomas, MD, FAAN | The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals. |
| Michael Gilligan, MBBS | Dr. Gilligan has nothing to disclose. |
| John R. Mills, MD, PhD | The institution of Dr. Mills has received research support from Werfen Diagnostics. Dr. Mills has received intellectual property interests from a discovery or technology relating to health care. |
| Connie Lesnick | Connie Lesnick has nothing to disclose. |
| Surendra Dasari | Surendra Dasari has nothing to disclose. |
| Eati Basal | Eati Basal has nothing to disclose. |
| Reghann LaFrance-Corey | Miss LaFrance-Corey has nothing to disclose. |
| Anastasia Zekeridou, MD, PhD, FAAN | The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. |
| Sean J. Pittock, MD, FAAN | Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care. |
| Andrew McKeon, MD | The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care. |
| Paulina Vargas | Ms. Vargas has nothing to disclose. |
| Naveen K. Paramasivan, MD | Dr. Paramasivan has nothing to disclose. |
| Divyanshu Dubey, MD, FAAN | The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. |
| Melissa M. Cortez, DO | The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Dysautonomia International. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project. |
| Kelsi Schiltz, PT | Dr. Schiltz has nothing to disclose. |
| Kathryn Johnson, PT | Dr. Johnson has nothing to disclose. |
| Ryan Pelo, PhD, PT | Dr. Pelo has nothing to disclose. |
| Lauren J. Ziaks, PT | Dr. Ziaks has nothing to disclose. |
| mohammad almomani, MD | Dr. almomani has nothing to disclose. |
| Ibrahim H. Lafi, MD | Dr. Lafi has nothing to disclose. |
| Balaji Krishnaiah, MD, FAAN | Dr. Krishnaiah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ACP. Dr. Krishnaiah has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Merck Manual. Dr. Krishnaiah has received publishing royalties from a publication relating to health care. |
| Nariman Noorbakhsh Sabet, MD | Dr. Noorbakhsh Sabet has nothing to disclose. |
| Danny J. Japon | Mr. Japon has nothing to disclose. |
| Tito D. Mendoza | Mr. Mendoza has nothing to disclose. |
| Alicia A. Velez | Miss Velez has nothing to disclose. |
| Carlos A. Rodríguez Alarcón, MD | Dr. Rodríguez Alarcón has nothing to disclose. |
| Hector David Meza Comparan, MD | Dr. Meza Comparan has nothing to disclose. |
| Beulah Augustin, MD | Dr. Augustin has nothing to disclose. |
| Luciola Martins Frota, MD | Dr. Martins Frota has nothing to disclose. |
| Michael Mathelier, BS | Mr. Mathelier has nothing to disclose. |
| Anum Khaliq, MD | Dr. Khaliq has nothing to disclose. |
| Daniela Pomar Forero, MD | Ms. Pomar Forero has nothing to disclose. |
| Bakhtawar Ahmad, MBBS | Dr. Ahmad has nothing to disclose. |
| Rodrigo F. Alcala Arana, Medical Student | Dr. Alcala Arana has nothing to disclose. |
| Mary E. Edwards, EdD | Dr. Edwards has received publishing royalties from a publication relating to health care. |
| Carolina B. Maciel, MD, MSCR, FAAN | Dr. Maciel has received research support from American Heart Association. Dr. Maciel has received research support from National Institute of Health. |
| Katharina M. Busl, MD, MS, FAAN | Dr. Busl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rissman Law. Dr. Busl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Huffman Powell Baley. Dr. Busl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for University Science. Dr. Busl has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SCCM. Dr. Busl has a non-compensated relationship as a Board Member with Art in Medicine that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Associate Editor with Critical Care Explorations that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Assistant Editor with Neurocritical Care that is relevant to AAN interests or activities. |
| Mark Hallett, MD, FAAN | Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Hallett has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainsway. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VoxNeuro. Dr. Hallett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for QuantalX. Dr. Hallett has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hallett has received intellectual property interests from a discovery or technology relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorder Society. Dr. Hallett has a non-compensated relationship as a Past-President with Functional Neurological Disorder Society that is relevant to AAN interests or activities. |
| Elizabeth L. Peckham, DO | The institution of Dr. Peckham has received research support from abbvie. The institution of Dr. Peckham has received research support from lilly. The institution of Dr. Peckham has received research support from Amlyx. The institution of Dr. Peckham has received research support from Cerevel. The institution of Dr. Peckham has received research support from Sage. The institution of Dr. Peckham has received research support from Annovis. The institution of Dr. Peckham has received research support from AriBio. The institution of Dr. Peckham has received research support from Ferrer. The institution of Dr. Peckham has received research support from Biogen. The institution of Dr. Peckham has received research support from UCB. The institution of Dr. Peckham has received research support from Roche. The institution of Dr. Peckham has received research support from Cerevance. The institution of Dr. Peckham has received research support from Aptinyx. |
| Winona W. Tse, MD | Dr. Tse has nothing to disclose. |
| Rajesh Pahwa, MD, FAAN | Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Neuroderm. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Blue Rock. The institution of Dr. Pahwa has received research support from Cerevance. The institution of Dr. Pahwa has received research support from Fasikl. The institution of Dr. Pahwa has received research support from Scion. The institution of Dr. Pahwa has received research support from UCB. The institution of Dr. Pahwa has received research support from Ono. The institution of Dr. Pahwa has received research support from Intra-cellular Therapies. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Michael J Fox Foundation . The institution of Dr. Pahwa has received research support from Neuron 23. The institution of Dr. Pahwa has received research support from Roche. |
| Holly A. Shill, MD, FAAN | Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc. Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. |
| Jessica Tate, MD | The institution of Dr. Tate has received research support from Ipsen. The institution of Dr. Tate has received research support from Boston Scientific. The institution of Dr. Tate has received research support from Revance Therapeutics. The institution of Dr. Tate has received research support from CHDI Foundation. The institution of Dr. Tate has received research support from NINDS. The institution of Dr. Tate has received research support from Michael J. Fox Foundation. |
| Rohit Dhall, MD, FAAN | Dr. Dhall has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Best Doctors Inc. Dr. Dhall has stock in Verve Therapeutics Inc. Dr. Dhall has stock in Roche Holding Limited. Dr. Dhall has stock in Enliven Therapeutics Inc. The institution of Dr. Dhall has received research support from Amneal. The institution of Dr. Dhall has received research support from Neuroderm. The institution of Dr. Dhall has received research support from Cerevel Therapeutics. The institution of Dr. Dhall has received research support from Neurocrine. The institution of Dr. Dhall has received research support from Neuraly. The institution of Dr. Dhall has received research support from SPARC. The institution of Dr. Dhall has received research support from Pharma2B. The institution of Dr. Dhall has received research support from Alexion. The institution of Dr. Dhall has received research support from Parkinsons Foundation. The institution of Dr. Dhall has received research support from UCB Pharma. The institution of Dr. Dhall has received research support from Inhibikase Therapeutics. The institution of Dr. Dhall has received research support from Amylyx Pharma. |
| Pinky H. Agarwal, MD, FAAN | Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals Inc. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion Pharmaceuticals. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AskBio. An immediate family member of Dr. Agarwal has stock in ALDEYRA THERAPEUTICS INC. An immediate family member of Dr. Agarwal has stock in Curis Inc. An immediate family member of Dr. Agarwal has stock in Citius Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Fortress Biotech. An immediate family member of Dr. Agarwal has stock in TG Therapeutics. An immediate family member of Dr. Agarwal has stock in ATYR PHARMA INC . An immediate family member of Dr. Agarwal has stock in CORVUS PHARMACEUTICALS INC . An immediate family member of Dr. Agarwal has stock in LAVA THERAPEUTICS . An immediate family member of Dr. Agarwal has stock in OVID THERAPEUTICS INC . An immediate family member of Dr. Agarwal has stock in TERNS PHARMACEUTICALS INC. An immediate family member of Dr. Agarwal has stock in VIKING THERAPEUTICS INC. Dr. Agarwal has stock in WAVE LIFE SCIENCES LTD. An immediate family member of Dr. Agarwal has stock in ProQr Therapeutics. An immediate family member of Dr. Agarwal has stock in Mind Medicine. An immediate family member of Dr. Agarwal has stock in Lyra Therapeutics. An immediate family member of Dr. Agarwal has stock in Larimer Therapeutics. An immediate family member of Dr. Agarwal has stock in Lantern Pharma. An immediate family member of Dr. Agarwal has stock in Black Diamond Therapeutics. An immediate family member of Dr. Agarwal has stock in Amylyx Pharma. An immediate family member of Dr. Agarwal has stock in Palisade Bio. An immediate family member of Dr. Agarwal has stock in Inozyme Pharma. An immediate family member of Dr. Agarwal has stock in Pyxis Oncology. An immediate family member of Dr. Agarwal has stock in Vertex Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Vyne Therapeutics. An immediate family member of Dr. Agarwal has stock in Reviva Pharmaceuticals Hld. An immediate family member of Dr. Agarwal has stock in Immuneering Corp. An immediate family member of Dr. Agarwal has stock in Imunon Inc. An immediate family member of Dr. Agarwal has stock in Enlivex Therapeutics. An immediate family member of Dr. Agarwal has stock in Candel Therapeutics. An immediate family member of Dr. Agarwal has stock in Applied Digital Corp. An immediate family member of Dr. Agarwal has stock in Atai Life Sciences. An immediate family member of Dr. Agarwal has stock in Adma Biologics. The institution of Dr. Agarwal has received research support from Biogen . The institution of Dr. Agarwal has received research support from CHDI Foundation. The institution of Dr. Agarwal has received research support from Eli Lilly. The institution of Dr. Agarwal has received research support from MJ Fox. The institution of Dr. Agarwal has received research support from Roche . The institution of Dr. Agarwal has received research support from Supernus. The institution of Dr. Agarwal has received research support from Nova Nordisc. The institution of Dr. Agarwal has received research support from Inhibikase. The institution of Dr. Agarwal has received research support from Intracellular therapeurtics. |
| Melita T. Petrossian, MD | An immediate family member of Dr. Petrossian has received personal compensation for serving as an employee of Nile AI. An immediate family member of Dr. Petrossian has received personal compensation for serving as an employee of Neurolutions. Dr. Petrossian has received personal compensation for serving as an employee of Kandu Health. Dr. Petrossian has stock in Kandu Health. An immediate family member of Dr. Petrossian has stock in Nile AI. An immediate family member of Dr. Petrossian has stock in Neurolutions. An immediate family member of Dr. Petrossian has stock in Nova Signal. An immediate family member of Dr. Petrossian has stock in Imperative Care. The institution of Dr. Petrossian has received research support from Praxis. The institution of Dr. Petrossian has received research support from NIH. |
| Mark F. Lew, MD, FAAN | Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for kyowa. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for neurocrine. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RegenXBio. Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyowa. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Lew has received research support from MJFF. Dr. Lew has received research support from NIH. |
| William Ondo, MD | Dr. Ondo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. The institution of Dr. Ondo has received research support from Cerevel. The institution of Dr. Ondo has received research support from SCION. The institution of Dr. Ondo has received research support from Harmony. Dr. Ondo has received publishing royalties from a publication relating to health care. |
| Kathryn H. Rosenbluth, PhD | Dr. Rosenbluth has received personal compensation for serving as an employee of Cala Health. Dr. Rosenbluth has stock in Cala Health. |
| Catherine Lawton, MD | Ms. Lawton has nothing to disclose. |
| Meg Mendoza, PhD | Dr. Mendoza has nothing to disclose. |
| Mark J. Kupersmith, MD, FAAN | Dr. Kupersmith has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal firms. Dr. Kupersmith has stock in SafeTherapeutics m,LLC. The institution of Dr. Kupersmith has received research support from NEI, NYEEI FDN, Shulman Family NAION fund. Dr. Kupersmith has received intellectual property interests from a discovery or technology relating to health care. |
| Ali G. Hamedani, MD, MHS | Dr. Hamedani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Hamedani has received personal compensation in the range of $0-$499 for serving as a Consultant for LoQus23. The institution of Dr. Hamedani has received research support from NIH. The institution of Dr. Hamedani has received research support from Biogen. The institution of Dr. Hamedani has received research support from Biohaven. |
| Gil I. Wolfe, MD, FAAN | Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Wolfe has received research support from UCB/Ra. The institution of Dr. Wolfe has received research support from Immunovant. The institution of Dr. Wolfe has received research support from Roche. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving as a Advisor with FDA Advisory Panel for Cellular, Tissue and Genetic Therapies. |
| Joome Suh, MD | Dr. Suh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Suh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. |
| Carolina Barnett Tapia, MD | Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD pharma. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. The institution of Dr. Barnett Tapia has received research support from Department of defense. The institution of Dr. Barnett Tapia has received research support from Muscular dystrophy canada. The institution of Dr. Barnett Tapia has received research support from MgNet. The institution of Dr. Barnett Tapia has received research support from NIH. The institution of Dr. Barnett Tapia has received research support from Cartesian. The institution of Dr. Barnett Tapia has received research support from Alexion. Dr. Barnett Tapia has received intellectual property interests from a discovery or technology relating to health care. |
| Yara O. Alkhodair, Jr., MBBS | Dr. Alkhodair has nothing to disclose. |
| Tiffany W. Chow, MD, FAAN | Dr. Chow has received personal compensation for serving as an employee of Alector, Inc.. Dr. Chow has stock in Alector, Inc.. Dr. Chow has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant on grant U19AG079774 with NIA. |
| Ging-Yuek R. Hsiung, MD, FAAN | Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Hsiung has received research support from CIHR. The institution of Dr. Hsiung has received research support from NIH. The institution of Dr. Hsiung has received research support from Eli Lilly. The institution of Dr. Hsiung has received research support from Biogen. |
| Boon Lead Tee, MD | The institution of Boon Lead Tee, MD has received research support from Global Brain Health Institute. The institution of Boon Lead Tee, MD has received research support from Alzheimer's Association. |
| Pei-Chuan Ho, PhD | The institution of Dr. Ho has received research support from NIA. |
| Phoenix Au-Yeung, Bsc | Ms. Au-Yeung has nothing to disclose. |
| Wai Haung Yu, PhD | Dr. Yu has nothing to disclose. |
| Guerry M. Peavy, PhD | Dr. Peavy has stock in MRK. Dr. Peavy has stock in ABT. Dr. Peavy has stock in JNJ. Dr. Peavy has stock in ABBV. The institution of an immediate family member of Dr. Peavy has received research support from NIH. The institution of Dr. Peavy has received research support from NIH. |
| Victor W. Henderson, MD, FAAN | Dr. Henderson has stock in Abbott, Amgen, Roche. The institution of Dr. Henderson has received research support from NIH. The institution of Dr. Henderson has received research support from Health IQ. Dr. Henderson has received personal compensation in the range of $500-$4,999 for serving as a External advisory committee member, Alzheimer's Disease Center with University of Kansas. Dr. Henderson has a non-compensated relationship as a adjunct (honorary) professor with Aarhus University that is relevant to AAN interests or activities. |
| Yun-Beom Choi, MD, PhD | The institution of Dr. Choi has received research support from Department of Veterans Affairs. |
| Dolly Reyes-Dumeyer | Dolly Reyes-Dumeyer has nothing to disclose. |
| Haeok Lee, PhD, RN | Prof. Lee has nothing to disclose. |
| Walter A. Kukull, PhD, FAAN | The institution of Dr. Kukull has received research support from NIH/NIA. Dr. Kukull has a non-compensated relationship as a Associate editor with Alzheimer's and Dementia TRCI (journal) that is relevant to AAN interests or activities. Dr. Kukull has a non-compensated relationship as a Editorial board with Journal of American Geriatrics Soc that is relevant to AAN interests or activities. |
| Yian Gu, PhD | The institution of Dr. Gu has received research support from NIH. |
| Gyungah R. Jun, PhD | Dr. Jun has nothing to disclose. |
| Van T. Park, PhD | The institution of Prof. Park has received research support from NIH. |
| Collin Y. Liu, MD | Dr. Liu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai/Biogen. Dr. Liu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. |
| Li-San Wang, PhD | Dr. Wang has nothing to disclose. |
| Hamid Ali, MBBS | Dr. Ali has nothing to disclose. |
| Ghada A. Mohamed, MD | Dr. Mohamed has nothing to disclose. |
| Xueqing Zhang, MD | Dr. Zhang has nothing to disclose. |
| Ashley Waring, MD | Dr. Waring has nothing to disclose. |
| Marc-Andre Cornier, MD | Dr. Cornier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for novo nordisk. Dr. Cornier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Cornier has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biophytis. Dr. Cornier has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zyversa. The institution of Dr. Cornier has received research support from Novartis. The institution of Dr. Cornier has received research support from Amgen. The institution of Dr. Cornier has received research support from Kaneka. The institution of Dr. Cornier has received research support from Ionis. |
| Wail Abdelhamid Amroune, MD | Mr. Amroune has nothing to disclose. |
| Shatha S. Alqurashi | Ms. Alqurashi has nothing to disclose. |
| Toka A. Banjar | Miss Banjar has nothing to disclose. |
| Feras M. Alharbi | Mr. Alharbi has nothing to disclose. |
| Ahmed Alkhiri | Mr. Alkhiri has nothing to disclose. |
| Manar F. Betar, Jr., MBBS | Miss Betar has nothing to disclose. |
| Aisha Halawani, MD | Dr. Halawani has nothing to disclose. |
| Hani Mufti, MD | Dr. Mufti has nothing to disclose. |
| Mohamed Ahmed, Sr., PhD | Dr. Ahmed has nothing to disclose. |
| Danya A. Aljafari | Ms. Aljafari has nothing to disclose. |
| Seraj O. Makkawi, MBBS, FRCPC, FAAN | Dr. Makkawi has nothing to disclose. |
| John Giang, MD | Dr. Giang has nothing to disclose. |
| Anson Pierce, PhD | Dr. Pierce has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Pierce has stock in Takeda Pharmaceuticals. |
| Mike Baratta, MCAHPM | Mr. Baratta has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Mr. Baratta has stock in Takeda Pharmaceuticals. Mr. Baratta has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with FNIH. |
| Joe Palandra | Mr. Palandra has nothing to disclose. |
| Gus Hui, PhD | Dr. Hui has nothing to disclose. |
| Jian Wu, PhD | Dr. Wu has nothing to disclose. |
| Aaron Wheeler | Mr. Wheeler has nothing to disclose. |
| Walter Wiley | Mr. Wiley has nothing to disclose. |
| Michael S. Woolf, PhD | Dr. Woolf has nothing to disclose. |
| Kumar Shah | Dr. Shah has nothing to disclose. |
| Moucun Yuan, PhD | Dr. Yuan has received personal compensation for serving as an employee of PPD, part of Thermo Fisher Scientific. |
| William R. Mylott, Jr., BS | Mr. Mylott has nothing to disclose. |
| Meng Ye | No disclosure on file |
| Omnia Ismaiel | No disclosure on file |
| Shibeshih M. Belachew | Dr. Belachew has received personal compensation for serving as an employee of Indivi. |
| Corrado Bernasconi, MD, PhD | Dr. Bernasconi has received personal compensation in the range of $1,000,000+ for serving as a Consultant for Roche. Dr. Bernasconi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Indivi / Healios. Dr. Bernasconi has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Vaderis. Dr. Bernasconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Excelya / Graegis Pharmaceuticals. Dr. Bernasconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pressura Neuro. |
| Antonio J. Rodriguez Romero | Mr. Rodriguez Romero has nothing to disclose. |
| Emmanuel J. Bartholome | Emmanuel J. Bartholome has received personal compensation for serving as an employee of Indivi AG. Emmanuel J. Bartholome has received personal compensation for serving as an employee of Biogen. |
| Carlos Luque Córdoba, Sr. | Mr. Luque Córdoba has nothing to disclose. |
| Claudia Mazza, PhD | Prof. Mazza has nothing to disclose. |
| Óscar G. Reyes Pupo, PhD | Dr. Reyes Pupo has nothing to disclose. |
| Catherine W. Imossi, MD | Dr. Imossi has nothing to disclose. |
| Jonathan Howard, MD | Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MCE Conferences. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has a non-compensated relationship as a Test writer with ABPN that is relevant to AAN interests or activities. |
| Philip T. Kuball, MD | Dr. Kuball has nothing to disclose. |
| Hannah Kopinsky, MD | Dr. Kopinsky has nothing to disclose. |
| Kelsey Kline, BS | Miss Kline has nothing to disclose. |
| Tyler M. Bielinski | Mr. Bielinski has nothing to disclose. |
| Grant N. Badger | Mr. Badger has nothing to disclose. |
| Veronica Bohl | Ms. Bohl has nothing to disclose. |
| Prateeka Koul, MD | Dr. Koul has nothing to disclose. |
| Anthony Noto, MD | Dr. Noto has nothing to disclose. |
| Clemens M. Schirmer, MD, PhD | Dr. Schirmer has received personal compensation for serving as an employee of Geisinger. Dr. Schirmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Balt. Dr. Schirmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Schirmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stryker. Dr. Schirmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viz.ai. Dr. Schirmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention. Dr. Schirmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Werfen. Dr. Schirmer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Schirmer has stock in NTI. Dr. Schirmer has stock in REIST. The institution of Dr. Schirmer has received research support from NIH. The institution of Dr. Schirmer has received research support from Medtronic. The institution of Dr. Schirmer has received research support from Cerenovus. The institution of Dr. Schirmer has received research support from MIVI. The institution of Dr. Schirmer has received research support from Balt. The institution of Dr. Schirmer has received research support from Microvention. The institution of Dr. Schirmer has received research support from Stryker. The institution of Dr. Schirmer has received research support from Penumbra. The institution of Dr. Schirmer has received research support from NICO. The institution of Dr. Schirmer has received research support from Route 92. |
| Philipp Hendrix, MD, PhD | Dr. Hendrix has nothing to disclose. |
| Diva J. Agarwal | Ms. Agarwal has nothing to disclose. |
| Raina Patel, Student | Ms. Patel has nothing to disclose. |
| Mira Hassan | Miss Hassan has nothing to disclose. |
| Sabiya Azim, Jr. | Miss Azim has nothing to disclose. |
| Jonathan Santoro, MD | Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Down Syndrome Society. |
| Shermila Pia, MD | Dr. Pia has nothing to disclose. |
| Saba Jafarpour, MD | Dr. Jafarpour has nothing to disclose. |
| Adam Lu, MD, PhD | Dr. Lu has nothing to disclose. |
| Mellad Khoshnood, MD | Dr. Khoshnood has nothing to disclose. |
| Laura Saucier, MD | Dr. Saucier has nothing to disclose. |
| Nusrat Ahsan, MD | Dr. Ahsan has nothing to disclose. |
| Wendy G. Mitchell, MD | Dr. Mitchell has nothing to disclose. |
| Zachary Bonzell, MD | Dr. Bonzell has nothing to disclose. |
| Margaret H. Downes | Miss Downes has nothing to disclose. |
| Soonmyung Hwang | Mr. Hwang has nothing to disclose. |
| Benjamin R. Kummer, MD, FAAN | Dr. Kummer has received personal compensation in the range of $0-$499 for serving as a Consultant for AlphaSights. Dr. Kummer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Syapse. Dr. Kummer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuraHealth. Dr. Kummer has received personal compensation in the range of $0-$499 for serving as a Consultant for RONIN. Dr. Kummer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Kummer has received personal compensation in the range of $0-$499 for serving as a Consultant for GLG. Dr. Kummer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Petauri Kinect. Dr. Kummer has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for 好色先生 . Dr. Kummer has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JMIR. Dr. Kummer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Kummer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Yoeli Gottlieb Etra LLP. Dr. Kummer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for The Ashley Law Firm. Dr. Kummer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Burns White Attorneys at Law. Dr. Kummer has stock in Syntrillo. The institution of Dr. Kummer has received research support from Icahn School of Medicine at Mount Sinai. Dr. Kummer has a non-compensated relationship as a Vice Chair Telehealth Subcommitte with 好色先生 that is relevant to AAN interests or activities. Dr. Kummer has a non-compensated relationship as a Vice Chair Quality Informatics Subcommittee with 好色先生 that is relevant to AAN interests or activities. |
| Mark Dakov, BS | Mr. Dakov has nothing to disclose. |
| Parul Agarwal | Parul Agarwal has nothing to disclose. |
| Massimo Marano, MD, PhD | Dr. Marano has nothing to disclose. |
| Rogan Magee, MD, PhD | Dr. Magee has nothing to disclose. |
| Francesca Blasi, MD | Dr. Blasi has nothing to disclose. |
| Fioravante Capone, PhD | Dr. Capone has nothing to disclose. |
| Gaia Anzini | No disclosure on file |
| Riccardo Antonio Ricciuti, Sr., MD | Dr. Ricciuti has nothing to disclose. |
| Matteo Maria Ottaviani, MD, PhD | Dr. Ottaviani has nothing to disclose. |
| Vincenzo Di Lazzaro, MD | Prof. Di Lazzaro has nothing to disclose. |
| Ashvath A. Pillai, Student | Mr. Pillai has nothing to disclose. |
| Fathimathul Henna, MBBS, Student | Miss Henna has nothing to disclose. |
| Archana Kaushik, MBBS | Ms. Kaushik has nothing to disclose. |
| Aishwarya J, MD | Ms. J has nothing to disclose. |
| Japjee Parmar, MBBS | Dr. Parmar has nothing to disclose. |
| James F. Howard, Jr., MD, FAAN | Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN (Horizon Therapeutics). Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Ltd. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck EMD Serono. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for H. Lundbeck A/S. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seismic Therapeutics. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Biopharma. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for MJH LifeSci. Dr. Howard has or had stock in Johnson & Johnson dividends.Dr. Howard has or had stock in Pfizer dividends. An immediate family member of Dr. Howard has or had stock in GlaxoSmithKline dividends.Dr. Howard has or had stock in Bristol Myer Squbb dividends.Dr. Howard has or had stock in AbbieVie Inc. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Cartestian Therapeutics. The institution of Dr. Howard has received research support from NMD Pharma. The institution of Dr. Howard has received research support from Ad Scientiam. The institution of Dr. Howard has received research support from Merck EMD Serono. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to AAN interests or activities. |
| Jeff Guptill, MD, FAAN | Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has or had stock in argenx. |
| Rosa H. Jimenez, MD, PhD | Dr. Jimenez has nothing to disclose. |
| Fien Gistelinck | Mrs. Gistelinck has nothing to disclose. |
| Sophie Steeland | Sophie Steeland has received personal compensation for serving as an employee of argenx. Sophie Steeland has stock in argenx. |
| Fien Verhamme, PhD | Dr. Verhamme has received personal compensation for serving as an employee of argenx. Dr. Verhamme has stock in argenx. |
| Sui H. Wong, MD | Dr. Wong has received personal compensation in the range of $0-$499 for serving as a Consultant for Argenx . Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant . The institution of Dr. Wong has received research support from Visual Snow Initiative. The institution of Dr. Wong has received research support from Myasthenia Gravis Foundation of America . Dr. Wong has received personal compensation in the range of $0-$499 for serving as a Co-inventor with University of Michigan licensing . |
| Ana L. Gonzalez Bellene, MD | Dr. GONZALEZ BELLENE has nothing to disclose. |
| Graciana Galiana | Graciana Galiana has nothing to disclose. |
| Francisco J. Peñalver, PhD | Dr. Peñalver has nothing to disclose. |
| Greg Memmott | Mr. Memmott has nothing to disclose. |
| Peter Fino | No disclosure on file |
| Lee dibble | No disclosure on file |
| Sheila Thomas | Sheila Thomas has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Sheila Thomas has stock in Jazz Pharmaceuticals. |
| James McAuley, PhD | Dr. McAuley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. |
| Christopher A. Jones, PhD | Dr. Jones has received personal compensation in the range of $100,000-$499,999 for serving as a Managing Partner Alternative Investments with UVM Health Network. |
| Elisabeth Kipping, MPH | Ms. Kipping has received personal compensation for serving as an employee of Evidation. |
| Michael Faithe, PharmD | Dr. Faithe has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Faithe has stock in Jazz Pharmaceuticals. Dr. Faithe has stock in Amgen . |
| Kristen Rosen, PhD | Dr. Rosen has received personal compensation for serving as an employee of Evidation Health. |
| Amanda E. Macone, MD | Dr. Macone has nothing to disclose. |
| Linda G. Baer, MSPH, CHCP | Ms. Baer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with Stanford University. Ms. Baer has received personal compensation in the range of $50,000-$99,999 for serving as a COO with ECHO Diabetes Action Network. |
| Julie L. White, MS | Ms. White has nothing to disclose. |
| Natalie Sanfratello, MPH | Ms. Sanfratello has nothing to disclose. |
| Horacio M. Rodriguez | Mr. Rodriguez has nothing to disclose. |
| Amber Lemons, PharmD | Dr. Lemons has nothing to disclose. |
| Deborah Hartman, PhD | Dr. Hartman has received personal compensation for serving as an employee of Centessa Pharmaceuticals. Dr. Hartman has stock in Centessa Pharmaceuticals. |
| Ellie IM, MD | Dr. IM has received personal compensation for serving as an employee of Centessa . Dr. IM has stock in Centessa. |
| Jennifer Kong, PhD | Dr. Kong has received personal compensation for serving as an employee of Centessa Pharmaceuticals. |
| EMILIANGELO RATTI, PhD | Dr. RATTI has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Centessa Pharmaceuticals . Dr. RATTI has stock in Centessa Pharmaceuticals. |
| Mario A. Accardi | Mr. Accardi has received personal compensation for serving as an employee of Centessa. Mr. Accardi has stock in Centessa. |
| Saurabh Saha, MD, PhD | Dr. Saha has received personal compensation for serving as an employee of Centessa Pharmaceuticals. |
| Kellyann Niotis, MD | Dr. Niotis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with PAREF. |
| Richard S. Isaacson, MD, FAAN | Dr. Isaacson has stock in Retain Health. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care. |
| Jennifer Reschke | Ms. Reschke has received personal compensation for serving as an employee of Retain Health. |
| Mark McInnis | Mr. McInnis has received personal compensation for serving as an employee of Retain Health. Mr. McInnis has stock in Retain Health. |
| Tammie A. Elgammal, MD | Dr. Elgammal has received personal compensation for serving as an employee of Retain Health, Inc.. Dr. Elgammal has stock in Retain Health. |
| Paula S. Scott | Ms. Scott has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Retain Health. Ms. Scott has received publishing royalties from a publication relating to health care. Ms. Scott has received publishing royalties from a publication relating to health care. Ms. Scott has received publishing royalties from a publication relating to health care. Ms. Scott has received personal compensation in the range of $500-$4,999 for serving as a Writer with Northwell Health. Ms. Scott has received personal compensation in the range of $10,000-$49,999 for serving as a writer with Peter Pauper Press. Ms. Scott has received personal compensation in the range of $5,000-$9,999 for serving as a writer with Better Health While Aging. Ms. Scott has received personal compensation in the range of $5,000-$9,999 for serving as a writer with Parade Magazine. |
| Sandeep Chinthapatla | Mr. Chinthapatla has received personal compensation for serving as an employee of Retain Health Inc. |
| Nabeel Saif | Mr. Saif has nothing to disclose. |
| Jeffrey Welge, PhD | Dr. Welge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Retain Health. |
| Robert D. Krikorian, PhD | The institution of Dr. Krikorian has received research support from NIH NIA. |
| Pietro Businaro | Pietro Businaro has nothing to disclose. |
| Chiara Milano, MD | Dr. Milano has nothing to disclose. |
| Claudia Papi, MD | Dr. Papi has nothing to disclose. |
| LAURA NARANJO, PhD | Dr. NARANJO has nothing to disclose. |
| Raquel Ruiz García, PhD | Dr. Ruiz García has nothing to disclose. |
| Lionel Arlettaz, MD-PhD | The institution of Dr. Arlettaz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Arlettaz has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for GSK. |
| Matteo Gastaldi, MD, PhD | Dr. Gastaldi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion, Roche, UCB, J&J. The institution of Dr. Gastaldi has received research support from Italian Ministry of Health, FISM, AE alliance. |
| Lidia Sabater, PhD | The institution of Dr. Sabater has received research support from Instituto de Salud Carlos III. |
| Josep O. Dalmau, MD, PhD, FAAN | Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. |
| Francesc R. Graus, MD | Dr. Graus has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Graus has received intellectual property interests from a discovery or technology relating to health care. |
| Marianna Spatola, MD, PhD, FAAN | The institution of Dr. Spatola has received research support from Spanish National Health Institute (Carlos III), FIS grant. The institution of Dr. Spatola has received research support from Spanish National Institute of Health - Miguel Servet Grant. The institution of Dr. Spatola has received research support from La Caixa Foundation. The institution of Dr. Spatola has received research support from European Research Coucil. |
| Rashmi Singh, Sr., MD | Dr. Singh has nothing to disclose. |
| Juber D. Shaikh, MD, DM (neurology) | Dr. Shaikh has nothing to disclose. |
| Sasya Pradhan, MD | Dr. Pradhan has nothing to disclose. |
| Siddhant Arora, MD | Dr. Arora has nothing to disclose. |
| Biswajit Banik, MD | Dr. Banik has nothing to disclose. |
| Yedatore S. Venkatesh, MD, FAAN | Dr. Venkatesh has nothing to disclose. |
| Sankeerth Challagundla, MD | Dr. Challagundla has nothing to disclose. |
| Andrew Jiang, MD | Mr. Jiang has nothing to disclose. |
| Gowri Anil Peethambar, MBBS | Dr. Anil Peethambar has nothing to disclose. |
| Ella Eastin | An immediate family member of Miss Eastin has received personal compensation for serving as an employee of Laura's House. |
| Jannika Machnik | Jannika Machnik has nothing to disclose. |
| Nicholas W. Larsen, MD | An immediate family member of Dr. Larsen has stock in Health Care Select SPDR. An immediate family member of Dr. Larsen has stock in Ishares Biotechnology. Dr. Larsen has stock in Amazon. |
| Lauren Stiles | Lauren Stiles has received personal compensation for serving as an employee of Dysautonomia International. |
| Jordan Seliger | Jordan Seliger has nothing to disclose. |
| Linda N. Geng, MD, PhD | The institution of Prof. Geng has received research support from Pfizer, Inc.. The institution of Prof. Geng has received research support from NIH. The institution of Prof. Geng has received research support from AHRQ. |
| Hector Bonilla, MD | Dr. Bonilla has nothing to disclose. |
| Phillip Yang | No disclosure on file |
| Mitchell G. Miglis, MD, FAAN | Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alight Health. Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint, LLC. Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2nd MD. Dr. Miglis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Miglis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Van Cott and Talamante. The institution of Dr. Miglis has received research support from Dysautonomia International. The institution of Dr. Miglis has received research support from National Institute of Health. Dr. Miglis has received publishing royalties from a publication relating to health care. |
| Amanda V. Gusovsky Chevalier, PhD | Dr. Gusovsky Chevalier has nothing to disclose. |
| Chun Chieh Lin, PhD | The institution of Dr. Lin has received research support from AAN. The institution of Dr. Lin has received research support from Genentech Inc. The institution of Dr. Lin has received research support from NIH. |
| Kevin A. Kerber, MD | Dr. Kerber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 好色先生. The institution of Dr. Kerber has received research support from National Institutes of Health. The institution of Dr. Kerber has received research support from Genentech, Inc . Dr. Kerber has received publishing royalties from a publication relating to health care. |
| Seuli Brill, MD | The institution of Dr. Brill has received research support from NIH. The institution of Dr. Brill has received research support from HRSA. The institution of Dr. Brill has received research support from PCORI. |
| James F. Burke, MD | Dr. Burke has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association/Circulation: Cardiovascular quality and outcomes. The institution of Dr. Burke has received research support from Genentech Foundation. The institution of Dr. Burke has received research support from NIH. |
| Sarita W. Maturu, MD | Dr. Maturu has nothing to disclose. |
| Namrah Aziz, MBBS | Dr. Aziz has nothing to disclose. |
| Saadia Sattar, MSc | Dr. Sattar has nothing to disclose. |
| Ayeesha K. Kamal, MD, MBBS | Dr. Kamal has nothing to disclose. |
| Peiyang Gao | Peiyang Gao has nothing to disclose. |
| Jintai Yu | No disclosure on file |
| David B. Abraham, MS | Mr. Abraham has nothing to disclose. |
| Frederico M. de Sousa Marinho Mendes Filho | Mr. de Sousa Marinho Mendes Filho has nothing to disclose. |
| Rebeca O. Silva, Student | Miss Silva has nothing to disclose. |
| Giovanna Salema Pascual | Miss Salema Pascual has nothing to disclose. |
| Christian K. Fukunaga, MS (Medical Student) | Mr. Fukunaga has nothing to disclose. |
| Elizabet Taylor P. Weba, Jr., Student | Miss Weba has nothing to disclose. |
| Luis O. Nogueira, medical student | Mr. NOGUEIRA has nothing to disclose. |
| Emanuelly L. Barbosa | Ms. Barbosa has nothing to disclose. |
| Leonardo Pipek, MD | Dr. Pipek has nothing to disclose. |
| Rafaela Farias Vidigal Nascimento, MD | Miss Nascimento has nothing to disclose. |
| Kenzo Ogasawara, MD | Dr. Ogasawara has nothing to disclose. |
| Pablo V. Feitoza, MD, PhD | Prof. Feitoza has nothing to disclose. |
| Kelly G. Gwathmey, MD | Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. |
| Vera Bril, MD | Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care. |
| Ali A. Habib, MD | Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/ Amgen. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jansen/Johnson & Johnson. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMDSerono/Merck. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jansen/Joohnson & Johnson. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from Horizon/Amgen. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Regeneron. The institution of Dr. Habib has received research support from Arcellx. The institution of Dr. Habib has received research support from Novartis. The institution of Dr. Habib has received research support from EMDSerono/Merck. The institution of Dr. Habib has received research support from Cour Pharmaceuticals. |
| Kristl Claeys, MD, PhD | Dr. Claeys has nothing to disclose. |
| Yessar M. Hussain, MD | The institution of Dr. Hussain has received research support from Alnylam Pharma. |
| Gregory Sahagian, MD, FAAN | Dr. Sahagian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Sahagian has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Sahagian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sahagian has received intellectual property interests from a discovery or technology relating to health care. |
| Elena Cortes-Vicente | Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Elena Cortes-Vicente has received research support from UCB Pharma. The institution of Elena Cortes-Vicente has received research support from Instituto de Salud Carlos III (España). |
| Edward Brauer | Edward Brauer has received personal compensation for serving as an employee of argenx. Edward Brauer has stock in argenx. |
| Deborah Gelinas, MD | Dr. Gelinas has received personal compensation for serving as an employee of argenx. Dr. Gelinas has stock in argenx. |
| Delphine Masschaele, PhD | Mrs. Masschaele has received personal compensation for serving as an employee of argenx. An immediate family member of Mrs. Masschaele has received personal compensation for serving as an employee of argenx. Mrs. Masschaele has stock in argenx. An immediate family member of Mrs. Masschaele has stock in argenx. |
| Renato Mantegazza, MD | Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Mantegazza has received research support from ERAPERMED, EU. |
| Andreas Meisel | Andreas Meisel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Andreas Meisel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Adivo. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Andreas Meisel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. The institution of Andreas Meisel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Andreas Meisel has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Andreas Meisel has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer/BMS. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Axunio. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Desitin. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genpharm. The institution of Andreas Meisel has received research support from Alexion. The institution of Andreas Meisel has received research support from argenx. The institution of Andreas Meisel has received research support from Octapharma. The institution of Andreas Meisel has received research support from Deutsche Myasthenie Gesellschaft. The institution of Andreas Meisel has received research support from Deutsche Forschungsgemeinschaft . The institution of Andreas Meisel has received research support from Bundesministerium für Wissenschaft und Forschung. The institution of Andreas Meisel has received research support from Leducq Foundation. The institution of Andreas Meisel has received research support from Einstein Stiftung Berlin. Andreas Meisel has received publishing royalties from a publication relating to health care. Andreas Meisel has received publishing royalties from a publication relating to health care. Andreas Meisel has a non-compensated relationship as a Chairman, Medical Advisory Board with Deutsche Myasthenie Gesellschaft that is relevant to AAN interests or activities. Andreas Meisel has a non-compensated relationship as a Chairman with Berliner Schlaganfall Gesellschaft that is relevant to AAN interests or activities. |
| Fang Sun, PhD, BM | Dr. Sun has nothing to disclose. |
| Shahram Attarian, MD, PhD | Prof. Attarian has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI, Pfizer LFB, Alnylam Biogen Argenx, UCB Alexion, Astrazenica, Amicus, Janssen, Novartis, Roche. Prof. Attarian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SANOFI, Biogen,Alnylam, Argenx, USB, Alexion Astrazenica, Janssen, Roche, Amgen. The institution of Prof. Attarian has received research support from National Institut of Health . |
| Li Liu, PhD | Dr. Liu has stock in argenx. |
| Said Alizada, MD | Dr. Alizada has nothing to disclose. |
| Asiye Tuba Ozdogar, PhD | Miss Ozdogar has nothing to disclose. |
| Gozde D. Unal, Jr., PT | Miss Unal has nothing to disclose. |
| irem Kara, PhD | Miss Kara has nothing to disclose. |
| Nurbanu AYGUNDUZ YAPICI, MD | Dr. AYGUNDUZ YAPICI has nothing to disclose. |
| Serkan Ozakbas, MD | Dr. Ozakbas has nothing to disclose. |
| Matanya Tirosh | Mr. Tirosh has received personal compensation for serving as an employee of Pfizer Pharmaceuticals Israel LTD. |
| Danna Davidovici | Danna Davidovici has received personal compensation for serving as an employee of Pfizer pharmaceutical LTD. |
| Yael Barer | Ms. Barer has nothing to disclose. |
| Erel Domany | Erel Domany has nothing to disclose. |
| Moshe Hoshen, PhD | Dr. Hoshen has nothing to disclose. |
| Sivan Gazit, MD | Dr. Gazit has nothing to disclose. |
| Amnon Mosek | No disclosure on file |
| Tabarak M. Mian, MD | Dr. Mian has nothing to disclose. |
| Rosalina Magalhaes Pereira, MD | Dr. Magalhaes Pereira has nothing to disclose. |
| Toral Patel | Toral Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Toral Patel has received intellectual property interests from a discovery or technology relating to health care. |
| Tu Dan, MD | Dr. Dan has nothing to disclose. |
| Michael Youssef, MD | Dr. Youssef has nothing to disclose. |
| Aaron Burshtein, MD | Dr. Burshtein has nothing to disclose. |
| Vineet Aggarwal | No disclosure on file |
| Jung Kim, MD | Dr. Kim has nothing to disclose. |
| Alexandra M. Livingston, DO | An immediate family member of Dr. Livingston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. An immediate family member of Dr. Livingston has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of an immediate family member of Dr. Livingston has received research support from Vertex. The institution of an immediate family member of Dr. Livingston has received research support from Roche. The institution of an immediate family member of Dr. Livingston has received research support from AstraZeneca. The institution of an immediate family member of Dr. Livingston has received research support from Enanta. |
| Sam Torbati, MD | Dr. Torbati has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Reback, McAndrews, Blessey, LLP. |
| Chae Y. Kim, MD | Dr. Kim has nothing to disclose. |
| Maryam Jamel, MD, Medical Student | Ms. Jamel has nothing to disclose. |
| Kylie C. Yamauchi | Ms. Yamauchi has nothing to disclose. |
| Bryan H. Chaleunxay | Mr. Chaleunxay has nothing to disclose. |
| Kenneth Lin | Mr. Lin has nothing to disclose. |
| Nhat Dainelle Vallo | Ms. Vallo has nothing to disclose. |
| Janette Bow-Keola | Miss Bow-Keola has nothing to disclose. |
| Michael Read, MD student | Mr. Read has nothing to disclose. |
| Shay Nakahira | Ms. Nakahira has nothing to disclose. |
| Kirra Borrello | Miss Borrello has nothing to disclose. |
| Ryan Nakamura | Mr. Nakamura has received personal compensation for serving as an employee of Hawaii Health & Harm Reduction Center. |
| Anita Cheung, MPH | Miss Cheung has nothing to disclose. |
| D-Dré Wright | Ms. Wright has nothing to disclose. |
| Enrique Carrazana | Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences, Apex Labs. Enrique Carrazana has stock in Neurelis, CND, Apex. |
| Amir H. Meghdadi, PhD | Dr. Meghdadi has received personal compensation for serving as an employee of Advanced Brain Monitoring. The institution of Dr. Meghdadi has received research support from National Institute of Health (NIH). |
| Kore K. Liow, MD, FACP | The institution of Dr. Liow has received research support from UCB. The institution of Dr. Liow has received research support from Livanova. The institution of Dr. Liow has received research support from Biogen. The institution of Dr. Liow has received research support from Novartis. The institution of Dr. Liow has received research support from Eisai. The institution of Dr. Liow has received research support from Engage Therapeutics. The institution of Dr. Liow has received research support from SK Lifescience. The institution of Dr. Liow has received research support from Cerevel. The institution of Dr. Liow has received research support from Xenon. The institution of Dr. Liow has received research support from NeuroDerm. The institution of Dr. Liow has received research support from Avanir. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Acadia. The institution of Dr. Liow has received research support from Prothena. The institution of Dr. Liow has received research support from SAGE. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Cyclerion. |
| Susana Dominguez Penuela, MD | Dr. Dominguez Penuela has nothing to disclose. |
| Greer Waldrop, MD | Dr. Waldrop has nothing to disclose. |
| Maria I. Reyes, MD | Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. |
| David Acero-Garces, MD | Dr. Acero-Garces has nothing to disclose. |
| Paula Barreras, MD | Dr. Barreras has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from 好色先生. |
| Kathryn Fitzgerald, PhD | Dr. Fitzgerald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Setpoint Medical. The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society. |
| Samuel Pleasure, MD, PhD | Dr. Pleasure has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Pleasure has received research support from NINDS, NIMH, NIDA, National MS Society, Brain Research Foundation, John Merck Fund, Whitehall Foundation, Lupus Research Association, Juvenile Diabetes Research Foundation. |
| H. Benjamin Larman | H. Benjamin Larman has received personal compensation for serving as an employee of Infinity Bio. H. Benjamin Larman has or had stock in Infinity Bio.H. Benjamin Larman has received intellectual property interests from a discovery or technology relating to health care. |
| Michael R. Wilson, MD, FAAN | Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ouro Medicines. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Indapta Therapeutics. Dr. Wilson has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Delve Bio. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cambridge Medical Experts. Dr. Wilson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Dunham Hallmark. Dr. Wilson has stock in Delve Bio. The institution of Dr. Wilson has received research support from Genentech / Roche. The institution of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from Novartis. The institution of Dr. Wilson has received research support from National Multiple Sclerosis Society. The institution of Dr. Wilson has received research support from Fanconi Anemia Research Foundation. The institution of Dr. Wilson has received research support from Department of Defense. The institution of Dr. Wilson has received research support from Chan Zuckerberg Initiative. The institution of Dr. Wilson has received research support from Kyverna Therapeutics. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Witness with US Dept of Justice. |
| Barney J. Stern, MD, FAAN | Dr. Stern has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Foundation for Sarcoidosis Research. The institution of Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. Dr. Stern has received publishing royalties from a publication relating to health care. |
| Jeffrey M. Gelfand, MD, MS, FAAN | Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities. |
| Carlos A. Pardo-Villamizar, MD | The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research . |
| Evan M. Johnson, MD | No disclosure on file |
| Anshum Patel | Dr. Patel has nothing to disclose. |
| Ipshita Garg, MBBS | Dr. Garg has nothing to disclose. |
| Laura A. Kirkpatrick, MD | The institution of Dr. Kirkpatrick has received research support from American Epilepsy Society. The institution of Dr. Kirkpatrick has received research support from Child Neurologist Career Development Program. The institution of Dr. Kirkpatrick has received research support from Child Neurology Foundation. The institution of Dr. Kirkpatrick has received research support from Rosenau Family Research Foundation. The institution of Dr. Kirkpatrick has received research support from Society of Family Planning. The institution of Dr. Kirkpatrick has received research support from Pediatric Epilepsy Research Consortium. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Meeting Attendee with One8 Foundation. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Meeting Attendee with Brigham and Women's Hospital. Dr. Kirkpatrick has received personal compensation in the range of $0-$499 for serving as a Meeting Attendee with Pediatric Epilepsy Research Consortium. Dr. Kirkpatrick has received personal compensation in the range of $0-$499 for serving as a Grant reviewer with Society of Family Planning. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Norton Children's Hospital. Dr. Kirkpatrick has a non-compensated relationship as a Board of Directors member with My Epilepsy Story that is relevant to AAN interests or activities. |
| Erin Friel | Miss Friel has nothing to disclose. |
| Jasmin Rivero-Guerra, Student-Worker | Ms. Rivero-Guerra has nothing to disclose. |
| Amy K. Tao | Ms. Tao has nothing to disclose. |
| Janani Kassiri, MD, PhD | Dr. Kassiri has nothing to disclose. |
| Marie E. Clements, MD | Dr. Clements has nothing to disclose. |
| Christina Briscoe Abath, MD | The institution of Dr. Briscoe Abath has received research support from Harvard Medical School. Dr. Briscoe Abath has a non-compensated relationship as a Board of Trustees Member with Brother's Brother Foundation that is relevant to AAN interests or activities. Dr. Briscoe Abath has a non-compensated relationship as a Professional Advisory Board with Epilepsy Foundation that is relevant to AAN interests or activities. |
| Page B. Pennell, MD, FAAN | The institution of Dr. Pennell has received research support from NIH. |
| Jessica Burke, PhD | Dr. Burke has nothing to disclose. |
| Sara E. Baumann, PhD | Dr. Baumann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Projet Jeune Leader (NGO). Dr. Baumann has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Asian Disaster Preparedness Center. |
| Traci Kazmerski | The institution of Traci Kazmerski has received research support from Cystic Fibrosis Foundation. The institution of Traci Kazmerski has received research support from NIH. |
| Rupleen Kaur | Miss Kaur has nothing to disclose. |
| Andrew Dhawan, MD | Dr. Dhawan has nothing to disclose. |
| Siavash Shirzadeh Barough, MD | Dr. Shirzadeh Barough has nothing to disclose. |
| Abhay Moghekar, MD | Dr. Moghekar has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Deluca and Weizenbaum. Dr. Moghekar has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Silver Golub and Tieteel. The institution of Dr. Moghekar has received research support from NIH. Dr. Moghekar has a non-compensated relationship as a Medical Advisory Board member with Hydrocephalus Association that is relevant to AAN interests or activities. Dr. Moghekar has a non-compensated relationship as a Medical Advisory Board member with Spinal CSF Leak Foundation that is relevant to AAN interests or activities. |
| Guenther Deuschl, MD, FAAN | Dr. Deuschl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Deuschl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific Cavion Functional Neuromodulation. The institution of Dr. Deuschl has received research support from Medtronic. Dr. Deuschl has received publishing royalties from a publication relating to health care. |
| Griet Loret, MD | Dr. Loret has nothing to disclose. |
| Norbert Kovacs | Norbert Kovacs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Norbert Kovacs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Norbert Kovacs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. |
| Marta Blazquez Estrada | Marta Blazquez Estrada has nothing to disclose. |
| David Pedrosa | David Pedrosa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. David Pedrosa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. David Pedrosa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific Corp.. David Pedrosa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. David Pedrosa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Desitin. David Pedrosa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. The institution of David Pedrosa has received research support from Boston Scientific Corp.. |
| Jens Volkmann, MD | Jens Volkmann, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceregate. Jens Volkmann, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Newronika. Jens Volkmann, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific. Jens Volkmann, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Jens Volkmann, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. Jens Volkmann, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott. The institution of Jens Volkmann, MD has received research support from DFG. The institution of Jens Volkmann, MD has received research support from BMBF. The institution of Jens Volkmann, MD has received research support from Boston Scientific. The institution of Jens Volkmann, MD has received research support from Medtronic. |
| Steffen Paschen | The institution of Steffen Paschen has received research support from Deutsche Forschungsgemeinschaft. The institution of Steffen Paschen has received research support from Parkinsonfonds. The institution of Steffen Paschen has received research support from UCB . |
| Lilly Chen | Lilly Chen has received personal compensation for serving as an employee of Boston Scientific . |
| Rajat Shivacharan | Dr. Shivacharan has received personal compensation for serving as an employee of Boston Scientific. |
| Edward Goldberg, MD | Dr. Goldberg has received personal compensation for serving as an employee of Boston Scientific . |
| Ana Oliveira | Ana Oliveira has nothing to disclose. |
| Jung-Il Lee, MD | Prof. Lee has nothing to disclose. |
| Rick Schuurman, MD, PhD | Prof. Schuurman has nothing to disclose. |
| Tuan H. Vu, MD | Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen (Horizon). Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from Mass Gen Hospital/Healy Platform Study. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Horizon/Amgen. The institution of Dr. Vu has received research support from Woolsey Pharma. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Johnson & Johnson. The institution of Dr. Vu has received research support from Immunovant. The institution of Dr. Vu has received research support from Regeneron. The institution of Dr. Vu has received research support from Dianthus. The institution of Dr. Vu has received research support from COUR. |
| Yuebing Li, MD, PhD, FAAN | Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. The institution of Dr. Li has received research support from Argenx. |
| Denis Korobko | Denis Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Denis Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Denis Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Denis Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biocad. Denis Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Denis Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Denis Korobko has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for sanofi. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jhonson&Jhonson. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra-Zeneca. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Russia. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Moscow. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra-Zeneca. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biocad. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Generium. Denis Korobko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. |
| Benjamin Van Hoorick | Dr. Van Hoorick has received personal compensation for serving as an employee of argenx. Dr. Van Hoorick has stock in argenx. |
| Jana Podhorna | Dr. Podhorna has received personal compensation for serving as an employee of argenx. Dr. Podhorna has stock in argenx. |
| Moana Hodari | Moana Hodari has nothing to disclose. |
| Kimiaki Utsugisawa, MD, PhD | Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Utsugisawa has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubisi Tanabe pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion phama. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Japan Blood Products Organization. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. |
| Francesco Sacca, MD, FAAN | Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexeo. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genpharm. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medpharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Madison Pharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zai Lab. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neopharm Israel. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson&Johnson. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Sacca has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Astrazeneca. The institution of Dr. Sacca has received research support from AIFA. The institution of Dr. Sacca has received research support from FARA. |
| Jan L. De Bleecker, MD, PhD, FAAN | Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgNX. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. De Bleecker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharmaceuticals. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. |
| Allisun Wiltshire | Miss Wiltshire has nothing to disclose. |
| Ananth Mahes | Mr. Mahes has nothing to disclose. |
| Marta San Luciano, MD, FAAN | Dr. San Luciano has received research support from NIH (NINDS). Dr. San Luciano has received research support from Raynor Cerebellum Project. |
| Sarah S. Wang, PhD | Dr. Wang has nothing to disclose. |
| Jose-Rafael P. Zuzuarregui, MD | Dr. Zuzuarregui has nothing to disclose. |
| Casey R. Tak, PhD | Dr. Tak has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Health technology companies. The institution of Dr. Tak has received research support from Pew Charitable Trusts. The institution of Dr. Tak has received research support from Bayer. The institution of Dr. Tak has received research support from Cystic Fibrosis Foundation. The institution of Dr. Tak has received research support from NIH. |
| Kirti Sivakoti, MD, MBBS | Dr. Sivakoti has nothing to disclose. |
| Ratthanon Prasitwarachot, PhD candidate | Mr. Prasitwarachot has nothing to disclose. |
| Anna K. Bonkhoff, MD | Dr. Bonkhoff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NeuroImage Clinical (Elsevier). |
| Frederic Schaper, MD, PhD | Dr. Schaper has nothing to disclose. |
| Shan Siddiqi, MD | Dr. Siddiqi has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Magnus Medical. Dr. Siddiqi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Brainsway Ltd. Dr. Siddiqi has stock in Brainsway Ltd. Dr. Siddiqi has stock in Magnus Medical. Dr. Siddiqi has received intellectual property interests from a discovery or technology relating to health care. |
| Alexander L. Cohen, MD, PhD, FAAN | The institution of Dr. Cohen has received research support from NIH. The institution of Dr. Cohen has received research support from Simons Foundation. |
| William Drew | Mr. Drew has nothing to disclose. |
| Michael Ferguson | Michael Ferguson has nothing to disclose. |
| Christopher Lin | No disclosure on file |
| Anne-Katrin Giese, MD | Dr. Giese has nothing to disclose. |
| Robert W. Regenhardt, MD, PhD | Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genomadix. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Johnson and Bell Trial Lawyers. Dr. Regenhardt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Buckley, Theroux, Kline, & Cooley Trial Lawyers. The institution of Dr. Regenhardt has received research support from National Institutes of Health. The institution of Dr. Regenhardt has received research support from Society of Vascular and Interventional Neurology. The institution of Dr. Regenhardt has received research support from Heitman Foundation. |
| Markus D. Schirmer, PhD | The institution of Dr. Schirmer has received research support from National Institute of Aging. |
| Christina Jern, MD, PhD | Prof. Jern has nothing to disclose. |
| Arne Lindgren, MD, PhD | Prof. Lindgren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arega. Prof. Lindgren has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurologi i Sverige Journal. Prof. Lindgren has received publishing royalties from a publication relating to health care. Prof. Lindgren has received publishing royalties from a publication relating to health care. Prof. Lindgren has received publishing royalties from a publication relating to health care. |
| Jane Maguire | No disclosure on file |
| Ona Wu | The institution of Ona Wu has received research support from NIH. Ona Wu has received intellectual property interests from a discovery or technology relating to health care. Ona Wu has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. |
| Sahar Zafar, MD | Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Zafar has received research support from NIH. Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker for a lecture with Marinus. |
| John Y. Rhee, MD, MPH | Dr. Rhee has stock in NTAP. Dr. Rhee has stock in TSLA. Dr. Rhee has stock in BABA. Dr. Rhee has stock in ZM. Dr. Rhee has stock in GM. Dr. Rhee has stock in PFF. Dr. Rhee has stock in AMZN. Dr. Rhee has stock in META. Dr. Rhee has stock in GE. The institution of Dr. Rhee has received research support from 好色先生. Dr. Rhee has received personal compensation in the range of $0-$499 for serving as a Director of the Hippocratic Forum with Hippocratic Society. |
| Eyal Y. Kimchi, MD, PhD | The institution of Dr. Kimchi has received research support from NIH. The institution of an immediate family member of Dr. Kimchi has received research support from NIH. |
| Andrew M. Naidech, MD, FAAN | Dr. Naidech has received publishing royalties from a publication relating to health care. |
| Amy Brodtmann, MBBS, PhD, FRACP | Prof. Brodtmann has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Prof. Brodtmann has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. Prof. Brodtmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Prof. Brodtmann has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medicines Australia. Prof. Brodtmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. Prof. Brodtmann has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Macpherson Kelley. The institution of Prof. Brodtmann has received research support from National Health and Medical Research Council. The institution of Prof. Brodtmann has received research support from Medical Research Future Fund. The institution of Prof. Brodtmann has received research support from National Heart Foundation. The institution of Prof. Brodtmann has received research support from Victorian Medical Research Acceleration Fund. Prof. Brodtmann has a non-compensated relationship as a Honorary Medical Advisor with Dementia Australia that is relevant to AAN interests or activities. Prof. Brodtmann has a non-compensated relationship as a Brain Health Initiative with Australian Football League that is relevant to AAN interests or activities. |
| Natalia Egorova | No disclosure on file |
| Sophia Gozzi | An immediate family member of Miss Gozzi has stock in LiveHire Ltd. |
| Thanh Phan, MD | Dr. Phan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. |
| Maurizio Corbetta, MD | Dr. Corbetta has nothing to disclose. |
| Jordan Grafman, PhD | Dr. Grafman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Grafman has received research support from NIH. Dr. Grafman has received publishing royalties from a publication relating to health care. |
| Natalia S. Rost, MD, MPH, FAAN, FAHA | Dr. Rost has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care. |
| Michael D. Fox, MD, PhD | Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. |
| Muneeb Ahmad Muneer | Mr. Muneer has nothing to disclose. |
| Eeshal Zulfiqar, MBBS | Ms. Zulfiqar has nothing to disclose. |
| Sonia Hurjkaliani | Dr. Hurjkaliani has nothing to disclose. |
| Inshal Jaffery, MBBS | Miss Jaffery has nothing to disclose. |
| Shaila Sharmin S. Saaki, MBBS | Dr. Saaki has nothing to disclose. |
| Syed Muhammad N. Bokhari | Mr. Bokhari has nothing to disclose. |
| Irra Tariq | Ms. Tariq has nothing to disclose. |
| Scott M. Belliston, DO | Dr. Belliston has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. |
| Joyce A. Jimenez Zambrano, MD | Dr. Jimenez Zambrano has nothing to disclose. |
| Arman Saied, MD | Dr. Saied has nothing to disclose. |
| Brianna Lupo | Miss Lupo has nothing to disclose. |
| Luciana Borrigueiro, Mestrado | Dr. Borrigueiro has nothing to disclose. |
| Deivyd V. Cavalcante, BSPS | Mr. Cavalcante has nothing to disclose. |
| Carla F. Hinojosa, Medical student | Miss Hinojosa has nothing to disclose. |
| Danielle M. Gianetti | Miss Gianetti has nothing to disclose. |
| Tyler L. Borko, BA | Mr. Borko has nothing to disclose. |
| Phillip Winters | Mr. Winters has nothing to disclose. |
| Stefan Sillau | Stefan Sillau has nothing to disclose. |
| Sadie Eggmann | Sadie Eggmann has nothing to disclose. |
| Sean Selva | Sean Selva has nothing to disclose. |
| Alanna Ritchie | Alanna Ritchie has nothing to disclose. |
| Kelli Money, MD, PhD | Dr. Money has nothing to disclose. |
| Paul D. Crane, MD | Dr. Crane has nothing to disclose. |
| Gregory Owens, PhD | Dr. Owens has received intellectual property interests from a discovery or technology relating to health care. |
| Jeffrey L. Bennett, MD, PhD, FAAN | Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immpact Bio. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIAC. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Bennett has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vindico. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Touch IME. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Efficient LLC. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pavich. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Marie Bush. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marks Gray. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Knight, Nicastro, MacKay. The institution of Dr. Bennett has received research support from Alexion. The institution of Dr. Bennett has received research support from Genentech. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care. |
| Amanda L. Piquet, MD, FAAN | The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cortez & Associates. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Falk Waas. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities. |
| David S. Younger, MD, DrPH, MPH, MS | Dr. Younger has nothing to disclose. |
| Navangi Patel, MD | Dr. Patel has nothing to disclose. |
| Hyunmi Choi, MD | Dr. Choi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Research by Elsevier. The institution of Dr. Choi has received research support from National Institute of Aging. |
| Jose Gutierrez, MD | Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cardiovascular Research Foundation. Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for White and Rusell. Dr. Gutierrez has received research support from NIH. Dr. Gutierrez has received publishing royalties from a publication relating to health care. Dr. Gutierrez has received publishing royalties from a publication relating to health care. |
| Cheng-Shiun Leu, PhD | Prof. Leu has nothing to disclose. |
| Tian Wang | Dr. Wang has nothing to disclose. |
| Jiying Han, MS | Miss Han has stock in Merck. Miss Han has stock in Eli Lilly. Miss Han has stock in Novo-Nordisk. |
| Sylwia Misiewicz, MA, EdM | Mrs. Misiewicz has nothing to disclose. |
| Emily Johnson, MD | Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EpiWatch. Dr. Johnson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Johnson has received research support from NIH. |
| W. T. Longstreth, Jr., MD, FAAN | The institution of Dr. Longstreth has received research support from NIH. |
| Mary Biggs, PhD | The institution of Dr. Biggs has received research support from NIH. |
| Annette Fitzpatrick, PhD | No disclosure on file |
| Steven J. Shea, MD | Dr. Shea has nothing to disclose. |
| Craig Johnson | Mr. Johnson has nothing to disclose. |
| Mitchell S. Elkind, MD, MS, FAAN | Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy. |
| Tatjana Rundek, MD, PhD | The institution of Dr. Rundek has received research support from NIH. |
| Kevin Strobino, MPH | Mr. Strobino has nothing to disclose. |
| Lisandro D. Colantonio, MD, PhD | The institution of Dr. Colantonio has received research support from Amgen. |
| Lei Huang, PhD | Ms. Huang has nothing to disclose. |
| Carolyn C. ZHU | Dr. ZHU has nothing to disclose. |
| Danurys Sanchez | Danurys Sanchez has nothing to disclose. |
| Richard P. Mayeux, MD, MSc, FAAN | Dr. Mayeux has nothing to disclose. |
| Natalie Bello | Natalie Bello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CRF. The institution of Natalie Bello has received research support from NIH. |
| Deborah A. Levine | No disclosure on file |
| Oluwadamilola R. Obalana | Miss Obalana has nothing to disclose. |
| Stefany P. Diaz Andino, MPH | Mrs. Diaz Andino has nothing to disclose. |
| Brian Petersen | Mr. Petersen has nothing to disclose. |
| Sofia Maia | Ms. Maia has nothing to disclose. |
| Evan Thacker, PhD | The institution of Evan Thacker, PhD has received research support from NIH. |
| Muhammad Hussain, MD | Dr. Hussain has nothing to disclose. |
| Nicholas Yelverton, DO | Dr. Yelverton has nothing to disclose. |
| Haseeb Goheer | Haseeb Goheer has nothing to disclose. |
| Muhammad I. Yousaf, MD | Dr. Yousaf has nothing to disclose. |
| Sheharyar Raashid, MD | Sheharyar Raashid, MD has nothing to disclose. |
| Kathryn B. Thornton, MD | Dr. Thornton has nothing to disclose. |
| Dylan D. Jayasuriya, MD | Dr. Jayasuriya has nothing to disclose. |
| Mackenzie Bergeron | Mrs. Bergeron has nothing to disclose. |
| Alex E. Schick | Ms. Schick has nothing to disclose. |
| Sara Hardy, MD | Dr. Hardy has received research support from the American Cancer Society. |
| Myla Strawderman | Myla Strawderman has nothing to disclose. |
| Dandan Zheng, PhD | Dr. Zheng has nothing to disclose. |
| Michael Cummings | The institution of Dr. Cummings has received research support from Siemans. |
| Michael Milano | Michael Milano has received publishing royalties from a publication relating to health care. |
| Allison Magnuson | Allison Magnuson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Society of Clinical Oncology. The institution of Allison Magnuson has received research support from National Institute of Health. The institution of Allison Magnuson has received research support from Fair Health/Hartford Foundation. |
| Jacqueline M. Behr, NP | Mrs. Behr has nothing to disclose. |
| Sarah Sammons, MD | Dr. Sammons has nothing to disclose. |
| Kenneth Y. Usuki, MD | Dr. Usuki has nothing to disclose. |
| Nimish A. Mohile, MD, FAAN | The institution of Dr. Mohile has received research support from Novocure. |
| Ruth O'Regan, MD | Dr. O'Regan has received personal compensation for serving as an employee of Pfizer. Dr. O'Regan has received personal compensation for serving as an employee of Biotheranostics. Dr. O'Regan has received personal compensation for serving as an employee of Gilead. Dr. O'Regan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. O'Regan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biotheranostics. Dr. O'Regan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. O'Regan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. O'Regan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biotheranostics. Dr. O'Regan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Gilead. Dr. O'Regan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACS. Dr. O'Regan has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. O'Regan has received research support from Puma. |
| Carey Anders, MD | Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IPSEN. Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seattle Genetics. Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunomedics. Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Elucida. Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Athenex. Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Anders has received publishing royalties from a publication relating to health care. Dr. Anders has received publishing royalties from a publication relating to health care. |
| David Hicks, MD | Dr. Hicks has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zenica. Dr. Hicks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zenica . |
| Lauryn Hemminger | Dr. Hemminger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. |
| Ajay Dhakal, MBBS | Dr. Dhakal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Dhakal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Empire State Hematology Oncology. Dr. Dhakal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MJH Life Sciences. The institution of Dr. Dhakal has received research support from Puma Biotechnology. The institution of Dr. Dhakal has received research support from Celcuity. |
| Alan Y. Huang | Mr. Huang has nothing to disclose. |
| Mackaleigh A. Levine, Research Coordinator | Ms. Levine has nothing to disclose. |
| Robert G. Wilson, DO | Dr. Wilson has nothing to disclose. |
| Christopher J. Cantrell, MD | Mr. Cantrell has nothing to disclose. |
| Anna K. Hayburn, PsyD | Dr. Hayburn has nothing to disclose. |
| Devora Shapiro, PhD | Dr. Shapiro has nothing to disclose. |
| Ahmad Hamza, MD | No disclosure on file |
| Ahmed R. Harb | Mr. Harb has nothing to disclose. |
| asmaa N. Ali, MD | Miss Ali has nothing to disclose. |
| Nada Mosad | Dr. Mosad has nothing to disclose. |
| Sadil M. Banikhaled, MD, Medical student | Miss Banikhaled has nothing to disclose. |
| Ramadan M. Abohendia, MBBS | Dr. Abohendia has nothing to disclose. |
| Amal A. Jubran, MD | Miss Jubran has nothing to disclose. |
| Zabeen K. Mahuwala, MD, FAAN | Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for academic CME. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Scientific affairs. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for amgen. The institution of Dr. Mahuwala has received research support from UCB, . The institution of Dr. Mahuwala has received research support from Alexion . The institution of Dr. Mahuwala has received research support from argenx . The institution of Dr. Mahuwala has received research support from immunovant. |
| Robert M. Pascuzzi, MD, FAAN | Dr. Pascuzzi has nothing to disclose. |
| John Vissing, MD | Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Prof. Vissing has received personal compensation in the range of $0-$499 for serving as a Consultant for Denali Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Italfarmaco. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Prof. Vissing has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson (Janssen). Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Edgewise Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Prof. Vissing has received research support from Rigshospitalet. The institution of Prof. Vissing has received research support from Avidity. The institution of Prof. Vissing has received research support from Sanofi. The institution of Prof. Vissing has received research support from Roche. The institution of Prof. Vissing has received research support from AnnJi. |
| Fiona Grimson | Fiona Grimson has received personal compensation for serving as an employee of UCB Pharma. Fiona Grimson has stock in UCB Pharma. |
| Thais T. Heras, Sr., MD | Dr. Heras has received personal compensation for serving as an employee of UCB Pharma S.A. |
| Jos Bloemers, PhD | Dr. Bloemers has received personal compensation for serving as an employee of UCB. Dr. Bloemers has stock in UCB. |
| Brian Grosberg, MD | Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma pharmaceuticals. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Theranica . Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Grosberg has stock in Theranica. The institution of Dr. Grosberg has received research support from Theranica. The institution of Dr. Grosberg has received research support from Amgen. The institution of Dr. Grosberg has received research support from Abbvie. The institution of Dr. Grosberg has received research support from Eli Lilly. The institution of Dr. Grosberg has received research support from Teva. The institution of Dr. Grosberg has received research support from Neurolief. Dr. Grosberg has received publishing royalties from a publication relating to health care. |
| Olivia Begasse De Dhaem, MD | Dr. Begasse De Dhaem has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Begasse De Dhaem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for JOGO. Dr. Begasse De Dhaem has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Begasse De Dhaem has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pain Medicine Journal. Dr. Begasse De Dhaem has received publishing royalties from a publication relating to health care. |
| Daod Pak, MD | Dr. Pak has nothing to disclose. |
| Jung-Hyun Lee, MD | Dr. Lee has nothing to disclose. |
| William W. Lytton, MD | Dr. Lytton has nothing to disclose. |
| Sergio L. Angulo Castro, MD, PhD | Dr. Angulo Castro has nothing to disclose. |
| Eunhee Choi, MD | Dr. Choi has nothing to disclose. |
| Robert McDougal | An immediate family member of Robert McDougal has received personal compensation for serving as an employee of Farnam Real Estate. The institution of Robert McDougal has received research support from NIH. Robert McDougal has a non-compensated relationship as a Webmaster with Organiztion for Computational Neuroscience that is relevant to AAN interests or activities. |
| Omid Mirmosayyeb, MD | Dr. Mirmosayyeb has nothing to disclose. |
| Jacob Balconi, MA | An immediate family member of Mr. Balconi has received personal compensation for serving as an employee of Authority Brands. An immediate family member of Mr. Balconi has received personal compensation for serving as an employee of Harbor Media. |
| Xinluan Dong | No disclosure on file |
| Nicholas C. Young | Mr. Young has nothing to disclose. |
| Michael Jaworski | No disclosure on file |
| Celeste Santivasci | Ms. Santivasci has nothing to disclose. |
| Kinga Szigeti, MD, PhD | No disclosure on file |
| Ralph H. Benedict, PhD | Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care. |
| Elisa G. Gouvea | Miss Gouvea has nothing to disclose. |
| Elielson Veloso da Silva, PhD | Dr. Veloso da Silva has nothing to disclose. |
| Andreza S. Lemos, PhD | Dr. Lemos has nothing to disclose. |
| Renan A. Fernandes | Ms. Fernandes has nothing to disclose. |
| Jéssica Vedovi | Jéssica Vedovi has nothing to disclose. |
| Larissa Duarte | Miss Duarte has nothing to disclose. |
| Helena França F. Ferreira, Master | Mr. Ferreira has nothing to disclose. |
| Soniza Vieira A. Leon, Sr., MD, PhD | Dr. Leon has nothing to disclose. |
| Ahmed M. Shaheen | Dr. Shaheen has a non-compensated relationship as a A Research Position Candidate Under Trial Task with Solvemed Company that is relevant to AAN interests or activities. |
| Belal M. Hamed, Jr., Medical student | Dr. Hamed has nothing to disclose. |
| Nour Shaheen, Sr., MBBS | Mr. Shaheen has nothing to disclose. |
| Ram K. Saha, MD | Dr. Saha has nothing to disclose. |
| Ahmed Negida, MD, PhD | Dr. Negida has nothing to disclose. |
| Mostafa Eltobgy | No disclosure on file |
| Sanam Zarei, MD | Dr. Zarei has received intellectual property interests from a discovery or technology relating to health care. |
| Alexandra B. Kornbluh, MD | Dr. Kornbluh has nothing to disclose. |
| Claire Har, Jr., MPH | Ms. Har has nothing to disclose. |
| Ilana L. Kahn, MD | Dr. Kahn has nothing to disclose. |
| Elizabeth M. Wells, MD | The institution of Dr. Wells has received research support from National Institute of Allergy and Infectious Diseases. |
| Gregory S. Day, MD, MSc, FAAN | Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with 好色先生. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing 好色先生, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a 好色先生al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities. |
| Leigh N. Sepeta, PhD | Dr. Sepeta has received personal compensation in the range of $500,000-$999,999 for serving as a Grant PI with Nih. Dr. Sepeta has a non-compensated relationship as a Special volunteer with Nih that is relevant to AAN interests or activities. |
| Monika Mikolajczak, MD | Dr. Mikolajczak has nothing to disclose. |
| Rajesh Burela, DO | Dr. Burela has nothing to disclose. |
| Paul Wright, MD, FAAN | Dr. Wright has nothing to disclose. |
| Yakov Isakov, DO | Dr. Isakov has nothing to disclose. |
| Seo Eun Hwang, MD | Ms. Hwang has nothing to disclose. |
| JAE MOON YUN, MD, PhD | Dr. YUN has nothing to disclose. |
| Be Long Cho | No disclosure on file |
| JIN HO PARK, MD | Prof. PARK has nothing to disclose. |
| Ji Young Kim, MD | Dr. Kim has nothing to disclose. |
| paul j. Utz, MD | Dr. Utz has nothing to disclose. |
| Safwan S. Jaradeh, MD, FAAN | Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam & Akcea. The institution of Dr. Jaradeh has received research support from Alnylam. |
| Maarten G. Lansberg, MD | Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Richard & Connor. Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Keating Jones Hughes. Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Chason, Rosner, Leary & Marshall. Dr. Lansberg has received publishing royalties from a publication relating to health care. |
| Srikanth Muppidi, MD, FAAN | Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J & J pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care. |
| Neha Dhawan | Neha Dhawan has nothing to disclose. |
| Gilat Schiff | Gilat Schiff has received personal compensation for serving as an employee of Insightec. |
| Giulia Frazzetta | Giulia Frazzetta has received personal compensation for serving as an employee of Insightec. |
| Katie Gant | Katie Gant has received personal compensation for serving as an employee of Insightec . |
| Augusto Grinspan, MD | Dr. Grinspan has received personal compensation for serving as an employee of Insightec. |
| Kevin W. Tsai, PhD | Mr. Tsai has received personal compensation for serving as an employee of Insightec. |
| Amit Sokolov | Amit Sokolov has received personal compensation for serving as an employee of Insightec. |
| Pei-Ning Hsu, MD | Dr. Hsu has nothing to disclose. |
| Tresa Zacharias, MD | An immediate family member of Dr. Zacharias has received personal compensation for serving as an employee of HCSC. Dr. Zacharias has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Liberty Mutual. Dr. Zacharias has received publishing royalties from a publication relating to health care. |
| João F. Lapenda | Mr. Lapenda has nothing to disclose. |
| Artur Menegaz de Almeida, MS | Mr. Menegaz de Almeida has nothing to disclose. |
| Ana Mattos | Miss Mattos has nothing to disclose. |
| Paulo V. Albuquerque | Mr. Albuquerque has nothing to disclose. |
| Lucas A. Araujo | Mr. Araujo has nothing to disclose. |
| Beatriz Mattos | Miss Mattos has nothing to disclose. |
| Andre G. Knopp, Student | Mr. Knopp has nothing to disclose. |
| Felipe L. Campos | Mr. Campos has nothing to disclose. |
| Maria F. Ferreira, Student | Miss Ferreira has nothing to disclose. |
| Camillo Farias | Mr. Farias has nothing to disclose. |
| Ana Laura Soares Silva, Medical Student | Ms. Soares Silva has nothing to disclose. |
| Catherine Garcia, MD | Dr. Garcia has nothing to disclose. |
| Keng Lam, MD | Dr. Lam has nothing to disclose. |
| Ashley E. Aaroe, MD | Dr. Aaroe has nothing to disclose. |
| Nazanin Majd, MD | Dr. Nazanin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo Dainippon Pharma Oncology. Dr. Nazanin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celularity . |
| Amishi Shah, MD | Dr. Shah has nothing to disclose. |
| Barbara O'Brien, MD | Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PlusTherapeutics. |
| Martin Tom, MD | Dr. Tom has nothing to disclose. |
| Nizar Tannir, MD | Dr. Tannir has nothing to disclose. |
| Debra Clamp, FACMPE | Ms. Clamp has nothing to disclose. |
| Jaya Trivedi, MD, FAAN | The institution of Dr. Trivedi has received research support from Avidity. |
| Alan Kramer, MD | No disclosure on file |
| Chelsea Landon, MHA | Mrs. Landon has nothing to disclose. |
| MARTHA SAJATOVIC, MD | Dr. SAJATOVIC has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck, Janssen, Teva, Otsuka, Alkermes. The institution of Dr. SAJATOVIC has received research support from Neurelis, Intra-Cellular, Merck, Otsuka, Alkermes, International Society for Bipolar Disorders (ISBD), National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), . Dr. SAJATOVIC has received publishing royalties from a publication relating to health care. |
| Gena R. Ghearing, MD | The institution of Dr. Ghearing has received research support from Center for Disease Control and Prevention. |
| Maegan Tyrrell, CCRP | Ms. Tyrrell has nothing to disclose. |
| Jessica Black, BA | Ms. Black has nothing to disclose. |
| Jacqueline Krehel-Montgomery, BA | Mrs. Krehel-Montgomery has nothing to disclose. |
| Richard Barigye, Msc | Mr. Barigye has nothing to disclose. |
| Joy Yala | No disclosure on file |
| Michael D. Privitera, MD, FAAN | Dr. Privitera has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK life science. Dr. Privitera has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace. Dr. Privitera has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK life science. Dr. Privitera has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Jazz. The institution of Dr. Privitera has received research support from Neurelis. The institution of Dr. Privitera has received research support from Biohaven. Dr. Privitera has received research support from Neurava. |
| Marvin A. Rossi, MD, PhD | Dr. Rossi has nothing to disclose. |
| Farren Briggs, PhD | The institution of Prof. Briggs has received research support from NIH. |
| Patrick Z. Liu, PhD | Dr. Liu has nothing to disclose. |
| Alan Napole, BS | Mr. Napole has nothing to disclose. |
| Lydia Denison, MD | Dr. Denison has nothing to disclose. |
| Noor F. Shaik, MD, PhD | Dr. Shaik has nothing to disclose. |
| Grace Anya A. Venezia, MD | Dr. Venezia has nothing to disclose. |
| Lovisa Ljungberg, MD | Dr. Ljungberg has nothing to disclose. |
| Michael A. Karamardian | Mr. Karamardian has nothing to disclose. |
| Colleen Peachey | Colleen Peachey has nothing to disclose. |
| Michael Buckley | Michael Buckley has nothing to disclose. |
| Charles J. Bae, MD | Dr. Bae has nothing to disclose. |
| Laura A. Stein, MD | Dr. Stein has nothing to disclose. |
| Denise J. Xu, MD | An immediate family member of Dr. Xu has received personal compensation for serving as an employee of Novartis. |
| Colin A. Ellis, MD | Dr. Ellis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epiminder. |
| Stephanie Zawada | Miss Zawada has nothing to disclose. |
| Oana M. Dumitrascu, MD, FAAN | Dr. Dumitrascu has nothing to disclose. |
| Caden Collins, College Graduate | Mr. Collins has nothing to disclose. |
| Bart Demaerschalk, MD, MSc, FRCPC, FAAN | Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Demaerschalk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurologist . The institution of Dr. Demaerschalk has received research support from NICHD. |
| Ali Ganjizadeh, MD | Dr. Ganjizadeh has nothing to disclose. |
| Bradley Erickson, MD, PhD | Dr. Erickson has nothing to disclose. |
| Yolanda C. Leon, PsyD, ABPdN | Dr. Leon has nothing to disclose. |
| K Brianalysse Nicolena Cedeño, BA | Ms. Cedeño has nothing to disclose. |
| Margarita Arencibia | Ms. Arencibia has nothing to disclose. |
| Bryan J. Neth, MD, PhD | Dr. Neth has nothing to disclose. |
| Aditya Raghunathan, MD | Dr. Raghunathan has nothing to disclose. |
| Umar Ghaffar, MBBS | Dr. Ghaffar has nothing to disclose. |
| Eva Alden, PhD | Dr. Alden has nothing to disclose. |
| Clifford R. Jack, Jr., MD | The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic. |
| Kathryn J. Ruddy, MD | The institution of Dr. Ruddy has received research support from National Institutes of Health. The institution of Dr. Ruddy has received research support from Department of Defense. Dr. Ruddy has received publishing royalties from a publication relating to health care. |
| Daniel S. Childs, MD | Dr. Childs has nothing to disclose. |
| r. jeffrey karnes, MD | The institution of Dr. karnes has received research support from FDA. |
| Jeffrey S Wefel | Jeffrey S Wefel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Jeffrey S Wefel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Jeffrey S Wefel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intracellular Therapies. The institution of Jeffrey S Wefel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cogstate. The institution of Jeffrey S Wefel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for GT Medical Technologies. The institution of Jeffrey S Wefel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Novocure. Jeffrey S Wefel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with NCI. |
| Mohamed Elnaeim, MBBS | Mohamed Elnaeim, MBBS has nothing to disclose. |
| Awab Kamal Mamoud Elnaeem, MD | Dr. Kamal Mamoud Elnaeem has nothing to disclose. |
| Ismat Babiker, MD | Dr. Babiker has nothing to disclose. |
| Eun Hye Kim, MD | Dr. Lee has stock in Pacific biosciences. |
| Brian L. Appavu, MD | Dr. Appavu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Natus. The institution of Dr. Appavu has received research support from American Heart Association. The institution of Dr. Appavu has received research support from United States Department of Defense. |
| Aline d. Matos, MD | The institution of Dr. Matos has received research support from Hoffmann LaRoche. |
| Andre Gomes, MD | Mr. Gomes has nothing to disclose. |
| Fernanda M. Maia, MD, PhD | Dr. Maia has nothing to disclose. |
| FLAVIA E. DAHY, MD | Miss DAHY has nothing to disclose. |
| Joao Victor Luisi de Moura, MD | Dr. Luisi de Moura has nothing to disclose. |
| Marcela V. Freire, MD | Dr. Freire has nothing to disclose. |
| JOSE E. VIDAL, MD, PhD | Dr. VIDAL has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen-Cilag. Dr. VIDAL has received research support from IMMY. |
| Rosa Marcusso N. Marcusso, Sr., MD | Prof. Marcusso has nothing to disclose. |
| Jerusa Smid, PhD | Dr. Smid has nothing to disclose. |
| Felipe Von Glehn Silva, MD, PhD, MSc, FAAN | Dr. Von Glehn Silva has nothing to disclose. |
| Jorge Casseb, MD | Dr. Casseb has nothing to disclose. |
| Augusto C. Penalva, PhD | Dr. Penalva has nothing to disclose. |
| Camila M. Romano, PhD | The institution of Dr. Romano has received research support from Conselho Nacional de Pesquisa e Desenvolvimento. |
| George Tachas, PhD | Dr. Tachas has stock in Percheron Therapeutic. Dr. Tachas has received personal compensation in the range of $100,000-$499,999 for serving as a Principal Scientist with Percheron Therapeutics Ltd. |
| Barbara Hanson, PhD | Dr. Hanson has nothing to disclose. |
| Lavanya Visvabharathy, PhD | The institution of Dr. Visvabharathy has received research support from NIH. |
| Igor J. Koralnik, MD, FAAN | Dr. Koralnik has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Investigation. The institution of Dr. Koralnik has received research support from National Institutes of Health. Dr. Koralnik has received publishing royalties from a publication relating to health care. |
| Advait Padhye, MBMSCI | Mr. Padhye has received personal compensation for serving as an employee of Percheron Therapeutics . Mr. Padhye has received intellectual property interests from a discovery or technology relating to health care. |
| Mark I. Boulos, MD, FRCPC, CSCN(EEG), MSc | Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision AQ. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sleep Medicine (journal). The institution of Dr. Boulos has received research support from Canadian Institutes of Health Research. The institution of Dr. Boulos has received research support from Slamen-Fast New Initiatives in Neurology Award. The institution of Dr. Boulos has received research support from Green Mountain . The institution of Dr. Boulos has received research support from RLS Foundation. The institution of Dr. Boulos has received research support from Temerty Centre for AI Research and 好色先生 in Medicine (T-CAIREM). The institution of Dr. Boulos has received research support from Heart & Stroke Foundation of Canada. The institution of Dr. Boulos has received research support from Alternative Funding Plan from the Academic Health Sciences Centres of Ontario. The institution of Dr. Boulos has received research support from StrokeCog. The institution of Dr. Boulos has received research support from McLaughlin Centre for Molecular Medicine . Dr. Boulos has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Jazz Pharmaceuticals. |
| Hans D. Katzberg, MD, FAAN | An immediate family member of Dr. Katzberg has received personal compensation for serving as an employee of Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Katzberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. |
| Mona Irannejad, Analyst | Miss Irannejad has nothing to disclose. |
| Jinyuru Yang | Miss Yang has nothing to disclose. |
| Sarah Berger | Ms. Berger has nothing to disclose. |
| Karthikeyan Umapathy, PhD | Dr. Umapathy has received research support from CIHR. |
| Tien Loc Le, MASc | Mr. Le has nothing to disclose. |
| Arun Sundaram, MD, FRCP | No disclosure on file |
| Karl Magtibay, PhD | Dr. Magtibay has nothing to disclose. |
| Sri Krishnan, PhD | Prof. Krishnan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Signal Processing. Prof. Krishnan has stock in Vitascope Inc. Prof. Krishnan has received publishing royalties from a publication relating to health care. |
| Heet Sheth | Mr. Sheth has nothing to disclose. |
| Lahiru Fernando, MBBS | Mr. Fernando has nothing to disclose. |
| Brian J. Murray, MD, FAAN | The institution of Dr. Murray has received research support from Wake Up Narcolepsy. Dr. Murray has received publishing royalties from a publication relating to health care. |
| Kevin Thorpe, MMath | Prof. Thorpe has nothing to disclose. |
| Lina A. Okar, MD | Dr. Okar has nothing to disclose. |
| Sandra Samuel, MD | Ms. Samuel has nothing to disclose. |
| Gabriela Mata, MD | Dr. Mata has nothing to disclose. |
| Pratap R. Chand, MD, FRCP, FAAN | Dr. Chand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. An immediate family member of Dr. Chand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda. Dr. Chand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Neuroscience. |
| William Whitton | William Whitton has received personal compensation for serving as an employee of Adelphi Real World. |
| Joshua Brown, PhD | Dr. Brown has received personal compensation for serving as an employee of Pfizer, Inc.. |
| Lucy Abraham | Lucy Abraham has received personal compensation for serving as an employee of Pfizer R&D UK Ltd. Lucy Abraham has stock in Pfizer R&D UK Ltd. |
| Karin Hygge Blakeman | Karin Hygge Blakeman has received personal compensation for serving as an employee of Pfizer. Karin Hygge Blakeman has stock in Pfizer. |
| James Jackson | James Jackson has nothing to disclose. |
| Lucy Hancock | Lucy Hancock has received personal compensation for serving as an employee of Adelphi Real World. |
| Feng Dai, PhD | Dr. Dai has received personal compensation for serving as an employee of Pfizer. |
| Sophie Barlow | Miss Barlow has received personal compensation for serving as an employee of Adelphi Real World. |
| Holly Jain, MD | Dr. Jain has received personal compensation for serving as an employee of Petauri Kinect. |
| Andrea Bozoki, MD, FAAN | Dr. Bozoki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creative Biopeptides. Dr. Bozoki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. The institution of Dr. Bozoki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AviadoBio. The institution of Dr. Bozoki has received research support from Cognition Therapeutics. The institution of Dr. Bozoki has received research support from EIP Pharma. The institution of Dr. Bozoki has received research support from Transposon Therapeutics. The institution of Dr. Bozoki has received research support from Alector . |
| Kimberly Huntington-Alfano, DO | Dr. Huntington-Alfano has nothing to disclose. |
| Sean Reeder, DO | Dr. Reeder has nothing to disclose. |
| Alan Kramer, MPH | Mr. Kramer has nothing to disclose. |
| Jennifer Zitser-Koren, MD | Dr. Zitser-Koren has nothing to disclose. |
| Hash Brown Taha | Mr. Taha has nothing to disclose. |
| Thomas Pelkmann, MD | Dr. Pelkmann has nothing to disclose. |
| Zahari Tchopev, MD | Dr. Tchopev has nothing to disclose. |
| Matthew Brock, MD | Dr. Brock has received research support from Department of Defense, Defense Health Program, Congressionally Directed Medical Research Programs. |
| Victoria Cocozza, DO | Dr. Cocozza has nothing to disclose. |
| Collin Clay, MD | Dr. Clay has nothing to disclose. |
| Helia Hosseini, MD | Dr. Hosseini has nothing to disclose. |
| Aristeidis Sotiras, PhD | Dr. Sotiras has stock in TheraPanacea. Dr. Sotiras has received personal compensation in the range of $500-$4,999 for serving as a Scientific Review Committee member with BrightFocus Foundation. |
| Arash Nazeri, MD | Dr. Nazeri has nothing to disclose. |
| Brian Gordon, PhD | Dr. Gordon has nothing to disclose. |
| Nelly C. Joseph-Mathurin, PhD | The institution of Dr. Joseph-Mathurin has received research support from Alzheimer's Association. The institution of Dr. Joseph-Mathurin has received research support from National Institute on Aging. Dr. Joseph-Mathurin has received personal compensation in the range of $500-$4,999 for serving as a Facilitator AAIC Live Event with PeerView Institute For Medical 好色先生. |
| Chihiro Sato, PhD | The institution of Dr. Sato has received research support from NIH. Dr. Sato has received intellectual property interests from a discovery or technology relating to health care. |
| Randall Bateman, MD | Dr. Bateman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for C2N Diagnostics . Dr. Bateman has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for C2N Diagnostics . Dr. Bateman has received stock or an ownership interest from C2N Diagnostics. The institution of Dr. Bateman has received research support from Alzheimer's SILQ Research Fund/ Barnes Jewish Hospital Foundation . The institution of Dr. Bateman has received research support from National Institutes of Health- R21AG067559. The institution of Dr. Bateman has received research support from Centene Corporation. The institution of Dr. Bateman has received research support from Rainwater Charitable Foundation . The institution of Dr. Bateman has received research support from Cure Alzheimer's Fund. The institution of Dr. Bateman has received research support from Cure Alzheimer's Fund. The institution of Dr. Bateman has received research support from Anonymous Foundation. The institution of Dr. Bateman has received research support from Cure Alzheimer's Fund. The institution of Dr. Bateman has received research support from BrightFocus Foundation. The institution of Dr. Bateman has received research support from Assn for Frontotemporal Degeneration FTD Biomarkers Initiative. The institution of Dr. Bateman has received research support from Rainwater Foundation. The institution of Dr. Bateman has received research support from NIH- R01NS095773. The institution of Dr. Bateman has received research support from AbbVie/Biogen/Eli Lilly. The institution of Dr. Bateman has received research support from NIH/NINDS/NIA- RF1AG061900 (R56AG061900 & R01NS065667). The institution of Dr. Bateman has received research support from Eisai. The institution of Dr. Bateman has received research support from Good Ventures Foundation. The institution of Dr. Bateman has received research support from National Institutes of Health- R01 AG070941. The institution of Dr. Bateman has received research support from National Institutes of Health-. The institution of Dr. Bateman has received research support from National Institutes of Health. The institution of Dr. Bateman has received research support from NIH- P50AG005681-36. The institution of Dr. Bateman has received research support from NIH/NIA- U19AG032438. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from Pharma Consortium. The institution of Dr. Bateman has received research support from Eli Lilly . The institution of Dr. Bateman has received research support from NIH/NIA- NIH R01AG053267. The institution of Dr. Bateman has received research support from Administrative Supplement 01- NIH . The institution of Dr. Bateman has received research support from Administrative Supplement 02- NIH . The institution of Dr. Bateman has received research support from NIH- 1U01AG059798. The institution of Dr. Bateman has received research support from NIH- R01AG068319. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from Roche. The institution of Dr. Bateman has received research support from NIH/NIA- R01AG046179. The institution of Dr. Bateman has received research support from GHR; Anonymous Foundation. The institution of Dr. Bateman has received research support from NIH/NIA- 1U01AG042791, 1U01AG042791. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from NIH/State Government- 5U19AG010483. Dr. Bateman has received intellectual property interests from a discovery or technology relating to health care. |
| Tammie Benzinger | Tammie Benzinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tammie Benzinger has received personal compensation in the range of $0-$499 for serving as a Consultant for Sora Neuroscience. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Tammie Benzinger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Tammie Benzinger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Tammie Benzinger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol, Myers Squibb. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PeerView. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. The institution of Tammie Benzinger has received research support from Siemens. The institution of Tammie Benzinger has received research support from Hyperfine. Tammie Benzinger has a non-compensated relationship as a Consultant with Siemens that is relevant to AAN interests or activities. Tammie Benzinger has a non-compensated relationship as a Consultant with Eisai that is relevant to AAN interests or activities. |
| Qing Tang, MS | Ms. Tang has nothing to disclose. |
| Brian Stamm, MD | Dr. Stamm has received personal compensation in the range of $10,000-$49,999 for serving as a Physician with Veterans Health Administration. |
| Joanne Daggy | Joanne Daggy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of Joanne Daggy has received research support from NIH. |
| Laura Myers | The institution of Laura Myers has received research support from VA. |
| Samantha Calcatera, PhD | Dr. Calcatera has nothing to disclose. |
| Katrina Spontak, MS | Ms. Spontak has nothing to disclose. |
| Jason Larson, Researcher | Mr. Larson has nothing to disclose. |
| William S. Musser, MD | Dr. Musser has nothing to disclose. |
| Lisa D. Hermann, MD | Dr. Hermann has nothing to disclose. |
| Teresa M. Damush, PhD | The institution of Dr. Damush has received research support from Veterans Health Administration. The institution of Dr. Damush has received research support from National Cancer Institute. The institution of Dr. Damush has received research support from PCORI. |
| Linda S. Williams, MD, FAAN | The institution of Dr. Williams has received research support from VA HSR&D. |
| Lisa Nobel | Ms. Nobel has nothing to disclose. |
| Gulbudin Muhammad, MD | Dr. Muhammad has nothing to disclose. |
| Hira Pervez, MD, MBBS | Dr. Pervez has nothing to disclose. |
| Fahham Asghar, MD | Mr. Asghar has nothing to disclose. |
| Syed Owais, MD | Dr. Owais has nothing to disclose. |
| Naeem Mahfooz, MD | Dr. Mahfooz has nothing to disclose. |
| Imran I. Ali, MD, FAAN | Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. |
| Ajaz Sheikh, MD | Dr. Sheikh has nothing to disclose. |
| Jonathan Trout, MD | Dr. Trout has nothing to disclose. |
| Steven Vernino, MD, PhD, FAAN | Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron. |
| Rachel R. Codden, MPH | Mrs. Codden has nothing to disclose. |
| Jenavieve Barson | Ms. Barson has nothing to disclose. |
| Geoffrey Laforge, PhD | An immediate family member of Dr. Laforge has received research support from National Institutes of Health. |
| Alex Billings | Miss Billings has nothing to disclose. |
| Moiz Lakhani, BHSc, MD (C) | Mr. Lakhani has nothing to disclose. |
| Angela T. Kwan, MSc | Miss Kwan has nothing to disclose. |
| Kayla Teopiz | Kayla Teopiz has received personal compensation in the range of $10,000-$49,999 for serving as a Contractor with Braxia Scientific Corp. Kayla Teopiz has received personal compensation in the range of $500-$4,999 for serving as a Contractor with Brain and Cognition Discovery Foundation. |
| Charnjit S. Nijjar, MD Candidate | Mr. Nijjar has nothing to disclose. |
| Shakila Meshkat, MD | Dr. Meshkat has nothing to disclose. |
| Sebastian Badulescu | Sebastian Badulescu has nothing to disclose. |
| Ho C. Man, MD | Prof. Man has nothing to disclose. |
| Greg Rhee, PhD | Prof. Rhee has nothing to disclose. |
| Hartej Gill, PhD | Mr. Gill has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. |
| Roger McIntyre | Roger McIntyre has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Viatris, Abbvie, Atai Life Sciences. Roger McIntyre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Viatris, Abbvie, Atai Life Sciences. Roger McIntyre has received personal compensation in the range of $5,000-$9,999 for serving as a Research Grant Support with CIHR/GACD/National Natural Science Foundation of China (NSFC) and the Milken Institute. |
| Yoya Ono | Mr. Ono has nothing to disclose. |
| Yasuko Mori, Sr., MD | Dr. Mori has nothing to disclose. |
| Nobuaki Yoshikura, MD, PhD | Dr. Yoshikura has nothing to disclose. |
| Brent L. Fogel, MD, PhD, FAAN | Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Ataxia Foundation. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ataxia Global Initiative. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genes. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuromarkers. The institution of Dr. Fogel has received research support from the National Institutes of Health. The institution of Dr. Fogel has received research support from the National Ataxia Foundation. The institution of an immediate family member of Dr. Fogel has received research support from the National Institutes of Health, the National Science Foundation, and the Department of Defense. The institution of Dr. Fogel has received research support from US Department of Defense . |
| Sonya Watson, MS CGC | Miss Watson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus Pharmaceuticals. |
| Kathie J. Ngo | Ms. Ngo has nothing to disclose. |
| Hannah A. Stevens, MS | Ms. Stevens has nothing to disclose. |
| Darice Y. Wong, PhD | The institution of an immediate family member of Dr. Wong has received research support from NIH. |
| Clara Lajonchere, PhD | Dr. Lajonchere has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognoa, Inc. Dr. Lajonchere has stock in Cognoa, Inc. The institution of Dr. Lajonchere has received research support from NIH. Dr. Lajonchere has received intellectual property interests from a discovery or technology relating to health care. |
| Daniel Moreno-Zambrano, MD | Dr. Moreno-Zambrano has nothing to disclose. |
| Yamila Remon Gonzalez, MD | Dr. Remon Gonzalez has nothing to disclose. |
| Juan Toral, MD, MPH | Dr. Toral has nothing to disclose. |
| Sonal Mehta, MD | Dr. Mehta has nothing to disclose. |
| Minhee Kim, MD, PhD | Dr. Kim has nothing to disclose. |
| Shikhar Khurana, MD | Dr. Khurana has nothing to disclose. |
| Adam Friedant, DO | Dr. Friedant has nothing to disclose. |
| Jonathan Dissin, MD | Dr. Dissin has received stock or an ownership interest from GlaxoSmithKline. Dr. Dissin has received stock or an ownership interest from Abbvie. |
| Marshall C. Freeman, MD, FAAN | Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Southern Headache Society . The institution of Dr. Freeman has received research support from AbbVie. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. The institution of Dr. Freeman has received research support from Satsuma. The institution of Dr. Freeman has received research support from Pfizer. The institution of Dr. Freeman has received research support from Ipsen. |
| Calli L. Cook, DNP, FNP-C, DAAN, FAAN | Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer . Dr. Cook has a non-compensated relationship as a Board Member with Alliance for Patient Access that is relevant to AAN interests or activities. |
| Annika Ehrlich, DNP, FNP-C, AQH, CNRN | Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie Pharmaceuticals. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pharmamark. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Focus MedEd. Dr. Ehrlich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for eNeura. Dr. Ehrlich has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Axome Therapeutics. Dr. Ehrlich has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Ehrlich has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neurology Advanced Practice Providers. Dr. Ehrlich has a non-compensated relationship as a Board President with Alliance for Headache Disorders Advocacy that is relevant to AAN interests or activities. Dr. Ehrlich has a non-compensated relationship as a Board President with The Headache Alliance that is relevant to AAN interests or activities. Dr. Ehrlich has a non-compensated relationship as a Advanced Practice Provider Board Liaison with American Headache Society that is relevant to AAN interests or activities. |
| Marielle K. Samaha, MD, FAHS, FAAN, FAAN | Dr. Samaha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for theranica. Dr. Samaha has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AAN . The institution of Dr. Samaha has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AAP. Dr. Samaha has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for theranica. |
| Maureen A. Moriarty, NP | Dr. Moriarty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Moriarty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Moriarty has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Moriarty has received research support from Teva. |
| Karissa Secora | Ms. Secora has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie Inc. Ms. Secora has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Impel Pharmaceuticals Inc.. |
| Juliana VanderPluym, MD | Dr. VanderPluym has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology and Neuroscience Reports. The institution of Dr. VanderPluym has received research support from Amgen. |
| Laur Marius Birlea, MD, FAAN | Dr. Birlea has nothing to disclose. |
| Ocilio R. Goncalves, MS | Mr. Goncalves has nothing to disclose. |
| Maria Antonia O. Machado Pereira | Miss Machado Pereira has nothing to disclose. |
| Beatriz Borba e Silva, Medical Student | Miss Borba e Silva has nothing to disclose. |
| Rafael R. Oliveira | Mr. Oliveira has nothing to disclose. |
| Izabely Dos reis de paula, Ms | Ms. Dos reis de paula has nothing to disclose. |
| Miriam L. Freimer, MD, FAAN | Dr. Freimer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J and J. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Freimer has received research support from Alnylum. The institution of Dr. Freimer has received research support from UCB. The institution of Dr. Freimer has received research support from NIH. The institution of Dr. Freimer has received research support from Janssen. Dr. Freimer has received research support from Avidity. Dr. Freimer has received research support from Fulcrum. The institution of Dr. Freimer has received research support from Dept of defense. The institution of an immediate family member of Dr. Freimer has received research support from Abcurro. Dr. Freimer has received personal compensation in the range of $10,000-$49,999 for serving as a presentations/teaching with UCB. |
| Urvi G. Desai, MD, FAAN | Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. |
| Raghav Govindarajan, MD, FAAN | Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care. |
| Min Kang, MD | Dr. Kang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Bioepis. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J&J. The institution of Dr. Kang has received research support from UCSF resource allocation program . |
| Shaida Khan, DO | Dr. Khan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB pharma. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Group instructor with Real CME. |
| Bhupendra O. Khatri, MD, FAAN | Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ER Squibb (Bristol Myer Squibb). Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizone. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyne. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seronoe. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for E.R. Squibb. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutic. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx US. The institution of Dr. Khatri has received research support from Biogen. |
| Todd D. Levine, MD | Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has or had stock in CND Life Sciences.Dr. Levine has or had stock in Corinthian reference lab. |
| Perry Shieh, MD, PhD, FAAN | Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Shieh has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst. |
| Michael D. Weiss, MD, FAAN | Dr. Weiss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB-RA. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Soleo. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. |
| Babak Boroojerdi, MD | Dr. Boroojerdi has received personal compensation for serving as an employee of UCB Biosciences. Dr. Boroojerdi has stock in UCB Biosciences. |
| Eumorphia DELICHA | Eumorphia DELICHA has nothing to disclose. |
| Andreea Lavrov | Andreea Lavrov has received personal compensation for serving as an employee of UCB Biosciences GmbH. An immediate family member of Andreea Lavrov has received personal compensation for serving as an employee of UCB Biosciences GmbH. Andreea Lavrov has stock in UCB Biosciences GmbH. An immediate family member of Andreea Lavrov has stock in UCB Biosciences GmbH. |
| Puneet V. Singh, MBBS | Dr. Singh has nothing to disclose. |
| Ashim Ahuja, MD | Dr. Ahuja has nothing to disclose. |
| John M. Ringman, MD, FAAN | The institution of Dr. Ringman has received research support from Avid Pharmaceuticals. The institution of Dr. Ringman has received research support from AltaMed. The institution of Dr. Ringman has received research support from CurePSP. |
| Aditya Chanpura, MD, MBBS | Dr. Chanpura has nothing to disclose. |
| Rajesh K. Gupta, MBBS | Dr. Gupta has nothing to disclose. |
| Shitiz K. Sriwastava, MBBS | Dr. Sriwastava has nothing to disclose. |
| Jan Rahmig, MD | Dr. Rahmig has nothing to disclose. |
| Philion Gatchoff, MD | Dr. Gatchoff has nothing to disclose. |
| Claire E. Delpirou Nouh, MD | The institution of Dr. Delpirou Nouh has received research support from Oklahomas Nathan Shock Center. Dr. Delpirou Nouh has a non-compensated relationship as a Volunteer/Board member with Oklahoma Alzheimer Association that is relevant to AAN interests or activities. |
| Chao Xu | Chao Xu has nothing to disclose. |
| Andrea Vincent | Andrea Vincent has received personal compensation for serving as an employee of Vista LifeSciences. The institution of Andrea Vincent has received research support from Medical Technology Enterprise Consortium (MTEC). |
| Leslie Guthery | Leslie Guthery has nothing to disclose. |
| Jason Sharps | Jason Sharps has nothing to disclose. |
| Fabiola Donna-Ferreira, MD | Dr. Donna-Ferreira has nothing to disclose. |
| James George | James George has nothing to disclose. |
| Angelia Kirkpatrick | Angelia Kirkpatrick has nothing to disclose. |
| Calin I. Prodan, MD | The institution of Dr. Prodan has received research support from US Department of Veterans Affairs (Merit award CX000340). |
| Emina Dzafic | Ms. Dzafic has nothing to disclose. |
| Hesham Kelani, MD | Dr. Kelani has nothing to disclose. |
| Ahmed Abd Elazim, MD | Dr. Abd Elazim has nothing to disclose. |
| Lauren V. Hatcher, MD | Dr. Hatcher has nothing to disclose. |
| Srikanth Adidam Venkata, MD | Dr. Adidam Venkata has nothing to disclose. |
| Selvalakshmi Rathinavelu, MD, MBBS | Dr. Rathinavelu has nothing to disclose. |
| Mohammad Jadidi, MD | Dr. Jadidi has nothing to disclose. |
| Artem Sunik, MD | Dr. Sunik has nothing to disclose. |
| Arthur D. Kay, MD | Dr. Kay has nothing to disclose. |
| David P. Lerner, MD | Dr. Lerner has received publishing royalties from a publication relating to health care. |
| Lisa R. Merlin, MD, FAAN | Dr. Merlin has nothing to disclose. |
| Diana Greene-Chandos, MD, FAAN | Dr. Greene-Chandos has nothing to disclose. |
| Maryam J. Syed, MBBS | Dr. Syed has nothing to disclose. |
| Rohit A. Marawar, MD, FAAN | Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Marawar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. |
| Doha Amin, DO | Miss Amin has nothing to disclose. |
| Gogi Kumar, MD | Dr. Kumar has nothing to disclose. |
| Laura Fonseca | Laura Fonseca has nothing to disclose. |
| Elissa Yozawitz, MD | Dr. Yozawitz has nothing to disclose. |
| Charuta N. Joshi, MBBS, MCSC, CSCN(EEG) | Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Longboard Pharmaceuticals. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Praxis. The institution of Dr. Joshi has received research support from Jazz pharmaceuticals. Dr. Joshi has received intellectual property interests from a discovery or technology relating to health care. Dr. Joshi has a non-compensated relationship as a Board of Directors with PERC that is relevant to AAN interests or activities. Dr. Joshi has a non-compensated relationship as a Scientific Advisor with CCC that is relevant to AAN interests or activities. Dr. Joshi has a non-compensated relationship as a treasurer with ICNA that is relevant to AAN interests or activities. |
| Clare Skora, MD | The institution of an immediate family member of Dr. Skora has received research support from National Science Foundation. An immediate family member of Dr. Skora has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Skora has received intellectual property interests from a discovery or technology relating to health care. |
| Sucheta M. Joshi, MD | No disclosure on file |
| Nassim Zecavati, MD, FAAN | Dr. Zecavati has nothing to disclose. |
| Elizabeth A. Ng, MD, FAAP, FAANEM, FACNS, FAES | Dr. Ng has nothing to disclose. |
| Hwai Y. Ooi, MD | Dr. Ooi has nothing to disclose. |
| Danielle I. Yerdon | Ms. Yerdon has nothing to disclose. |
| David Q. Mao, MD | Dr. Mao has nothing to disclose. |
| Bryan Paulo L. Canlas, DO | Dr. Canlas has nothing to disclose. |
| Michel A. Ritenuti, DO | Dr. Ritenuti has nothing to disclose. |
| Krima Patel, DO | Dr. Patel has nothing to disclose. |
| Jenny Hua, DO | Dr. Hua has nothing to disclose. |
| Mark Boyer, DO | Dr. Boyer has nothing to disclose. |
| Anne Trager, DO | Dr. Trager has nothing to disclose. |
| Zoe O. Marinides, MD | Dr. Marinides has nothing to disclose. |
| Virginia Baker, MD | Dr. Baker has nothing to disclose. |
| Glen A. Cook, Jr., MD, FAAN | Dr. Cook has stock in Aspire Biopharma. An immediate family member of Dr. Cook has stock in Aspire Biopharma. |
| Jordan S. Dubow, MD | Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revalesio . |
| Debra G. Silberg, MD, PhD | Dr. Silberg has received personal compensation for serving as an employee of Beyond Celiac. Dr. Silberg has received personal compensation for serving as an employee of Finch. Dr. Silberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Ellodi. Dr. Silberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Silberg Consulting, LLC. Dr. Silberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Silberg has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Ellodi. Dr. Silberg has stock in Takeda. Dr. Silberg has received intellectual property interests from a discovery or technology relating to health care. |
| Erin B. Miller, MPH | Ms. Miller has received personal compensation for serving as an employee of Beyond Celiac. The institution of Ms. Miller has received research support from Takeda Pharmaceuticals. |
| Kate T. Avery, MPH | Ms. Avery has received personal compensation for serving as an employee of Beyond Celiac. An immediate family member of Ms. Avery has stock in Johnson & Johnson. |
| Kimmy Su, MD | Dr. Su has nothing to disclose. |
| John Sanderson, MD | Dr. Sanderson has nothing to disclose. |
| Cyrus P. Zabetian, MD | The institution of Dr. Zabetian has received research support from American Parkinson Disease Association. The institution of Dr. Zabetian has received research support from Department of Veterans Affairs. The institution of Dr. Zabetian has received research support from NIH. Dr. Zabetian has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities. |
| Richard J. Nowak, MD | Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janseen . The institution of Dr. Nowak has received research support from UCB. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Janseen. The institution of Dr. Nowak has received research support from Immunovant . The institution of Dr. Nowak has received research support from argenx. The institution of Dr. Nowak has received research support from Amgen. Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities. |
| Minjee Park, MSc | Ms. Park has received personal compensation for serving as an employee of Alira Health. |
| Pushpa Narayanaswami, MD, MBBS, FAAN | Dr. Narayanaswami has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for UCB. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx USA. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD pharma. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD-Serono (Merck usa). Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Immuneabs. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viridian. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta-Bio. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Bio. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve, Wiley. Dr. Narayanaswami has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Narayanaswami has or had stock in Dr. Reddys laboratories.Dr. Narayanaswami has or had stock in Doximity. The institution of Dr. Narayanaswami has received research support from Alexion. The institution of Dr. Narayanaswami has received research support from NIH. The institution of Dr. Narayanaswami has received research support from Argenx. The institution of Dr. Narayanaswami has received research support from Cabaletta Bio. Dr. Narayanaswami has received publishing royalties from a publication relating to health care. Dr. Narayanaswami has a non-compensated relationship as a Member, Finance Committee with AANEM that is relevant to AAN interests or activities. |
| Nizar Souayah, MD, FAAN | Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care. |
| Michael Kutch, MS | Mr. Kutch has nothing to disclose. |
| Amaia Zurinaga | Miss Zurinaga has nothing to disclose. |
| Aurélie CHEKROUN MARTINOT | Mrs. CHEKROUN MARTINOT has nothing to disclose. |
| Nolan Campbell, PhD | Dr. Campbell has received personal compensation for serving as an employee of Johnson and Johnson. |
| Zia U. Choudhry, MD, PhD | Dr. Chaudhry has received personal compensation for serving as an employee of Johnson & Johnson. Dr. Chaudhry has received personal compensation for serving as an employee of Takeda Pharmaceuticals. |
| Bardiya Ghaderi Yazdi, MD | Dr. Ghaderi Yazdi has nothing to disclose. |
| Seyed Hani Hojjati, PhD | Dr. Hojjati has nothing to disclose. |
| Nancy Foldi, PhD | Dr. Foldi has nothing to disclose. |
| Ray Razlighi, PhD | Prof. Razlighi has nothing to disclose. |
| Charlotte Ward | No disclosure on file |
| Elizabeth Teperov | Elizabeth Teperov has nothing to disclose. |
| Kushal Naik | No disclosure on file |
| CECILE BLEIN, PhD | Dr. BLEIN has received personal compensation for serving as an employee of argenx. Dr. BLEIN has stock in argenx. |
| Sreehari Dinesh, MD | Dr. Dinesh has nothing to disclose. |
| Sankar P. Gorthi, MD, FAAN | Dr. Gorthi has nothing to disclose. |
| Dulari Gupta, MD, MBBS | Dr. Gupta has nothing to disclose. |
| Rafaella Cazé de Medeiros, MD | Miss Cazé de Medeiros has nothing to disclose. |
| Shuo M. Sun, PhD | Dr. Sun has nothing to disclose. |
| Sebastien Haneuse | Sebastien Haneuse has received personal compensation for serving as an employee of Harvard University. Sebastien Haneuse has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. |
| Lidia Maria V. Moura, MD, PhD, MPH, FAAN | Dr. Moura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Moura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Moura has received research support from Centers for Diseases Control and Prevention (CDC SIP20-007) . The institution of Dr. Moura has received research support from Epilepsy Foundation of America . The institution of Dr. Moura has received research support from NIH - NIA and NINDS. Dr. Moura has received personal compensation in the range of $50,000-$99,999 for serving as a Expert Advisor with Epilepsy Foundation . |
| Julianne Brooks | Julianne Brooks has nothing to disclose. |
| Madhav Sankaranarayanan | Mr. Sankaranarayanan has nothing to disclose. |
| Jeffrey Yu, PhD | Dr. Yu has received personal compensation for serving as an employee of Alexion. Dr. Yu has stock in AstraZeneca. |
| Adrian Kielhorn | Adrian Kielhorn has received personal compensation for serving as an employee of Alexion. Adrian Kielhorn has stock in Alexion. |
| Jim C. Murdoch, PhD | Dr. Murdoch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for M&B Sciences. Dr. Murdoch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for XOME. |
| Marcus M. Martin, PhD | Dr. Martin has nothing to disclose. |
| Eddilisa Martin, PHARMD | Dr. Martin has nothing to disclose. |
| Kelly McNeil-Posey, RN | Mrs. McNeil-Posey has received personal compensation for serving as an employee of Alexion Pharma. |
| Barbara Mungin, PhD | Dr. Mungin has nothing to disclose. |
| Yiyi Xia | Ms. Xia has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Ms. Xia has stock in Astrazeneca. |
| Wendy Erler, MBA | Mrs. Erler has received personal compensation for serving as an employee of Alexion Astra Zeneca. Mrs. Erler has stock in Alexion Astra Zeneca. |
| Nuwan Kurukulasuriya | Dr. Kurukulasuriya has received personal compensation for serving as an employee of AstaZeneca/Alexion. Dr. Kurukulasuriya has received personal compensation for serving as an employee of AstraZeneca/Alexion. Dr. Kurukulasuriya has stock in AstraZeneca/Alexion. Dr. Kurukulasuriya has stock in AstraZeneca/Alexion. |
| Richard A. Able, Jr., PhD | Dr. Able has received personal compensation for serving as an employee of Praxis Medicines. Dr. Able has received personal compensation for serving as an employee of PTC Therapeutics. Dr. Able has stock in Praxis Medicines. Dr. Able has received personal compensation in the range of $0-$499 for serving as a Employee with PTC therapeutics. |
| Lillian Matthews, PhD | Dr. Matthews has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Matthews has stock in Praxis Precision Medicines. |
| Alex La Croix | Mr. La Croix has received personal compensation for serving as an employee of Praxis Precision Medicines. Mr. La Croix has stock in Praxis Precision Medicines. |
| Carol Clark | Ms. Clark has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Praxis Precision Medicines. |
| Marcio Souza | Marcio Souza has received personal compensation for serving as an employee of Praxis Precision Medicines. |
| Shuhei Nishiyama, MD, PhD | Dr. Nishiyama has nothing to disclose. |
| Michael Levy, MD, PhD, FAAN | Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health. |
| Takahisa Mikami, MD | Dr. Mikami has nothing to disclose. |
| A. Gordon Smith, MD, FAAN | Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for US Department of Justice. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Lexicon. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Smith has received research support from NIH (NINDS, NIDDK). Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received personal compensation in the range of $0-$499 for serving as a Study Section with NIH. |
| Neelam Goyal, MD, FAAN | Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Goyal has received research support from Argenx. |
| Cynthia Qi | Cynthia Qi has received personal compensation for serving as an employee of argenx. |
| Arash Mahajerin, MD, MSCr | Dr. Mahajerin has received personal compensation for serving as an employee of argenx. Dr. Mahajerin has stock in argenx. |
| Renee Campbell, MD | Dr. Campbell has received personal compensation for serving as an employee of argenx. Dr. Campbell has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Guidehouse. |
| Matt Jefferson | Matt Jefferson has received personal compensation for serving as an employee of argenx. Matt Jefferson has stock in argenx. |
| Rohit Menon | Rohit Menon has received personal compensation for serving as an employee of ZS Associates. |
| Sam Selvaraj, Bachelor of Technology | Mr. Selvaraj has received personal compensation for serving as an employee of ZS Associates. |
| Mai Sato, PhD | Dr. Sato has received personal compensation for serving as an employee of ZS Associates. |
| Casandra MacLeod, DO | Dr. MacLeod has nothing to disclose. |
| Deborah Hornacek, MD | Dr. Hornacek has nothing to disclose. |
| Ashwaq Almalki, MD | Dr. Almalki has nothing to disclose. |
| Nagma Dalvi, MD | Dr. Dalvi has nothing to disclose. |
| Daniel Lax, MD | Dr. Lax has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Lax has received personal compensation in the range of $500-$4,999 for serving as a CME Lecturer with American Headache Society. |
| Michael Rigby, MD, PhD | Dr. Rigby has nothing to disclose. |
| Leland Barnard | Leland Barnard has nothing to disclose. |
| Zachary A. Trottier | Mr. Trottier has nothing to disclose. |
| Aaron R. Switzer, MD | Dr. Switzer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Company Limited. |
| Yue Liu | Ms. Liu has nothing to disclose. |
| Zhen Hong | Prof. Hong has nothing to disclose. |
| Varsha Muddasani, MBBS | Dr. Muddasani has nothing to disclose. |
| Apoorva Subramanian, MD | Dr. Subramanian has nothing to disclose. |
| Nandakumar Mohan, DO | Dr. Mohan has nothing to disclose. |
| Saman Zafar, MD | Dr. Zafar has nothing to disclose. |
| Ryan R. Walsh, MD, PhD, FAAN | Dr. Walsh has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Walsh has stock in Praxis Precision Medicines. |
| Megan Sniecinski | Megan Sniecinski has received personal compensation for serving as an employee of Praxis Precision Medicines. Megan Sniecinski has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Praxis Precision Medicines. |
| Taylor Crush, MPH | Mrs. Crush has received personal compensation for serving as an employee of Praxis Precision Medicines. Mrs. Crush has stock in Praxis Precision Medicines . |
| claudio lavareda santos, MD | Dr. lavareda santos has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. lavareda santos has stock in Praxis Precision Medicines. |
| Steven Petrou, FAHMS | Dr. Petrou has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Petrou has stock in Praxis Precision Medicines. The institution of Dr. Petrou has received research support from Praxis Precision Medicines. Dr. Petrou has received intellectual property interests from a discovery or technology relating to health care. |
| Aparna Wagle-Shukla, MD, FAAN | Dr. Wagle-Shukla has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Encora. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Tremor research group. The institution of Dr. Wagle-Shukla has received research support from NIH. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as a reviewer with NIH. |
| Peter A. LeWitt, MD | Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. LeWitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. LeWitt has received research support from Michael J Fox Foundation. |
| Gerardo Gutierrez, MD | Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. An immediate family member of Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharmamar. An immediate family member of Dr. Gutierrez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. An immediate family member of Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol, Myers, Squibb. An immediate family member of Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra-Zeneca. Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra-Zeneca. Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson&Johnson. Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Gutierrez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Gutierrez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Gutierrez has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alter. |
| Rocío Gómez, Other | Ms. Gómez has received personal compensation for serving as an employee of Roche Farma Spain, Medical Department. |
| Javier Sotoca Fernandez | Javier Sotoca Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Javier Sotoca Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Javier Sotoca Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Javier Sotoca Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Javier Sotoca Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. |
| Adrian Ares-Luque, MD | Dr. Ares-Luque has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Ares-Luque has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. |
| Ramon Villaverde Gonzalez | Ramon Villaverde Gonzalez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Ramon Villaverde Gonzalez has received research support from Roche. |
| Virginia Reyes Garrido, Jr., MD | Ms. Reyes Garrido has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Ms. Reyes Garrido has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi . Ms. Reyes Garrido has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Ms. Reyes Garrido has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ROCHE. Ms. Reyes Garrido has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Ms. Reyes Garrido has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Ms. Reyes Garrido has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NOVARTIS . Ms. Reyes Garrido has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall. Ms. Reyes Garrido has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Ms. Reyes Garrido has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. |
| Thais Armangue, MD | Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP. |
| Luis Querol, MD, PhD | Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. The institution of Dr. Querol has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Querol has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ArgenX. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avilar. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocryst. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KPL. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lycia. The institution of Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Querol has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Querol has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Querol has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Querol has received research support from GBS-CIDP Foundation International. The institution of Dr. Querol has received research support from Grifols. The institution of Dr. Querol has received research support from ISCIII. The institution of Dr. Querol has received research support from CIBERER. The institution of Dr. Querol has received research support from UCB. The institution of Dr. Querol has received research support from ArgenX. |
| Elisa Salas Alonso | Elisa Salas Alonso has nothing to disclose. |
| Paola Diaz, MD | Mrs. Diaz has nothing to disclose. |
| Jorge Maurino | Jorge Maurino has received personal compensation for serving as an employee of Roche Pharma Spain, Medical Department. |
| Raul G. Nogueira, MD | Dr. Nogueira has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Hybernia, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, and Synchron (consulting fees) as well as for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, RapidPulse and Perfuze ( stock options). Dr. Nogueira has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firms. Dr. Nogueira has received stock or an ownership interest from Viz-AI, Perfuze, Cerebrotech, Reist/Q'Apel Medical, Truvic, and Viseon. The institution of Dr. Nogueira has received research support from Cerenovus. |
| Alhamza Al-Bayati, MD | Dr. Al-Bayati has nothing to disclose. |
| Marcelo Rocha, MD, PhD | The institution of Dr. Rocha has received research support from NIH. |
| Matthew T. Starr, MD | Dr. Starr has nothing to disclose. |
| Lucas Rios Rocha, MD | Dr. Rios Rocha has nothing to disclose. |
| Nirav Bhatt, MD | Dr. Bhatt has nothing to disclose. |
| Anmol Almast | Miss Almast has nothing to disclose. |
| Mohamed Fahmy Doheim | Mr. Doheim has nothing to disclose. |
| Jussie Correia Lima, MD | Dr. Correia Lima has nothing to disclose. |
| Bradley Gross, MD | Dr. Gross has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Gross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Microvention. Dr. Gross has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. |
| Michael Lang, MD | Dr. Lang has nothing to disclose. |
| Abdullah M. Al-Qudah, MD | Dr. Al-Qudah has nothing to disclose. |
| Justin M. Nolte, MD | Dr. Nolte has nothing to disclose. |
| Syed H. Inam, MD | Dr. Inam has nothing to disclose. |
| Bishal Dhakal | Bishal Dhakal has nothing to disclose. |
| Qurat Ul Ain Muhammad, MBBS | Dr. Muhammad has nothing to disclose. |
| Rojina Pokharel, MBBS | Dr. Pokharel has nothing to disclose. |
| Ram Subedi, MD | Ram Subedi has nothing to disclose. |
| Sagun Dawadi, MBBS | Dr. Dawadi has nothing to disclose. |
| Aashish Baniya, MBBS | Dr. Baniya has nothing to disclose. |
| Kushal Shrestha | Kushal Shrestha has nothing to disclose. |
| Raju Paudel, MD | Dr. Paudel has nothing to disclose. |
| Prabin Basnet, MBBS | Dr. Basnet has nothing to disclose. |
| Tigran Kesayan, MD | Dr. Kesayan has nothing to disclose. |
| David R. Curfman, MD | Dr. Curfman has nothing to disclose. |
| Daniel B. Larach, MD | An immediate family member of Dr. Larach has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intuitive Surgical. |
| Amanda Toye, MD | Dr. Toye has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for General Dynamics Information Technology. |
| Jennifer M. Slayton, RN, DNP | Dr. Slayton has nothing to disclose. |
| Carin McAbee, MA | Ms. McAbee has nothing to disclose. |
| Kelly M. Brown, MD | An immediate family member of Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. An immediate family member of Dr. Brown has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Black Swan. The institution of an immediate family member of Dr. Brown has received research support from Sirtex. |
| Hayley Rector, PharmD | Dr. Rector has nothing to disclose. |
| Elizabeth Huggins | Elizabeth Huggins has nothing to disclose. |
| Tyler W. Barrett, MD MSCI, MD | Dr. Barrett, MD MSCI has nothing to disclose. |
| Dane M. Chetkovich, MD, PhD, FAAN | Dr. Chetkovich has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Legal Matters. The institution of Dr. Chetkovich has received research support from NIH. Dr. Chetkovich has a non-compensated relationship as a committee service member with ABPN that is relevant to AAN interests or activities. |
| Mercedes F. Martin, NP | Mrs. Martin has received personal compensation for serving as an employee of UCB. |
| Laurie M. Bailey, BCPA | Ms. Bailey has received personal compensation for serving as an employee of UCB, Inc.. Ms. Bailey has stock in UCB, Inc.. |
| Tracy Dixon-Salazar | Tracy Dixon-Salazar has received personal compensation for serving as an employee of Lennox-Gastaut Syndrome (LGS) Foundation. |
| Mary Anne Meskis, N/A | Mrs. Meskis has received personal compensation in the range of $100,000-$499,999 for serving as a Executive Director with Dravet Syndrome Foundation. |
| Amelie Lothe, PhD | Dr. Lothe has received personal compensation for serving as an employee of UCB. Dr. Lothe has stock in UCB. |
| Mitsuyuki Matsumoto, PhD | Dr. Matsumoto has received personal compensation for serving as an employee of Arialys Therapeutics, Inc.. Dr. Matsumoto has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Arialys Therapeutics, Inc.. Dr. Matsumoto has or had stock in Arialys Therapeutics, Inc..Dr. Matsumoto has received intellectual property interests from a discovery or technology relating to health care. |
| Shanni Yamaki | Shanni Yamaki has received personal compensation for serving as an employee of Arialys Therapeutics Inc. . |
| Roghiye Kazimi | Roghiye Kazimi has nothing to disclose. |
| Vallari Eastman | Vallari Eastman has nothing to disclose. |
| Amir Razai | Amir Razai has received personal compensation for serving as an employee of Arialys . |
| Scott Snipas | Scott Snipas has received personal compensation for serving as an employee of Arialys Therapeutics . |
| Mari Maurer | Ms. Maurer has received personal compensation for serving as an employee of Arialys Therapeuticss, Inc.. Ms. Maurer has received personal compensation for serving as an employee of ESCAPE Bio. Ms. Maurer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ReCode Therapeutics. Ms. Maurer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momentum Pharma. Ms. Maurer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ESCAPE Bio. Ms. Maurer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys Therapeutics. |
| Mathew Mitchell | Mr. Mitchell has received personal compensation for serving as an employee of Arialys Therapeutics. |
| Martin Jefson, PhD | Dr. Jefson has received personal compensation for serving as an employee of Arialys Therapeutics. Dr. Jefson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Arialys Therapeutics. |
| Peter Flynn, PhD | Dr. Flynn has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Artiva. Dr. Flynn has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Arialys. |
| Nancy Monson | Nancy Monson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. Nancy Monson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenrAb, Inc.. Nancy Monson has stock in GenrAb, Inc.. The institution of Nancy Monson has received research support from NIH. Nancy Monson has received intellectual property interests from a discovery or technology relating to health care. |
| Benjamin M. Greenberg, MD, FAAN | Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care. |
| John Kevin Pendas, MD | Dr. Pendas has nothing to disclose. |
| John Ciotti, MD | Dr. Ciotti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Ciotti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ciotti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Ciotti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Ciotti has received research support from National MS Society. |
| John Cassel, MD | Dr. Cassel has nothing to disclose. |
| Swetha Renati, MD | Dr. Renati has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Renati has received personal compensation in the range of $500-$4,999 for serving as a NeuroSAE with 好色先生 . |
| Konrad Rejdak, PhD | Dr. Rejdak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck, Biogen, Bayer, Sanofi, Teva, Roche, Takeda. Dr. Rejdak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen, Bayer, Sanofi, Teva, Roche, Takeda. |
| Gary R. Cutter, PhD | Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN. |
| Kevin C. O'Connor, PhD | Kevin C. O'Connor, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Immunovant. Kevin C. O'Connor, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Kevin C. O'Connor, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurocrine. Kevin C. O'Connor, PhD has stock in Cabaletta. The institution of Kevin C. O'Connor, PhD has received research support from Seismic. The institution of Kevin C. O'Connor, PhD has received research support from Argenx. Kevin C. O'Connor, PhD has received intellectual property interests from a discovery or technology relating to health care. |
| Mazen M. Dimachkie, MD, FAAN | Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 好色先生 (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. |
| Jacqueline Palace | Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono, Medimmune, Argenx, Janssen, AMgen, UCB, Roche, Novartis, Amplo, Alexion, . Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche, UCB, Alexion, Amgen. Dr. Palace has or had stock in Astra Zenica. The institution of Dr. Palace has received research support from Roche, AMPLO, Alexion, UCB,. argenx, amgen. Dr. Palace has received intellectual property interests from a discovery or technology relating to health care. |
| Axel Nolting, MD | Dr. Nolting has received personal compensation for serving as an employee of Merck Healthcare KGaA. Dr. Nolting has stock in Merck KGaA. |
| Sathej Gopalakrishnan, PhD | Dr. Gopalakrishnan has received personal compensation for serving as an employee of Merck KGaA. An immediate family member of Dr. Gopalakrishnan has received personal compensation for serving as an employee of AbbVie Deutschland GmbH &Co KG. An immediate family member of Dr. Gopalakrishnan has received personal compensation for serving as an employee of Certara. An immediate family member of Dr. Gopalakrishnan has received personal compensation for serving as an employee of Merck KGaA. Dr. Gopalakrishnan has stock in Merck KGaA. An immediate family member of Dr. Gopalakrishnan has stock in AbbVie Deutschland GmbH & Co KG. |
| Claire Le Bolay, MD | Mrs. Le Bolay has received personal compensation for serving as an employee of Merck Santé s.a.s. . |
| Andrija Javor | Andrija Javor has received personal compensation for serving as an employee of Biogen. Andrija Javor has received stock or an ownership interest from Biogen. |
| Nektaria Alexandri | Nektaria Alexandri has received personal compensation for serving as an employee of Merck Healthcare KGaA. |
| Dominic Jack | Dominic Jack has received personal compensation for serving as an employee of Merck KGaA, Darmstadt, Germany. |
| Henry J. Kaminski, MD, FAAN | Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta Bio. The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canopy Immunotherapeutics. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curie.bio. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Care Constitution. Dr. Kaminski has stock in mimivax. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care. |
| LynnMarie Jarratt, MD | Dr. Jarratt has nothing to disclose. |
| Daniel D. Barnett, MD | Dr. Barnett has nothing to disclose. |
| Iffat Ara Suchita, MD | Dr. Suchita has nothing to disclose. |
| Annapoorna Bhat, MD | Dr. Bhat has nothing to disclose. |
| Amir A. Mbonde, MD | Dr. Mbonde has nothing to disclose. |
| Ali A. Alsarah, MD | Dr. Alsarah has nothing to disclose. |
| Adam Dmytriw | Adam Dmytriw has nothing to disclose. |
| Quentin Moyer | No disclosure on file |
| Joshua A. Hirsch, MD | Dr. Hirsch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hirsch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Relievant. Dr. Hirsch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Hirsch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Hirsch has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Balt. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. |
| Aneesh B. Singhal, MD, FAAN | An immediate family member of Dr. Singhal has received personal compensation for serving as an employee of Biogen. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Firms. Dr. Singhal has received research support from NIH-NINDS. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Honorarium (好色先生) with Biogen. |
| Thabele M. Leslie-Mazwi, MD | Dr. Leslie-Mazwi has a non-compensated relationship as a Board Member with American Brain Foundation that is relevant to AAN interests or activities. Dr. Leslie-Mazwi has a non-compensated relationship as a Council Member with American Heart Association/American Stroke Association that is relevant to AAN interests or activities. |
| Aman Patel | Aman Patel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Microvention. Aman Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Aman Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Aman Patel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Penumbra. |
| Michael Young, MD | The institution of Dr. Young has received research support from NIH/NINDS. The institution of Dr. Young has received research support from Department of Defense. The institution of Dr. Young has received research support from Chen Institute. |
| Matthew Remz, MD | Dr. Remz has nothing to disclose. |
| Jason L. Chan, MD, PhD | Dr. Chan has nothing to disclose. |
| Jun Yu, MD | Dr. Yu has nothing to disclose. |
| Michael S. Okun, MD, FAAN | Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care. |
| Nur Walker-Pizarro, MD | Dr. Walker-Pizarro has nothing to disclose. |
| Jessie A. Henson, RN | Mrs. Henson has nothing to disclose. |
| Julie Wesler, RN | Ms. Wesler has nothing to disclose. |
| Jonatan Hornik, MD | Dr. Hornik has nothing to disclose. |
| Alejandro Hornik, MD | Dr. Hornik has nothing to disclose. |
| Amber Schwertman | Mrs. Schwertman has nothing to disclose. |
| Karam Dallow, MD | Dr. Dallow has nothing to disclose. |
| Andrea Loggini, MD, MPH MBA | Dr. Loggini has nothing to disclose. |
| Paola I. Rodríguez | Ms. Rodríguez has nothing to disclose. |
| Sofia Rael, MD | Dr. Rael has nothing to disclose. |
| Maria Peris Celda, MD, PhD | Dr. Peris Celda has nothing to disclose. |
| Angela Dispenzieri, MD | Prof. Dispenzieri has nothing to disclose. |
| Ugur Sener, MD | Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Pharmaceuticals. Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. |
| Adilson DaCosta, MD, PhD, MSc | Dr. DaCosta has nothing to disclose. |
| Gerome B. Vallejos, MD | Mr. Vallejos has nothing to disclose. |
| Joao Vitor Mahler, MD | Dr. Mahler has received research support from The Sumaira Foundation. |
| Asad Ahrar, MD | Dr. Ahrar has nothing to disclose. |
| Beenish Javaid, MD | Dr. Javaid has nothing to disclose. |
| Jiangyong Min, MD | Dr. Min has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic . Dr. Min has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for CredentialMed, LLC. The institution of Dr. Min has received research support from Corerwell Health Foundation . |
| Hailey Brigger | Ms. Brigger has nothing to disclose. |
| Ian P. Johnson | Mr. Johnson has nothing to disclose. |
| Rachel Forman, MD | Dr. Forman has nothing to disclose. |
| Emma S. Peasley | Miss Peasley has nothing to disclose. |
| Joel Smith, Clinical Researcher | Mr. Smith has nothing to disclose. |
| Alison Champagne | Mrs. Champagne has nothing to disclose. |
| Julia Zabinska | Ms. Zabinska has nothing to disclose. |
| Guido J. Falcone, MD | The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA. |
| Lauren H. Sansing, MD | Dr. Sansing has nothing to disclose. |
| Rohan Arora, MD | The institution of Dr. Arora has received research support from Bayer. |
| Carlos Mena-Hurtado | Carlos Mena-Hurtado has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Terumo. Carlos Mena-Hurtado has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BD. Carlos Mena-Hurtado has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Expert witness. The institution of Carlos Mena-Hurtado has received research support from Shockwave. |
| Munachi N. Okpala, NP | Ms. Okpala has nothing to disclose. |
| Cheryl Bushnell, MD, MHS | The institution of Dr. Bushnell has received research support from PCORI. The institution of Dr. Bushnell has received research support from NIH/NINDS. Dr. Bushnell has received intellectual property interests from a discovery or technology relating to health care. Dr. Bushnell has received publishing royalties from a publication relating to health care. |
| Michael T. Mullen, MD | Dr. Mullen has received publishing royalties from a publication relating to health care. |
| Jordana Cohen | Jordana Cohen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Jordana Cohen has received research support from National Institutes of Health. Jordana Cohen has received publishing royalties from a publication relating to health care. |
| Debbie Cohen | Debbie Cohen has nothing to disclose. |
| Adam De Havenon, MD, FAAN | Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care. |
| Steven R. Messe, MD, FAHA, FAAN | Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Terumo. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WL Gore. The institution of Dr. Messe has received research support from WL Gore. The institution of Dr. Messe has received research support from Mallinkrodt. The institution of Dr. Messe has received research support from Biogen. Dr. Messe has received intellectual property interests from a discovery or technology relating to health care. Dr. Messe has received publishing royalties from a publication relating to health care. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving as a Clinical Event Committee for the CONFORMAL left atrial appendage occlusion trial with Yale Cardiovascular Research Group. |
| Kevin N. Sheth, MD, FAAN | Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care. |
| Danya K. Kaye | Mrs. Kaye has received personal compensation for serving as an employee of UCB Biopharma SRL. Mrs. Kaye has stock in UCB Biopharma SRL. |
| Cedric Laloyaux, PhD | Dr. Laloyaux has received personal compensation for serving as an employee of UCB. |
| Rebecca Burns, PhD, PharmD | Dr. Burns has received personal compensation for serving as an employee of UCB. Dr. Burns has stock in UCB. |
| Jesus E. Pina-Garza, MD | Dr. Pina-Garza has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk. Dr. Pina-Garza has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Pina-Garza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Analysis Group/Acadia. Dr. Pina-Garza has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Same as consultant disclosure. Dr. Pina-Garza has received publishing royalties from a publication relating to health care. |
| Joseph I. Sirven, MD, FAAN | Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Sirven has received publishing royalties from a publication relating to health care. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as a Host/ Co producer with WJCT Public Media. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Federal Aviation Administration . |
| Tanya Bhatia, UCB Patient Author | Ms. Bhatia has nothing to disclose. |
| Shalee Cunneen | Mrs. Cunneen has nothing to disclose. |
| Shelly Meitzler | Shelly Meitzler has received personal compensation for serving as an employee of TSC Alliance. |
| Susan Linn, MSW | Ms. Linn has received personal compensation for serving as an employee of Epilepsy Foundation New England. |
| Joseph C. Melott | Mr. Melott has nothing to disclose. |
| Adeel A. Memon, MD | The institution of Dr. Memon has received research support from NIH/NINDS. |
| Kate Gelman | Kate Gelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Neuroscience. Kate Gelman has stock in Neuralink Corp. |
| Benjamin Z. Mendelson | Mr. Mendelson has nothing to disclose. |
| Peter Konrad | Peter Konrad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. |
| Abdul H. Khan, MBBS | Dr. Khan has nothing to disclose. |
| James M. Winkley, MD | Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Sanofi. Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Teva. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. The institution of Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for J&J. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amgen . Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG therapeutics. An immediate family member of Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Teva. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Alexion. Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for BMS. Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for amgen . Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB . Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for J&J. Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG therapeutics. The institution of Dr. Winkley has received research support from Noveratis. The institution of Dr. Winkley has received research support from Merck. The institution of Dr. Winkley has received research support from Sanofi. The institution of Dr. Winkley has received research support from Biogen. The institution of Dr. Winkley has received research support from Alexion. |
| Lida Zeinali, MD | Dr. Zeinali has received personal compensation for serving as an employee of Alexion Pharmaceuticals, AstraZeneca Rare Disease. Dr. Zeinali has stock in AstraZeneca. |
| Vern C. Juel, MD, FAAN | Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. The institution of Dr. Juel has received research support from argenx. The institution of Dr. Juel has received research support from Alexion. The institution of Dr. Juel has received research support from Janssen. The institution of Dr. Juel has received research support from NIH Rare Diseases Network. |
| Rup Tandan, MD, FRCP, FAAN | Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Apellis. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Tandan has received research support from Alexion. The institution of Dr. Tandan has received research support from Apellis. The institution of Dr. Tandan has received research support from Cytokinetics. |
| Andrew J. Gordon, MD | Dr. Gordon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion . Dr. Gordon has received personal compensation in the range of $0-$499 for serving as a Consultant for Vertex. Dr. Gordon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Gordon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Gordon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cassiday. |
| Ashley Yegin | Ashley Yegin has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Ashley Yegin has stock in Alexion Pharmaceuticals. |
| Chuang Liu, PhD | Dr. Liu has received personal compensation for serving as an employee of Alexion. |
| William Hoffman, MD | The institution of Dr. Hoffman has received research support from United States Air Force. Dr. Hoffman has a non-compensated relationship as a Member with United States Air Force that is relevant to AAN interests or activities. |
| Patricio Castro Suarez | Mr. Castro Suarez has nothing to disclose. |
| Claudia Cruzalegui Bazán | Miss Cruzalegui Bazán has nothing to disclose. |
| Kevin S. Capra Sanabria | Dr. Capra Sanabria has nothing to disclose. |
| Lucero del Pilar Peltroche Ramos, MS | Miss Peltroche Ramos has nothing to disclose. |
| Carlos Rodrigo Q. Vicuña | Mr. Vicuña has nothing to disclose. |
| Victoria Mazo, MD | Dr. Mazo has nothing to disclose. |
| James Hickman, MD | Dr. Hickman has nothing to disclose. |
| Tyra Gatewood | Ms. Gatewood has nothing to disclose. |
| Yolanda Pina, MD | Dr. Pina has nothing to disclose. |
| Monica Avila, MD | Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ascendis . |
| Júlia N. Andrade | Mrs. Andrade has nothing to disclose. |
| Luis H. Soares Silva | Mr. Soares Silva has nothing to disclose. |
| Jennifer V. Da Silva Bentes, MS | Miss Da Silva Bentes has nothing to disclose. |
| Antônio Victor Cavalcanti Araújo, MS | Mr. Araújo has nothing to disclose. |
| Maria Luiza Lima Schneider, MS | Miss Lima Schneider has nothing to disclose. |
| Fernanda M. Tamashiro | Miss Tamashiro has nothing to disclose. |
| Luis Sobreira, MS | Mr. Sobreira has nothing to disclose. |
| Katherine McFarlane, MS | Ms. McFarlane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Ms. McFarlane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. |
| Wesley Kerr, MD, PhD | Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Lifesciences. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kerr has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for QurAlis. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. The institution of Dr. Kerr has received research support from NINDS. The institution of Dr. Kerr has received research support from American Epilepsy Society. The institution of Dr. Kerr has received research support from 好色先生. The institution of Dr. Kerr has received research support from SK Life Science. The institution of Dr. Kerr has received research support from Biohaven Pharmaceuticals. Dr. Kerr has received publishing royalties from a publication relating to health care. |
| Judy Chang, MD | The institution of Dr. Chang has received research support from NIH. The institution of Dr. Chang has received research support from NIH. The institution of Dr. Chang has received research support from NIH. |
| Elizabeth Harrison, MD | Dr. Harrison has nothing to disclose. |
| Teresa Capella | Teresa Capella has nothing to disclose. |
| Courtney E. McIlduff, MD | The institution of Dr. McIlduff has received research support from NIH - R21NSNS118434. The institution of Dr. McIlduff has received research support from NIH - R01MH111875. The institution of Dr. McIlduff has received research support from Blavatnik Family Fund. Dr. McIlduff has received publishing royalties from a publication relating to health care. |
| Seward B. Rutkove, MD, FAAN | Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH. |
| Sarah Verga | Miss Verga has nothing to disclose. |
| Marelisa Albelo Martinez, MD | Dr. Albelo Martinez has nothing to disclose. |
| Syed Rizvi, MD | Dr. Rizvi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono Roche Bristol Myers . Dr. Rizvi has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Na. |
| Jonathan Cahill, MD, FAAN | The institution of Dr. Cahill has received research support from Roche / Genentech. Dr. Cahill has received publishing royalties from a publication relating to health care. |
| Ma Su Su Aung, MD | Dr. Aung has nothing to disclose. |
| Khine Yadanar Sein, MD | Dr. Sein has nothing to disclose. |
| Areeba Shoaib, MBBS | Dr. Shoaib has nothing to disclose. |
| Muhammad Osama, MBBS | Dr. Osama has nothing to disclose. |
| Muhammad Abdullah Ali, MBBS | Dr. Ali has nothing to disclose. |
| Nevin Shalaby | Nevin Shalaby has nothing to disclose. |
| Mye Basheer, MD | Prof. Basheer has nothing to disclose. |
| Hatem Shehata, MD | Dr. Shehata has nothing to disclose. |
| Aparna Kalyani Pariyadath, MBBS | Dr. Pariyadath has nothing to disclose. |
| Elizabeth Chernyak, MD | Dr. Chernyak has received research support from Maimonides Research and Development Foundation . Dr. Chernyak has received research support from 好色先生 . |
| Paul Mystkowski, MD | Dr. Mystkowski has received personal compensation for serving as an employee of Novo Nordisk. Dr. Mystkowski has stock in Novo Nordisk. |
| Elnara Fazio-Eynullayeva | Ms. Fazio-Eynullayeva has received personal compensation for serving as an employee of Novo Nordisk. Ms. Fazio-Eynullayeva has stock in Novo Nordisk. |
| Sarah Cotton | Sarah Cotton has nothing to disclose. |
| Eddie Jones, BA | Eddie Jones, BA has nothing to disclose. |
| Sophie J. Kirkman, BSc | Ms. Kirkman has nothing to disclose. |
| Soeren Mattke, MD, PhD | Dr. Mattke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mattke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for C2N. Dr. Mattke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Mattke has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Senscio Systems. The institution of Dr. Mattke has received research support from various companies, CMS. |
| Lei Lv, PhD | Dr. Lv has received personal compensation for serving as an employee of Novo Nordisk . |
| Michael W. Nicolle, MD | Dr. Nicolle has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Nicolle has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various legal firms. |
| Jessica D. Williamson, MD student, MS | Ms. Williamson has nothing to disclose. |
| Mill Etienne, MD, MPH, FAAN | Dr. Etienne has nothing to disclose. |
| Rahim Hirani, MD/PhD candidate | Mr. Hirani has nothing to disclose. |
| Maria Mastropaolo, MD | Dr. Mastropaolo has nothing to disclose. |
| Daniella Iglesias Hernández, MD | Dr. Iglesias Hernández has nothing to disclose. |
| Jessica Hunter, MD | Dr. Hunter has nothing to disclose. |
| Lea Saab, MD | Dr. Saab has nothing to disclose. |
| Floyd Silva, MD | Dr. Silva has nothing to disclose. |
| Maha Irfan, MD, MB BCH | Dr. Irfan has nothing to disclose. |
| Luiz Henrique Medeiros Geraldo, MD, PhD | Dr. Medeiros Geraldo has nothing to disclose. |
| Bavica Gummadi, DO | Dr. Gummadi has nothing to disclose. |
| Michael McAree, DO | Dr. McAree has nothing to disclose. |
| Rebecca Lalchan, DO | Dr. Lalchan has nothing to disclose. |
| Elina Zakin, MD, FAAN | The institution of Dr. Zakin has received research support from American Board of Psychiatry and Neurology. |
| Rithvik Gundlapalli | Mr. Gundlapalli has nothing to disclose. |
| Syeda Amrah Hashmi, MBBS | Dr. Hashmi has nothing to disclose. |
| Ifrah Zawar, MD | The institution of Dr. Zawar has received research support from Alzheimer's association. The institution of Dr. Zawar has received research support from American epilepsy society . The institution of Dr. Zawar has received research support from NIH. The institution of Dr. Zawar has received research support from University of Virginia. |
| Cuong P. Luu, Medical Student | Mr. Luu has nothing to disclose. |
| Youngwon youn, MD | Dr. youn has nothing to disclose. |
| Jordan N. Ranum | Mr. Ranum has nothing to disclose. |
| Jennifer Perrault | Miss Perrault has nothing to disclose. |
| Bryan M. Krause, PhD | The institution of Dr. Krause has received research support from National Institutes of Health. |
| Matthew I. Banks, PhD | Prof. Banks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for VCENNA, Inc,. The institution of Prof. Banks has received research support from National Institutes of Health. The institution of Prof. Banks has received research support from National Science Foundation. |
| Laura J. Buyan Dent, MD, PhD | Dr. Buyan Dent has nothing to disclose. |
| Kip Ludwig, PhD | Dr. Ludwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVRx. Dr. Ludwig has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NeuroOne. Dr. Ludwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuraWorx. Dr. Ludwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ONWARD . Dr. Ludwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Presidio Medical. Dr. Ludwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Restora Medical. Dr. Ludwig has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Ludwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Battelle. Dr. Ludwig has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BlackFynn. Dr. Ludwig has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuronoff. Dr. Ludwig has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroOne. Dr. Ludwig has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Presidio Medical. Dr. Ludwig has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neuronoff. An immediate family member of Dr. Ludwig has stock in NeuroOne. Dr. Ludwig has stock in NeuraWorx. Dr. Ludwig has stock in Neuronoff. The institution of Dr. Ludwig has received research support from Abbott. The institution of Dr. Ludwig has received research support from Alfred Mann Foundation. The institution of Dr. Ludwig has received research support from LivaNova. The institution of Dr. Ludwig has received research support from Presidio Medical. Dr. Ludwig has received intellectual property interests from a discovery or technology relating to health care. |
| Wendell Lake | Wendell Lake has nothing to disclose. |
| Aaron Suminski | The institution of Aaron Suminski has received research support from Abbott Neuromodulation. |
| Jordana Sandy, DO | Dr. Sandy has nothing to disclose. |
| Paul Partyka, DO, PhD | Dr. Partyka has nothing to disclose. |
| Richard Friedland, MD | Dr. Friedland has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Coverys. Dr. Friedland has stock in Radloop. |
| Muhammad Sohaib Khan | Mr. Khan has nothing to disclose. |
| Mohammad Danish, MBBS | Mr. Danish has nothing to disclose. |
| Wania Moeen | Dr. Moeen has nothing to disclose. |
| Minaam Farooq, MD, MBBS | Dr. Farooq has nothing to disclose. |
| Arun Subash, MD, MBBS | Mr. Subash has nothing to disclose. |
| Maheen Hashmi, MD | Dr. Hashmi has nothing to disclose. |
| Umar Mahmood, MBBS | Dr. Mahmood has nothing to disclose. |
| Muzamil Khan, MBBS | Dr. Khan has nothing to disclose. |
| Muhammad Jansher, MBBS | Mr. Jansher has nothing to disclose. |
| Aliyan Nadeem, MBBS, Student | Mr. Nadeem has nothing to disclose. |
| Sakshi Roy, MBBS | Miss Roy has nothing to disclose. |
| Maryam Inam Zaroo, MBBS | Dr. Zaroo has nothing to disclose. |
| Kelly Nicol, MD | Dr. Nicol has nothing to disclose. |
| Daniel Falcao, DO, FAAN | Dr. Falcao has nothing to disclose. |
| Maha Alattar, MD | Dr. Alattar has nothing to disclose. |
| Emma M. Parolisi, MD | Ms. Parolisi has nothing to disclose. |
| Alessio Sarnataro, MD | Dr. Sarnataro has nothing to disclose. |
| Chiara Pane, MD | Dr. Pane has nothing to disclose. |
| Nunzia Cuomo, MD | Dr. Cuomo has nothing to disclose. |
| Alessia Bonfini Rendina, PA | Miss Bonfini Rendina has nothing to disclose. |
| Giorgia Puorro | Giorgia Puorro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Elma Research. Giorgia Puorro has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Alexion. |
| Angela Marsili | Angela Marsili has nothing to disclose. |
| Kehan Zhao, MD | Dr. Zhao has nothing to disclose. |
| Niravkumar Barot, MD | Dr. Barot has nothing to disclose. |
| Daniel Press, MD | Dr. Press has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CND Life Sciences. Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Burke Neuroscience Board. The institution of Dr. Press has received research support from NIH. The institution of Dr. Press has received research support from Biogen. The institution of Dr. Press has received research support from Janssen. Dr. Press has received publishing royalties from a publication relating to health care. Dr. Press has received personal compensation in the range of $500-$4,999 for serving as a Advisory Panel Member with FDA. |
| Erik Uhlmann, MD | Dr. Uhlmann has nothing to disclose. |
| Garrett M. Friedman, MD | Dr. Friedman has nothing to disclose. |
| Shefalika Prasad | Ms. Prasad has nothing to disclose. |
| Victor Goulenko, MD | Mr. Goulenko has nothing to disclose. |
| Robert Plunkett, MD | Dr. Plunkett has nothing to disclose. |
| Kenneth Snyder, MD, PhD | Dr. Snyder has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Canon. |
| Dheerendra Prasad, MD | Dr. Prasad has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Elekta AB. Dr. Prasad has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for American College of Radiation Oncology. |
| Hannah Enyart, MD | Dr. Enyart has received personal compensation in the range of $0-$499 for serving as a attendee at a sponsored educational dinner with covered meal with Octapharma, Ubrelvy. |
| Mark Armanious, MD | Dr. Armanious has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME 好色先生. Dr. Armanious has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. |
| Chan Gu, MD | Dr. Gu has stock in JNJ, ABBV, and LLY. |
| Stephen Aradi, MD | Dr. Aradi has nothing to disclose. |
| Leonardo J. Cardoso, MS | Mr. Cardoso has nothing to disclose. |
| Savio Batista, MD | Mr. Batista has nothing to disclose. |
| Matheus D. Pereira, MD | Dr. Pereira has nothing to disclose. |
| Elison E. Araujo Lima, MD | Dr. Araujo Lima has nothing to disclose. |
| Anderson Matheus P da Silva, Sr., PhD | Prof. P da Silva has nothing to disclose. |
| Ryoichi Inoue, MD | Dr. Inoue has nothing to disclose. |
| ELIZABETH WEINANDY, RDN | Ms. WEINANDY has nothing to disclose. |
| Nabil A. Khandker, MD | Dr. Khandker has nothing to disclose. |
| Amir Barmada, BS | Mr. Barmada has nothing to disclose. |
| Ronald Go | Ronald Go has nothing to disclose. |
| John C. Benson, MD | Dr. Benson has nothing to disclose. |
| Gaurav Goyal | Gaurav Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Recordati. Gaurav Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sobi. Gaurav Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Electra. |
| W. O. Tobin, PhD, MBBCh, BAO, FAAN | Dr. Tobin has received publishing royalties from a publication relating to health care. |
| Tom Punnen | Mr. Punnen has nothing to disclose. |
| Darin T. Okuda, MD, FAAN | Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortechs AI. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas BioPharma. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from Alexion. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care. |
| Andres Gudino | Mr. Gudino has nothing to disclose. |
| Carlos Dier | No disclosure on file |
| Elena Sagues, MD | Ms. Sagues has nothing to disclose. |
| Martin A. Cabarique, MD | Dr. Cabarique has nothing to disclose. |
| Gustavo A. Chiriboga | Mr. Chiriboga has nothing to disclose. |
| Navami Shenoy | Ms. Shenoy has nothing to disclose. |
| Alexander J. Van Dam | Mr. Van Dam has nothing to disclose. |
| Shubhangi Setia, MBBS | Dr. Setia has nothing to disclose. |
| Sebastian Sanchez Herrera, MD | Sebastian Sanchez Herrera has nothing to disclose. |
| Edgar Samaniego, MD, FAAN | Dr. Samaniego has received personal compensation for serving as an employee of University of Iowa. Dr. Samaniego has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Terumo Neuro. Dr. Samaniego has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rapid Medical. Dr. Samaniego has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for J&J Neuro. Dr. Samaniego has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Metronic. Dr. Samaniego has received personal compensation in the range of $0-$499 for serving as a Consultant for iSchemaView. Dr. Samaniego has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Society of Neurointerventional Surgery. Dr. Samaniego has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neurointerventional Surgery. |
| Linker E. Viñan Paucar, Sr. | Mr. Viñan Paucar has nothing to disclose. |
| Maria G. Chacon | Dr. Chacon has nothing to disclose. |
| Presley M. Gruezo, Jr. | Mr. Gruezo has nothing to disclose. |
| Isabella S. Egüez | Mrs. Egüez has nothing to disclose. |
| Soledad M. Salazar, Student | Miss Salazar has nothing to disclose. |
| María G. Rimbaldo, Miss | Miss Rimbaldo has nothing to disclose. |
| Luis F. Leyton Aguilar, MD | Dr. Leyton Aguilar has nothing to disclose. |
| Daniel E. Ocampo, Sr., MD | Dr. Ocampo has nothing to disclose. |
| Luis Yepez | Luis Yepez has nothing to disclose. |
| Rocio A. Santibanez, MD, FAAN | Dr. Santibanez has nothing to disclose. |
| Genesis Y. Loor, Jr., MD | Miss Loor has nothing to disclose. |
| Estefania Jackeline Suquilanda Rovayo | Miss Suquilanda Rovayo has nothing to disclose. |
| Andre Paszkiewicz Salcedo, Sr., Student | Mr. Paszkiewicz Salcedo has nothing to disclose. |
| Eti Muharremi, MD | Eti Muharremi, MD has nothing to disclose. |
| Sean M. Pennetti, MD | Dr. Pennetti has nothing to disclose. |
| Robert Fulbright, MD | Dr. Fulbright has nothing to disclose. |
| Joachim M. Baehring, MD, FAAN | Dr. Baehring has nothing to disclose. |
| Carlo Antozzi, MD | Dr. antozzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. antozzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for janssen. Dr. antozzi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Dr. antozzi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson Johnson. |
| Tomasz Berkowicz, MD, PhD | Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Investments S.A.R.L. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orion Pharma Poland. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viatris Healthcare. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Connectmedica Sp. z o.o.. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medycyna Praktyczna - Szkolenia s.c.. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biofarm Sp. z o.o.. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mylan Healthcare Sp. z o.o.. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zaklady Farmaceutyczne Polpharma SA. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bonnier Healthcare Sp. z o.o.. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer Polska Sp. z o.o.. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen Poland Sp. z o.o.. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer AG. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for QAH Sp z o.o.. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aflofarm Farmacja Polska. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TVIP. |
| Artur Druzdz | Artur Druzdz has nothing to disclose. |
| Rachana Gandhi, MD | Dr. Gandhi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Gandhi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Gandhi has received research support from Akcea Therapeutics. The institution of Dr. Gandhi has received research support from UCB. |
| Jana Zschüntzsch, MD, PhD | Dr. Zschüntzsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Zschüntzsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Zschüntzsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kedrion. Dr. Zschüntzsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Zschüntzsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Zschüntzsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Zschüntzsch has received research support from Argenx. The institution of Dr. Zschüntzsch has received research support from European commission. The institution of Dr. Zschüntzsch has received research support from UCB. The institution of Dr. Zschüntzsch has received research support from GB-A. |
| Marion Boehnlein | Marion Boehnlein has stock in UCB. |
| Mark Morris, MSc | Mr. Morris has received personal compensation for serving as an employee of UCB Pharma L. |
| Maria I. Leite, MD | The institution of Dr. Leite has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon / Amgen. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela/Horizon/Amgen. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Leite has received research support from Non-Profit Organization - Myaware. The institution of Dr. Leite has received research support from UCB - Ra Pharma. The institution of Dr. Leite has received research support from Non-Profit Organization - Muscular Dystrophy UK. |
| Jamil Numan, MD | Dr. Numan has nothing to disclose. |
| Micaela R. Owens, DO | Dr. Owens has nothing to disclose. |
| Kaitlyn E. Heintzelman, MD/PhD Student | Ms. Heintzelman has nothing to disclose. |
| David Fletcher | Mr. Fletcher has nothing to disclose. |
| Yagya Adhikari, MBBS | Dr. Adhikari has received personal compensation for serving as an employee of Cooper University Hospital. |
| Sangam Shah | Dr. Shah has nothing to disclose. |
| Madhur Bhattatai, MBBS | Dr. BHATTARAI has nothing to disclose. |
| Amita Paudel | Dr. Paudel has nothing to disclose. |
| Olga R. Thon, MD | Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Thon has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon. |
| Jesse Thon, MD | An immediate family member of Dr. Thon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. |
| Kathryn E. Dent, MD | Dr. Dent has nothing to disclose. |
| Matthew Hart, MD | Dr. Hart has nothing to disclose. |
| Amandeep Dolla, MBBS | Dr. Dolla has nothing to disclose. |
| Syed Omar Shah, MD | Dr. Shah has nothing to disclose. |
| Jing Lin, MD | Dr. Lin has nothing to disclose. |
| yue li, MD, PhD | Dr. li has nothing to disclose. |
| Mengcui Gui | The institution of Ms. Gui has received research support from Beijing Huikang Charity Foundation . |
| zhijun li, MD, PhD | Dr. li has nothing to disclose. |
| Bitao Bu, MD, PhD | The institution of Prof. Bu has received research support from Beijing Huikang Charrity Foundation. |
| Jyothsna Ravula | No disclosure on file |
| Satish Jetta | Satish Jetta has received intellectual property interests from a discovery or technology relating to health care. |
| Vinod Goyal | Vinod Goyal has received intellectual property interests from a discovery or technology relating to health care. |
| Veera Raghava Chowdary Palacharla, Scientist | Mr. Palacharla has stock in Suven Life Sciences Limited. Mr. Palacharla has received intellectual property interests from a discovery or technology relating to health care. |
| Vijay Benade | Vijay Benade has nothing to disclose. |
| Anil Shinde | Anil Shinde has received intellectual property interests from a discovery or technology relating to health care. |
| Renny Abraham, PhD | Mr. Abraham has nothing to disclose. |
| Santosh Pandey, MVSc, DABT | Mr. Pandey has nothing to disclose. |
| Ramkumar S, Chief Scientist | Mr. S has nothing to disclose. |
| Abdul Rasheed Mohammed, PhD | Mr. Mohammed has nothing to disclose. |
| Pradeep Jayarajan, PhD | Pradeep Jayarajan, PhD has received personal compensation for serving as an employee of Suven Life Sciences Ltd. Pradeep Jayarajan, PhD has or had stock in Suven Life Sciences.Pradeep Jayarajan, PhD has received intellectual property interests from a discovery or technology relating to health care. |
| Venkat Jasti | Venkat Jasti has stock in Suven Life Sciences Ltd. Venkat Jasti has received intellectual property interests from a discovery or technology relating to health care. |
| Ramakrishna Nirogi, PhD | Dr. Nirogi has nothing to disclose. |
| Gerardo M. Luna-Peralta | Mr. Luna-Peralta has nothing to disclose. |
| Fritz F. Vascones Roman, Sr. | Mr. Vascones Roman has nothing to disclose. |
| Adriana M. Reyes Barreto, Medical Student | Miss Reyes Barreto has nothing to disclose. |
| Miguel F. Cabanillas Lazo | Mr. Cabanillas Lazo has nothing to disclose. |
| Karlos A. Acurio, MD | Mr. Acurio has nothing to disclose. |
| Cecilia Raraz | Miss Raraz has nothing to disclose. |
| Ivan Alegre-Cordero | Mr. Alegre-Cordero has nothing to disclose. |
| Ruslan Akhmedullin, MPH | Mr. Akhmedullin has nothing to disclose. |
| Abdalmalik Bin Khunayfir, MD | Dr. Bin Khunayfir has nothing to disclose. |
| Stewart A. Factor, DO, FAAN | Dr. Factor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. The institution of Dr. Factor has received research support from RHO. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. |
| Nicholas Au Yong | An immediate family member of Nicholas Au Yong has received personal compensation for serving as an employee of Intuitive Surgical Inc.. An immediate family member of Nicholas Au Yong has received personal compensation for serving as an employee of Medtronic Inc.. An immediate family member of Nicholas Au Yong has stock in Intuitive Surgical Inc.. An immediate family member of Nicholas Au Yong has stock in Medtronic Inc.. The institution of Nicholas Au Yong has received research support from NIH. The institution of Nicholas Au Yong has received research support from Craig H. Neilsen Foundation. The institution of Nicholas Au Yong has received research support from Air Force Office of Scientific Research. Nicholas Au Yong has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Nicholas Au Yong has received intellectual property interests from a discovery or technology relating to health care. |
| Richa Tripathi, MD | Dr. Tripathi has nothing to disclose. |
| John Sturgis, MD | Dr. Sturgis has nothing to disclose. |
| Komal Sawlani, MD | Dr. Sawlani has nothing to disclose. |
| David C. Preston, MD, FAAN | Dr. Preston has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FBI, US Attorney, Insurance Fraud Investigative Units. Dr. Preston has received publishing royalties from a publication relating to health care. |
| Bashar Katirji, MD, FAAN | Dr. Katirji has nothing to disclose. |
| Shiny Joy, MD, MBBS | Dr. Joy has nothing to disclose. |
| Manjari Tripathi, MD | Dr. Tripathi has nothing to disclose. |
| Rajesh Kumar Singh | Rajesh Kumar Singh has nothing to disclose. |
| Deepti Vibha, MD | Dr. Vibha has nothing to disclose. |
| Awadh Kishor Pandit, MD, MBBS, DM | Dr. Pandit has nothing to disclose. |
| Achal K. Srivastava, MD, FAAN | Dr. Srivastava has nothing to disclose. |
| Anu Gupta | The institution of Dr. Gupta has received research support from ICMR. |
| Arunmozhimaran Elavarasi, MD | Dr. Elavarasi has stock in Pfizer. Dr. Elavarasi has stock in PGHL. The institution of Dr. Elavarasi has received research support from All India Institute of Medical Sciences, New Delhi. The institution of Dr. Elavarasi has received research support from Indian Council for Medical Research. |
| Rohit Bhatia, MD, MBBS, DM | Dr. Bhatia has nothing to disclose. |
| Ayush Agarwal, DM | Dr. Agarwal has nothing to disclose. |
| Animesh Das, MD | Dr. Das has nothing to disclose. |
| Jamir Pitton Rissardo, MD | Dr. Pitton Rissardo has nothing to disclose. |
| Ana Leticia Fornari Caprara, MD | Dr. Fornari Caprara has nothing to disclose. |
| Vishnu V. Byroju, MD | Dr. Byroju has nothing to disclose. |
| Xavier Soehnlen | Mr. Soehnlen has nothing to disclose. |
| James Liao, MD | The institution of Dr. Liao has received research support from American Parkinson Disease Association. The institution of Dr. Liao has received research support from a Cleveland Clinic - IBM Research Collaboration, in the form of in-kind support. Dr. Liao has received intellectual property interests from a discovery or technology relating to health care. Dr. Liao has a non-compensated relationship as a Investigator with Adult Hydrocephalus Research Network that is relevant to AAN interests or activities. |
| Stephen Jones, MD, PhD | Dr. Jones has nothing to disclose. |
| Sean Nagel, MD | Dr. Nagel has nothing to disclose. |
| Richard Rammo, MD | Dr. Rammo has nothing to disclose. |
| Claire Sonneborn | Claire Sonneborn has received personal compensation in the range of $0-$499 for serving as a Consultant with The Sumaira Foundation. |
| Jacqueline Pesa | Jacqueline Pesa has received personal compensation for serving as an employee of Johnson and Johnson. |
| Louis Jackson, PharmD | Dr. Jackson has received personal compensation for serving as an employee of Johnson and Johnson. |
| Alexander Keenan | Alexander Keenan has received personal compensation for serving as an employee of Janssen Pharmaceuticals. Alexander Keenan has received stock or an ownership interest from Johnson and Johnson. |
| Gregor Gibson | Mr. Gibson has nothing to disclose. |
| Joe Conyers | Mr. Conyers has nothing to disclose. |
| Muhui Fu, MD, PhD | Dr. Fu has nothing to disclose. |
| Jeffery Gunter | The institution of Jeffery Gunter has received research support from NIH. Jeffery Gunter has received intellectual property interests from a discovery or technology relating to health care. |
| Ryota Satoh, PhD | Dr. Satoh has nothing to disclose. |
| Rodolfo G. Gatto, MD, PhD | Dr. Gatto has nothing to disclose. |
| Farwa Ali, MD | Dr. Ali has nothing to disclose. |
| Heather Clark | The institution of Heather Clark has received research support from NIH. Heather Clark has received publishing royalties from a publication relating to health care. |
| Julie Stierwalt | The institution of Julie Stierwalt has received research support from NIH. Julie Stierwalt has received publishing royalties from a publication relating to health care. |
| Yehkyoung C. Stephens, PA | Mrs. Stephens has nothing to disclose. |
| Hossam Youssef, MD | Mr. Youssef has nothing to disclose. |
| Nha Trang Thu Pham | Nha Trang Thu Pham has received personal compensation for serving as an employee of Mayo Clinic. |
| Val J. Lowe, MD | Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals. |
| Keith A. Josephs, Jr., MD, FAAN | Dr. Josephs has nothing to disclose. |
| Jennifer Whitwell, PhD | The institution of Dr. Whitwell has received research support from NIH. |
| Ram Kinker Mishra, PhD | Dr. Mishra has received personal compensation for serving as an employee of BioSensics LLC. |
| ILKAY YILDIZ POTTER, PhD | Dr. YILDIZ POTTER has received personal compensation for serving as an employee of BIOSENSICS LLC. |
| Adonay Nunes | Adonay Nunes has nothing to disclose. |
| Meghan McAnally, MD | Dr. McAnally has nothing to disclose. |
| Carsten G. Bonnemann, MD | Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with RYR1 Foundation that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Genethon that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Sarepta Therapeutics that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Kate Therapeutics that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with CureCMD that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Seal Therapeutics that is relevant to AAN interests or activities. |
| Petra W. Duda, MD, PhD | Dr. Duda has received personal compensation for serving as an employee of UCB. Dr. Duda has stock in UCB. |
| Ashkan Vaziri, PhD | Dr. Vaziri has received personal compensation for serving as an employee of Biosensics. |
| Amanda C. Guidon, MD, MPH | An immediate family member of Dr. Guidon has received personal compensation for serving as an employee of GE Healthcare. Dr. Guidon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Guidon has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN - Continuum. The institution of Dr. Guidon has received research support from NINDS. Dr. Guidon has received publishing royalties from a publication relating to health care. Dr. Guidon has a non-compensated relationship as a Committee Member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Guidon has a non-compensated relationship as a Executive Committee Member with Neuromuscular Study Group that is relevant to AAN interests or activities. |
| Mahesh Kumar, MBBS | Dr. Kumar has nothing to disclose. |
| Benjamin Brewer, PhD | Dr. Brewer has nothing to disclose. |
| J. E. Ahlskog, MD, PhD | Dr. Ahlskog has received publishing royalties from a publication relating to health care. |
| Ana Enriquez | Mrs. Enriquez has received personal compensation for serving as an employee of BioSensics LLC. Mrs. Enriquez has received research support from NIH. |
| Abigail Lindsay | Miss Lindsay has nothing to disclose. |
| Zoe Sheitman, PT | Ms. Sheitman has nothing to disclose. |
| Carina Stafstrom, BS | Miss Stafstrom has nothing to disclose. |
| Nirubol Tosakulwong | Nirubol Tosakulwong has nothing to disclose. |
| Stephen Weigand | Stephen Weigand has nothing to disclose. |
| Christopher Schwarz | The institution of Christopher Schwarz has received research support from NIH. |
| Matthew Senjem | Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic. |
| Yousef A. Hawas | Mr. Hawas has a non-compensated relationship as a Faculty with 好色先生 Institution (AANI); NeuroBytes: Medical Students Series that is relevant to AAN interests or activities. |
| Abdullah Ashraf Hamad | Dr. Hamad has nothing to disclose. |
| Mostafa M. Meshref, MD | Dr. Meshref has nothing to disclose. |
| Rashad G. Mohamed, MBBS | Dr. Mohamed has nothing to disclose. |
| Manar A. Mabrouk, MBBS | Dr. Mabrouk has nothing to disclose. |
| Mohamed Elbehary, Jr., MD | Dr. Elbehary has nothing to disclose. |
| Ahmed Elshahat, MD | Dr. Elshahat has nothing to disclose. |
| Basem H. Fouda, MD, MBBS, PhD, FEBN | Dr. Fouda has nothing to disclose. |
| Leah G. Mann, PhD | Dr. Mann has nothing to disclose. |
| Jose Casado | Jose Casado has received personal compensation for serving as an employee of Biosensics. |
| Paula Trujillo Diaz | Paula Trujillo Diaz has nothing to disclose. |
| Jessie Iregui | Miss Iregui has nothing to disclose. |
| Amy Wynn, NP | Ms. Wynn has nothing to disclose. |
| Cynthia Wong | Cynthia Wong has received personal compensation for serving as an employee of Alterity Therapeutics. An immediate family member of Cynthia Wong has received personal compensation for serving as an employee of RefleXion Medical. Cynthia Wong has stock in Teva. An immediate family member of Cynthia Wong has stock in 10x Genomics. |
| David A. Stamler, MD | Dr. Stamler has received personal compensation for serving as an employee of Alterity Therapeutics. Dr. Stamler has stock in Alterity Therapeutics. |
| Daniel O. Claassen, MD, FAAN | Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Michigan. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics . Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from CHDI. |
| Henry J. Kaminski | No disclosure on file |
| Sabrina Sacconi, MD | Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LUPIN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMICUS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for FULCRUM THERAPEUTICS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for AXELYS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for OLOGY. The institution of Dr. Sacconi has received research support from Solve FSHD. |
| Antoine Regnault, PhD | Dr. Regnault has received personal compensation for serving as an employee of Modus Outcomes. |
| Mustafa Al-Kharsan, MD | Dr. Al-Kharsan has nothing to disclose. |
| Omar Jawdat, MD | Dr. Jawdat has nothing to disclose. |
| Matthew Varon, MD | Dr. Varon has nothing to disclose. |
| Jeffrey Statland, MD | Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA. |
| Mamatha Pasnoor, MD, FAAN | Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen. |
| Long F. Davalos, MD | Dr. Davalos has nothing to disclose. |
| Samantha Colgan, MAS, CCRP | Miss Colgan has nothing to disclose. |
| Andrew Heim | Andrew Heim has nothing to disclose. |
| Constantine Farmakidis, MD, FAAN | Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J&J. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Muscular Dystrophy Association. |
| Nahid Olfati, MD | Dr. Olfati has nothing to disclose. |
| Ali Shoeibi | No disclosure on file |
| Mina Farahnezhad, Jr., MD | Dr. Farahnezhad has nothing to disclose. |
| Saeed Akhlaghi, PhD | Dr. Akhlaghi has nothing to disclose. |
| Ebrahim Abdollahian | No disclosure on file |
| Hamid Reza Kobravi, PhD | Dr. Kobravi has nothing to disclose. |
| Hamideh Ghaemi, PhD | Dr. Ghaemi has nothing to disclose. |
| niloufar keshvari, Master's degree | Miss keshvari has nothing to disclose. |
| Mobina Ramezani, Master degree | Miss Ramezani has nothing to disclose. |
| Amir Khanmirzaei, MD | Dr. Khanmirzaei has nothing to disclose. |
| Shannon Y. Chiu, MD, MSc | Dr. Chiu has received research support from NIH. |
| Cecilia Tremblay | Cecilia Tremblay has nothing to disclose. |
| Nan Zhang | Nan Zhang has nothing to disclose. |
| Charles H. Adler, MD, PhD, FAAN | Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care. |
| Shyamal Mehta, MD, PhD, FAAN | Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharma. Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Mehta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CNS Ratings. |
| Erika Driver-Dunckley, MD, FAAN | Dr. Driver-Dunckley has nothing to disclose. |
| David Shprecher, DO, FAAN | Dr. Shprecher has received personal compensation for serving as an employee of Banner Health. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanders+Parks. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medplace. The institution of Dr. Shprecher has received research support from MJFF. The institution of Dr. Shprecher has received research support from Cognition Therapeutics. The institution of Dr. Shprecher has received research support from Biogen. The institution of Dr. Shprecher has received research support from Neuraly. The institution of Dr. Shprecher has received research support from Jazz Pharmaceuticals. The institution of Dr. Shprecher has received research support from Sanofi Aventis. The institution of Dr. Shprecher has received research support from Annovis. The institution of Dr. Shprecher has received research support from Neurocrine. The institution of Dr. Shprecher has received research support from Teva. The institution of Dr. Shprecher has received research support from Nuvelution. The institution of Dr. Shprecher has received research support from EIP Pharma. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson's and MDS. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Parkinson's Movement Disorder Alliance. |
| Christine Belden | Christine Belden has nothing to disclose. |
| Geidy Serrano | Geidy Serrano has nothing to disclose. |
| Thomas Beach | Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona. |
| Parichita Choudhury, MD | The institution of Dr. Choudhury has received research support from Lewy Body Dementia Association. The institution of Dr. Choudhury has received research support from Arizona Alzheimer's Consortium. |
| Irina Tsirkin, MD | Dr. Tsirkin has nothing to disclose. |
| Mohamed Khateb | Mohamed Khateb has nothing to disclose. |
| Dvir Aran, PhD | Dr. Aran has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Elevance Heatlh. Dr. Aran has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Link Cell Therapies. |
| Amit Katz, MD | Dr. Katz has nothing to disclose. |
| Federico J. Rodriguez-Porcel, MD, FAAN | Dr. Rodriguez-Porcel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioVie. Dr. Rodriguez-Porcel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WCG. Dr. Rodriguez-Porcel has received research support from NIH. Dr. Rodriguez-Porcel has received publishing royalties from a publication relating to health care. |
| Junaid H. Siddiqui, MD | Dr. Siddiqui has nothing to disclose. |
| Nikolaus McFarland, MD, PhD, FAAN | Dr. McFarland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sutter Health. Dr. McFarland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharmaceuticals. Dr. McFarland has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. The institution of Dr. McFarland has received research support from NIH, Michael J. Fox Foundation, Huntington Disease Society for America, CurePSP, and Mission MSA.. Dr. McFarland has received publishing royalties from a publication relating to health care. |
| Vivian Zhao | Ms. Zhao has nothing to disclose. |
| Sonja W. Scholz, MD, FAAN | Dr. Scholz has received personal compensation for serving as an employee of National Institutes of Health. An immediate family member of Dr. Scholz has received personal compensation for serving as an employee of National Institutes of Health. The institution of Dr. Scholz has received research support from National Institutes of Health. The institution of an immediate family member of Dr. Scholz has received research support from National Institutes of Health. An immediate family member of Dr. Scholz has received intellectual property interests from a discovery or technology relating to health care. Dr. Scholz has a non-compensated relationship as a Scientific Advisory Council Member with Lewy Body Dementia Association that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Editorial Board Member with JAMA Neurology that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Editorial Board Member with Journal of Parkinson's Disease that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Scientific Advisory Board Member with Mission MSA that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Scientific Advisory Board Member with The GBA1 Canada Initiative (G-Can) that is relevant to AAN interests or activities. |
| Huw R. Morris, MD, PhD | Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprinoia. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Morris has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Personal injury / Negligence cases. The institution of Dr. Morris has received research support from Parkinson's UK. The institution of Dr. Morris has received research support from Michael J Fox Foundartion. The institution of Dr. Morris has received research support from Cure Parkinson's Trust. The institution of Dr. Morris has received research support from PSP Association. The institution of Dr. Morris has received research support from CBD Solutions. The institution of Dr. Morris has received research support from Drake Foundation. The institution of Dr. Morris has received research support from Medical Research Council. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Cure PSP that is relevant to AAN interests or activities. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Parkinson's UK that is relevant to AAN interests or activities. |
| Martha A. Nance, MD | Dr. Nance has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Voyager. Dr. Nance has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROche. Dr. Nance has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Nance has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. An immediate family member of Dr. Nance has received stock or an ownership interest from Fresca. The institution of Dr. Nance has received research support from HDSA. The institution of Dr. Nance has received research support from Parkinson Foundation. Dr. Nance has received research support from Parkinson Foundation. The institution of Dr. Nance has received research support from Neuraly. Dr. Nance has received personal compensation in the range of $500-$4,999 for serving as a speaker with AAN. |
| Niccolo Mencacci, MD, PhD | The institution of Dr. Mencacci has received research support from NIH. |
| Tatiana Foroud, PhD | The institution of Dr. Foroud has received research support from NIH. The institution of Dr. Foroud has received research support from Michael J. Fox Foundation. The institution of Dr. Foroud has received research support from Parkinson Foundation. Dr. Foroud has received personal compensation in the range of $500-$4,999 for serving as a Member of an Advisory Committee with Mayo Clinic, University of Pennsylvania, Allen Institute, Mt. Sinai, Van Andel Institute. |
| Laura Heathers, BA, CCRP | Mrs. Heathers has nothing to disclose. |
| Jennifer Verbrugge | Jennifer Verbrugge has nothing to disclose. |
| Mandy N. Miller, MS, CGC | Mrs. Miller has nothing to disclose. |
| Maysen Mesaros | Maysen Mesaros has nothing to disclose. |
| Lawrence S. Honig, MD, PhD, FAAN | Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Honig has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Honig has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Dr. Honig has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms . The institution of Dr. Honig has received research support from Roche. The institution of Dr. Honig has received research support from Eisau. Dr. Honig has received research support from Alector. The institution of Dr. Honig has received research support from Transposon. |
| Anthony E. Lang, MD, FAAN | Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care. |
| Paolo M. Moretti, MD | The institution of Dr. Moretti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Inc. The institution of an immediate family member of Dr. Moretti has received research support from NIH. The institution of an immediate family member of Dr. Moretti has received research support from VHA. The institution of an immediate family member of Dr. Moretti has received research support from DOD. |
| Kristophe Diaz, PhD | Dr. Diaz has nothing to disclose. |
| Jennifer Brummet, PhD | Dr. Brummet has received personal compensation for serving as an employee of CurePSP. |
| Anne Marie A. Wills, MD | Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant, a CVS/Caremark company. Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi/Genzyme. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceuticals. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Wills has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx Pharmaceuticals. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharmaceuticals. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Wills has received research support from Parkinson's Foundation. The institution of Dr. Wills has received research support from Biogen. The institution of Dr. Wills has received research support from Roche/Genentech. The institution of Dr. Wills has received research support from BioSensics. |
| Chinyere Obasi, BA (researcher) | Mr. Obasi has nothing to disclose. |
| Catherine Martinez, Clinical Research Coordinator | Ms. Martinez has nothing to disclose. |
| Giulietta Riboldi, MD | The institution of Dr. Riboldi has received research support from Prevail Therapeutics. |
| Timothy Shepherd, MD, PhD | Dr. Shepherd has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medicolegal cases. Dr. Shepherd has stock in MICroStructure Imaging (MICSI). Dr. Shepherd has received intellectual property interests from a discovery or technology relating to health care. |
| Yilong Ma, PhD | The institution of Dr. Ma has received research support from AskBio. The institution of Dr. Ma has received research support from Aspen Neuroscience . The institution of Dr. Ma has received research support from Blue Rock . The institution of Dr. Ma has received research support from Bayer. |
| Christine Stahl, MD | Dr. Stahl has nothing to disclose. |
| David Eidelberg, MD, FAAN | Dr. Eidelberg has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for MeiraGTx. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TreeFrog Therapeutics. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Blue Rock Therapeutics, Inc.. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SANA Biotechnology, Inc. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bio Vie, Inc.. Dr. Eidelberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for KenaiTx, Inc.. Dr. Eidelberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspen Neuroscience. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oxford University Press. The institution of Dr. Eidelberg has received research support from The Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Eidelberg has received research support from Lupus Research Alliance. The institution of Dr. Eidelberg has received research support from National Institutes of Health. The institution of Dr. Eidelberg has received research support from Blue Rock Therapeutics. The institution of Dr. Eidelberg has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Eidelberg has received research support from The Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Eidelberg has received research support from National Institute of Allergy and Infectious Diseases. The institution of Dr. Eidelberg has received research support from Aspen Neurosciences, Inc. . The institution of Dr. Eidelberg has received research support from NIH. Dr. Eidelberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Eidelberg has received intellectual property interests from a discovery or technology relating to health care. |
| Steven Frucht, MD | Dr. Frucht has nothing to disclose. |
| Ivan Guan, MD | Dr. Guan has nothing to disclose. |
| Sujata P. Thawani, MD | Dr. Thawani has nothing to disclose. |
| Julia Greenberg, MD | Dr. Greenberg has a non-compensated relationship as a Editorial Board Member with Neurology Resident and Fellow Section that is relevant to AAN interests or activities. |
| Sophia T. Tong | Ms. Tong has nothing to disclose. |
| Kiril Kiprovski, MD | Dr. Kiprovski has nothing to disclose. |
| Aravind Ganesh, MD | Dr. Ganesh has received personal compensation in the range of $0-$499 for serving as a Consultant for Figure 1. Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Canada. Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Ganesh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Ganesh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Let's Get Proof (Collavidence Inc). Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生 (journals Neurology and Neurology: Clinical Practice). Dr. Ganesh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association (journal: Stroke). Dr. Ganesh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers (for Frontiers in Neurology). Dr. Ganesh has or had stock in SnapDx.Dr. Ganesh has or had stock in Collavidence Inc.Dr. Ganesh has or had stock in DataSimpl. The institution of Dr. Ganesh has received research support from Canadian Institutes of Health Research . The institution of Dr. Ganesh has received research support from Alberta Innovates. The institution of Dr. Ganesh has received research support from University of Calgary Centre for Clinical Research. The institution of Dr. Ganesh has received research support from Innovation 4 Health. The institution of Dr. Ganesh has received research support from Government of Canada INOVAIT. The institution of Dr. Ganesh has received research support from Campus Alberta Neuroscience. The institution of Dr. Ganesh has received research support from Alzheimer Society of Canada. The institution of Dr. Ganesh has received research support from Heart and Stroke Foundation of Canada. The institution of Dr. Ganesh has received research support from New Frontiers in Research Fund. The institution of Dr. Ganesh has received research support from Panmure House. The institution of Dr. Ganesh has received research support from Brain Canada. The institution of Dr. Ganesh has received research support from MSI Foundation. The institution of Dr. Ganesh has received research support from France Canada Research Fund. Dr. Ganesh has received intellectual property interests from a discovery or technology relating to health care. |
| Ratna K. Bhavaraju-Sanka, MD, FAAN | Dr. Bhavaraju-Sanka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Bhavaraju-Sanka has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. |
| Josephine Jacobs, PharmD | Mrs. Jacobs has nothing to disclose. |
| Colleen Barthol, PharmD | Mrs. Barthol has nothing to disclose. |
| Emily Mata, PharmD | Dr. Mata has nothing to disclose. |
| Rachel L. Ho, PhD | Dr. Ho has nothing to disclose. |
| Sotiris G. Mitropanopoulos, MD | Dr. Mitropanopoulos has nothing to disclose. |
| Melissa Armstrong, MD, MSc, FAAN, FAAN | The institution of Dr. Armstrong has received research support from National Institutes of Health. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. The institution of Dr. Armstrong has received research support from The Michael J. Fox Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has received personal compensation in the range of $500-$4,999 for serving as a DSMB member with National Institutes of Health. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities. |
| David Vaillancourt | David Vaillancourt has received personal compensation for serving as an employee of Automated Imaging Diagnostics. David Vaillancourt has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of David Vaillancourt has received research support from NIH. David Vaillancourt has received intellectual property interests from a discovery or technology relating to health care. |
| Stephen Coombes, PhD | Dr. Coombes has received personal compensation in the range of $10,000-$49,999 for serving as a partner with Neuroimaging Solutions LLC. |
| Jinhan Park | Mr. Park has nothing to disclose. |
| Racheed M. Mani, MD | Dr. Mani has nothing to disclose. |
| Liu Yang, PhD | Dr. Yang has nothing to disclose. |
| Jade Basem, BA | Ms. Basem has nothing to disclose. |
| Susan M. Fiore | No disclosure on file |
| Petar M. Djuric, PhD | The institution of Prof. Djuric has received research support from NSF. |
| Michael Egnor, MD | Dr. Egnor has nothing to disclose. |
| Fatemeh Amini, MScR | Miss Amini has nothing to disclose. |
| Jack Lawrence | Mr. Lawrence has received personal compensation for serving as an employee of Vitaccess. The institution of Mr. Lawrence has received research support from UCB. |
| Sally Vincent, MSc | Miss Vincent has nothing to disclose. |
| Tsitsi Monera-Penduka, PhD | Dr. Monera-Penduka has nothing to disclose. |
| Geraldine Hall, Bachelors | Ms. Hall has received personal compensation for serving as an employee of Vitaccess. The institution of Ms. Hall has received research support from UCB. |
| Alasdair Fellows, MSc | Mr. Fellows has nothing to disclose. |
| Mark Larkin, PhD | Dr. Larkin has received personal compensation for serving as an employee of Vitaccess. |
| Anna Scowcroft | Anna Scowcroft has received personal compensation for serving as an employee of UCB. Anna Scowcroft has stock in UCB. |
| Raphaelle Beau Lejdstrom | Raphaelle Beau Lejdstrom has received personal compensation for serving as an employee of UCB Frachim SA. |
| Natasa Savic | Mrs. Savic has nothing to disclose. |
| Saiju Jacob, MD, FAAN | Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Pharmaceuticals. Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharmaceuticals. Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Terumo BCT. Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argen X. Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. |
| Amanda Hayes, Patient expert | Mrs. Hayes has nothing to disclose. |
| Hongbo Yang, PhD | Dr. Yang has nothing to disclose. |
| Mandy Du, PhD | Dr. Du has received personal compensation for serving as an employee of Analysis Group. Dr. Du has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Analysis Group. |
| Xin Chen | Ms. Chen has received personal compensation for serving as an employee of Analysis Group. Ms. Chen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Analysis Group. |
| Glenn A. Phillips, PhD | Dr. Phillips has received personal compensation for serving as an employee of argenx. Dr. Phillips has stock in argenx. |
| Geke Zhu | Mr. Zhu has nothing to disclose. |
| Han Zhou | No disclosure on file |
| Wanying F. Wang | Miss Wang has nothing to disclose. |
| Yongbo Ma | No disclosure on file |
| Xiangtao Nie | No disclosure on file |
| Wenjing Qi | No disclosure on file |
| Lei Hao | No disclosure on file |
| Xiuming Guo | No disclosure on file |
| Júlia dos Santos Monteiro, MS | Dr. dos Santos Monteiro has nothing to disclose. |
| Mohammed B. Baker | Mr. Baker has nothing to disclose. |
| Haneen Aljaiuossi, MD | Miss Aljaiuossi has nothing to disclose. |
| Dina T. Badawi, MD | Dr. Badawi has nothing to disclose. |
| Mohammad O. Al-Khawaldeh, MD | Dr. Al-Khawaldeh has nothing to disclose. |
| Leen G. Alsayeh, OT | Ms. Alsayeh has nothing to disclose. |
| Yazan Badie Jalil EL-Dayeh | Mr. EL-Dayeh has nothing to disclose. |
| Sadeen Eid | Sadeen Eid has nothing to disclose. |
| Amer Jaradat, MD | Dr. Jaradat has nothing to disclose. |
| Jera Kruja, MD | Dr. Kruja has nothing to disclose. |
| Altin Kuqo, MD, PhD | Dr. Kuqo has nothing to disclose. |
| Hamza M. Ahmed, MBBS | Dr. Ahmed has nothing to disclose. |
| Quoc Bao Nguyen, MD | Mr. Nguyen has nothing to disclose. |
| Ahmad Al-Awwad, MD | Dr. Al-Awwad has nothing to disclose. |
| Bhrugav G. Raval, MD | Dr. Raval has nothing to disclose. |
| Philion L. Hoff | No disclosure on file |
| Jessica V. Amos, MD | Mrs. Amos has nothing to disclose. |
| Jordan Ellis | No disclosure on file |
| Joshua R. Ehrlich | Joshua R. Ehrlich has nothing to disclose. |
| Randall Pérez Rojas, MD | Dr. Pérez Rojas has nothing to disclose. |
| Viviana Binns Rojas, MBBS | No disclosure on file |
| Yuliana Montero Solano, MD | Dr. Montero Solano has nothing to disclose. |
| Gioconda Feoli Pacheco, MD | No disclosure on file |
| Daniel Quesada Astorga, MD | Dr. Quesada Astorga has nothing to disclose. |
| Ahmed Hamza, MD | Mr. Hamza has nothing to disclose. |
| Michelle Sigona, PhD | Mrs. Sigona has received personal compensation for serving as an employee of Insightec. |
| Jia-yi Wu, MD | Miss Wu has nothing to disclose. |
| Michael C. Irizarry, MD | Dr. Irizarry has received personal compensation for serving as an employee of Eisai, Inc.. |
| Christopher van Dyck, MD | Christopher van Dyck, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Christopher van Dyck, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Christopher van Dyck, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Christopher van Dyck, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. An immediate family member of Christopher van Dyck, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supurnus. An immediate family member of Christopher van Dyck, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Polaris Management Partners. The institution of Christopher van Dyck, MD has received research support from Roche/Genentech. The institution of Christopher van Dyck, MD has received research support from Eli Lilly. The institution of Christopher van Dyck, MD has received research support from Biogen. The institution of Christopher van Dyck, MD has received research support from Biohaven. The institution of Christopher van Dyck, MD has received research support from Eisai. The institution of Christopher van Dyck, MD has received research support from UCB. The institution of Christopher van Dyck, MD has received research support from Cerevel. The institution of Christopher van Dyck, MD has received research support from Janssen. |
| David Li | David Li has received personal compensation for serving as an employee of Eisai. |
| Shobha Dhadda | Shobha Dhadda has received personal compensation for serving as an employee of Eisai Inc. |
| Steven M. Hersch, MD, PhD | Dr. Hersch has received personal compensation for serving as an employee of Eisai Inc.. Dr. Hersch has stock in Voyager Therapeutics. The institution of an immediate family member of Dr. Hersch has received research support from NIH. Dr. Hersch has received intellectual property interests from a discovery or technology relating to health care. |
| Larisa Reyderman | Larisa Reyderman has nothing to disclose. |
| Lynn D. Kramer, MD, FAAN | Dr. Kramer has received personal compensation for serving as an employee of Eisai Inc. Dr. Kramer has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Eisai Co., Ltd.. |
| Shane Musick, MD | Dr. Musick has nothing to disclose. |
| Sai Varun Bethina, MBBS | Dr. Bethina has nothing to disclose. |
| Idha Sood | Dr. Sood has nothing to disclose. |
| BeLong Cho, MD, PhD | The institution of Prof. Cho has received research support from Korean National Evidence based healthcare Collaboration Agency. |
| Dustin Nowacek | Mr. Nowacek has received personal compensation for serving as an employee of Argenx. Mr. Nowacek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Mr. Nowacek has stock in Argenx. |
| Jin-Tai Yu, PhD | Prof. Yu has nothing to disclose. |
| Dustin Nowacek, MD | Dr. Nowacek has received personal compensation for serving as an employee of Argenx. Dr. Nowacek has or had stock in Argenx. |